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iCONVENTIONS AND NOMENCLATURE
In the text that follows, numbers appearing as a
54)
superscript, followed by a single bracket thus denote references, 
while those written in line with the text, between paired brackets 
thus (48) indicate drawings of chemical formulae, and may be referred 
to in the text as fstructure (48)*. In drawings of structure, 
stereochemistry is not implied unless specifically indicated; a 
thickened or dotted bond denotes a substituent located respectively 
above or below the plane of the paper.
Wherever possible, trivial names of steroids have been used 
in the text, the systematic names of which are given in the list 
below. In Tables 19-21 and in Appendix I, the following 
abbreviations of steroid types have been employed:-
A = Androstane
A* = Androstene
P
P* =
p.. :
Trivial Name 
Estetrol
Estradiol
Estriol
Estrone
Androstenedione
Androsterone
Dehydroepiandroster- 
one (DHA)
Dianabol
Etiocholanolone
Etiocholenic acid
Pregnane
Pregnene
Pregnadiene
Systematic Name
3,15c* ,16c* ,17)3 -Tetrahydroxy-estra-l,3,5(l0)- 
triene.
3,17)3 -Dihydroxy-estra-1,3,5(10)-triene.
3,16c* ,17^ 3 -Dihydroxy-estra-1,3,5(l0)-triene.
3-Hydroxy-estra-l,3,5(l0)-trien-17-one.
4-Androstene-3,17-dione.
3(* -Hydroxy-5 c*-androstan-17-one.
3)3 -Hydroxy-5-androsten-17-one.
17c* -Methyl-17|3 -hydroxy-1,4-androstadien-3-one 
3c* -Hydroxy-5^ -androstan-17-one.
1713 -Carboxy-4-androsten-3-one.
16(* -Hydroxydehydroepiandrosterone/
ii
Trivial Name
16 (* -Hydroxydehydroepiandrosterone 
(l6c*-0H-DHA)
16 P-Hydroxydehydroepiandrosterone 
(16(2>-0H-DHA)
16-Ketoandrostenediol (16-Keto-AD)
11-Ketoandrosterone
11-Ketoetiocholanolone
5d-Dihydrotestosterone
Testosterone
Aldosterone
Betamethasone
Cortexolone (Reichstein*s S) 
Corticosterone (Kendall,s B) 
Cortisol (Kendall*s F)
Cortisone (Kendall,s E)
Cortol
|3-Cortol
Cortolone
f3-Cortolone
11-Dehydrocorticosterone 
(Kendall,s A)
6,7-Dehydrodexamethasone
11-Deoxycorticosterone (DOC) 
Dexamethasone
Systematic Name
3 p ,16d -Dihydroxy-5-androsten-17-one.
3|3 ,16f3 -Dihydroxy-5-androsten-17-one.
3(3 ,17(3 -Dihydroxy-5-androsten-16-one .
3 c* -Hydroxy-5c* -androstane-11,
17-dione.
3<* -Hydroxy-5 -androstane-11,17- 
dione.
17p-Hydroxy-5c* -androstan -3-one.
17p -Hydroxy-4-androsten-3-one.
11 p,21-Dihydroxy-4-pregnene-3,20- 
dion-18-al.
9 c*-Fluoro-16 p -methyl-11 p ,17c* ,21- 
trihydroxy-l54-pregnadiene-3,20- 
dione.
17 c*,21-Dihydroxy-4-pregnene-3,20- 
dione.
1113 ,21-Dihydroxy-4-pregnene-3,20- 
dione.
lip ,17c* ,21-Trihydroxy-4-pregnene-
3,20-dione.
17 c*,21-Dihydroxy-4-pregnene-3,11,
20-trione.
5 p-Pregnane-3<* ,11 p ,17 c* ,20 c* ,21- 
pentol.
5p -Pregnane-3 c* ,11 p ,17 c* ,20p ,21- 
pentol.
3 c*, 17 c* , 20 c* ,21-Tetrahydroxy-5p- 
pregnan-ll-one.
3 c* , 17 c* ,20 p , 21-Tetrahydroxy-5 p - 
pregnan-ll-one.
21-Hydroxy-4-pregnene-3, 11,20- 
trione.
9c* -Fluoro-16 c* -methyl-11 (3 ,17 cC ,
21-trihydroxy-1,4,6-pregnatriene-
n  r \ O _l -• —j  J Z u - u ± Q t  its •
21-Hydroxy-4-pregnene-3,20-dione.
9c*-Fluoro-16d-methyl-11 p ,17c* , 
21-trihydroxy-l,4-pregnadiene-3,
20-dione.
Ill
Dihydrocortexolone (DHS)
l,2-Dihydro-6,7-
dehydrodexamethasone
Dihydrocortisol (DHF)
alio -Dihydrocortisol 
(allo-PHF)
Dihydrocortisone (DHE)
20 o*-Dihydroprednisolone
9c* -Fluorocortisol
6c* -Fluoroprednisolone
9d -Fluoroprednisolone
6 p-Hydroxycortisol
16c* -Hydroxypregnenolone 
17c* -Hydroxypregnenolone
21-Hydroxypregnenolone 
16c* -Hydroxyprogesterone 
17c* -Hydroxyprogesterone 
18-Hydroxyprogesterone
16-Ketopregnenolone 
Prednisolone
Prednisone
Pregnanediol
Pregnanetriol
Pregnanolone
Pregnenolone
Progesterone
T etrahydrocorticosterone
allo-Tetrahydrocortiscos- 
terone (allo-THB)
17c* ,21-Dihydroxy-513-pregnane-3,20- 
dione.
9 c* -Fluoro-16o*-methyl-11 p ,17oC ,21- 
trihydroxy-4,6-pregnadiene-3,20-dicne.
11p ,17 d ,21-Trihydroxy-5p -pregnane-
3,20-dione.
lip ,17d ,21-Trihydroxy-5c*-pregnane-
3.20-dione.
17c*,21-Dihydroxy-5p -pregnane-3,11, 
20-trione.
11 p ,17d ,20 c* , 21-Tetrahydroxy-l,4- 
pregnadien -3-one.
9d -Fluoro-11 (3 ,17d ,21-trihydroxy-4- 
pregnene-3,20-dione.
6c*-Fluoro-lip ,17c* ,21-trihydroxy-
1.4-pregnadiene-3,20-dione.
gc* -Fluoro-lip ,17d ,21-trihydroxy-
1.4-pregnadiene-3,20-dione.
6 p,lip ,17d,21-Tetrahydroxy-4-pregnene-
3.20-dione.
3 P j16 d-Dihydroxy-5-pregnen-20-one.
3 p,17c* -Dihydroxy-5-pregnen-20-one.
3 p,21-Dihydroxy-5-pregnen-20-one. 
16o*-Hydroxy-4-pregnene-3,20-dione.
17c* -Hydroxy-4-pregnene-3,20-dione.
18-Hydroxy-4-pregnene-3,20-dione.
3 p-Hydroxy-5-pregnene-16,20-dione.
lip ,17c* ,21-Trihydroxy-l,4-pregnadiene-
3.20-dione.
17c*, 21-Dihydroxy-l,4-pregnadiene-3,ll, 
20-trione.
5 p-Pregnane-3d ,20 c* — diol.
5p -Pregnane-3d ,17c* ,20c* -triol.
3C*-Hydroxy-5p -pregnan-20-one.
3p -Hydroxy-5-pregnen-20-one.
4 -Pregnene-3,20-dione.
(THB) 3 o* ,11 p,21-Trihydroxy-5 p -pregnan-20-one.
3 c*,11 p,21-Trihydroxy-5 d - pregnan-20- 
one.
iv/
Tetrahydrodehydrocorti costerone 
(THfl)
alio -Tetrahydrodehydrocorticos- 
terone (allo-THfl)
Tetrahydrocortisol (THF)
allo-Tetrahydrocortisol (allo-THF)
Tetrahydrocortisone (THE)
3 cA,21-Dihydroxy-5 |3 -pregnane- 
11, 20-dione.
3 cA , 21-Dihydroxy-5cA. -pregnane-11, 
20-dione.
3 cA ,llf3 ,17cA ,21-Tetrahydroxy- 
5 J3-pregnan-20-one.
3 cA ,11 [3 ,17cA ,21-Tetrahydroxy- 
5cA -pregnan-20-one.
3cA ,17cA ,21-Trihydroxy-5(3 - 
pregnane-11,20-dione.
SOURCES OF REFERENCE COMPOUNDS AND REAGENTS
v
Dimethyldiacetoxysilane - gift from Dr. 3.C. Orr, Huntington
Laboratory, Massachusetts General Hospital, 
Boston, U.S.A.
Sodium bismuthate - gift from Dr. O.K. Norymberski, Unit for
Endocrine Chemistry, Department of 
Zoology, the University, Sheffield.
The following reagents were donated by Dr. D.3. Outred
(Beecham Research Laboratories):
sec-Butoxyamine hydrochloride (1-Aminoxy-l-methylpropane hydrochloride) 
Isobutoxyamine hydrochloride (l-Aminoxy-2-methylpropane hydrochloride) 
Isopentoxyamine hydrochloride (l-Aminoxy-3-methylbutane hydrochloride) 
jn-Pentoxyamine hydrochloride (1-Aminoxypentane hydrochloride)
Other alkoxyamines were commercial samples.
5 d -Androstan-17-one, 5<d-pregnan-20-one and 16-dehydropregnenolone 
were gifts from Dr. G.F. Woods (Organon Laboratories, Newhouse, 
Scotland).
3^,11|2> -Dihydroxy-5-androsten-17-one and 3 ,11,16d-trihydroxy-
5-androsten-17-one were supplied by Dr. R.W. Kelly (MRC Cinical 
Endocrinology Unit, Edinburgh, Scotland).
The following steroids were donated by Professor W. Klyne and 
Dr. D.N. Kirk (MRC Steroid Reference Collection, Westfield College, 
London):-
5-Androstene- 313 ,16f3,17|3-triol 
3 |2> ,16p -Dihydroxy-5-androsten-17-one 
5-Pregnene - 3|3 ,17d ,20j3 -triol 
5-Pregnene - 3^ ,20d ,21-triol 
5-Pregnene - 3 , 20|3 ,21-triol
5-Pregnene - 3 (2>, 17 oL , 20d ,21-tetrol 
5 (2>-Pregnane - 3j3 ,16|2>,20d-triol 
3 ,11|2> -Dihydroxy-5 &-pregnan-20-one
3|3 ,16cL-Dihydroxy-5d -pregnan-20-one 
3{?> ,16d -Dihydroxy-5-pregnan-20-one 
3d ,17d -Dihydroxy-5|3 -pregnan-20-one 
3|3 ,17d -Dihydroxy-5d -pregnan-20-one 
3 |&,17d ,21-Trihydroxy-5-pregnen-20-one 
16d -Hydroxyprogesterone
vi
18-Hydroxyprogesterone
Professor E.C. Horning (Institute for1 Lipid Research, Baylor College 
of Medicine, Houston, Texas, U.S.A.) kindly supplied the following 
compounds:-
5-Androstene-3 |2»,11|3 ,17j3 -triol 
5-Androstene-3 |3 ,16 OC ,17c* -triol 
5-Androstene-3 f$ ,16 c* ,17/3 -triol 
3 /2>,16c* -Dihydroxy-5-androsten-17-one 
5-Pregnene-3 ^  ,16c*,20c* -triol
5-Pregnene-3 ,17c* ,20c*-triol 
3(3 ,16c* -Dihydroxy-5-pregnen-20-one 
3 ^ ,21-Dihydroxy-5-pregnen-20-one 
3^ , 1113 ,17 c* , 21-Tetrahydroxy-5-pregnen-20-one 
3 |3 ,16 c* ,17 c* ,21-Tetrahydroxy-5-pregnen-20-one 
5 -Pregnane-3 c* ,6 c* ,20/3 - triol 
5 /3 -Pregnane-3 jb ,20 jS,21-triol 
5 j3 -Pregnane-3 c* ,6c*-diol-20-one 
alio -THA 
alio -THB
Other steroids used in this work were commeccial samples, obtained
from the following suppliers:-
The Upjohn Co., Kalamazoo, Michigan, U.S.A.
Sigma Chemical Co. St. Louis, Missouri, U.S.A.
Koch-Light Laboratories Ltd. Colnbrook, Bucks, England.
Pfizer Ltd., Sandwich, Kent, England.
Eastman Organic Chemicals, Rochester, IM.Y. U.S.A.
B.D.H. Laboratory Chemicals Division, Poole, England#
Ikapharm, Ramat-Can, Israel.
Schwartz-Mann Inc., I\tew York, N.Y., U.S.A.
Fluka AG, Buchs, Switzerland.
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SUIWIARY
Steroids have, for many years, been recognised as an 
important class of compounds, because of their occurrence in 
almost all living systems and widespread use in pharmaceutical 
preparations. Many steroids, e.g. the corticosteroids, possess 
hormonal activity, and their analysis in biological fluids is 
consequently of considerable interest.
In the work described in this thesis, gas — liquid 
chromatography (GLC) and combined gas chromatography-mass 
spectrometry (GC-MS) were applied to the analysis of steroids of 
biological significance, with particular interest centring on the 
corticosteroid family. As a result of the thermal lability of 
many of these compounds, particularly those possessing the 
"dihydroxyacetone" side-chain, modification of the basic structure 
is a prerequisite in any gas-phase analytical procedure. Of the 
two•approaches currently employed in this area, namely oxidative 
cleavage of the corticosteroid side-chain, and conversion of 
functional groups to suitable derivatives, the latter technique 
was studied in some detail. The possible value of the 17&,21-anhydro 
(oxetanone) derivative in stabilising steroidal dihydroxyacetones 
for gas chromatography was investigated for fourteen representative 
examples of this type. Although these cyclic derivatives were 
found to possess desirable GC-MS properties, their application to 
analytical separations was hindered by the lack of a suitable 
preparative method. A number of other derivatives which have been 
described previously for the gas-phase separation of corticosteroids 
were also examined; these included trimethylsilyl (TMS) ethers, 
jD-methyloxime trimethylsilyl (MO-TMS) ethers, acetonides, 
dimethylsiliconides and cyclic boronate esters. These derivatives 
were compared with respect to their ease of preparation, stability, 
retention characteristics and mass spectra. The technique of/
2.
of "single ion monitoring" (SIM) was applied to the quantitative 
detection of five representative derivatives of Reichstein's 
Substance S. The sensitivity with which single, characteristic 
fragment ions in their mass spectra could be measured varied 
considerably between derivatives, the limit of detection in the 
most favourable case (the lick ,21-anhydro derivative) being 400 pg. 
However., the derivative of choice for general use was found to be 
•the MO-TMS ether, on account of its convenience of preparation, 
range of detectable concentration and applicability to all six 
types of corticosteroid side-chain.
In view of the above findings on the suitability of 
oxime-TMS ethers for the characterisation of steroids by GC-MS, 
several O^alkylhydroxylamines were evaluated as reagents for the 
conversion of reactive ketosteroids to their JD-alkyloxime derivatives. 
O^Butyloximes and _0-pentyloximes proved to be useful in this 
respect by virtue of their structurally informative mass spectra 
#nd the convenient increments in retention time accompanying their 
formation* particular, _0-isopentyloxime trimethylsilyl
(iPOr-TMS) ethers were of value in affording gas-phase "group" 
geparations of keto- from hydroxysteroids. This type of derivative, 
tpgether with the ^»benzyloxime trimethylsilyl (BO-TMS) ether, was 
applied to the GC-MS determination of urinary steroid profiles from 
neyjborn infants: samples from both normal and pathological cases
were examined. An advantage of the iPO-TMS ethers in profile 
analysis was that derivatives of steroidal diketones were eluted 
at normal operating temperatures, whereas di-BO derivatives remain 
undetected due to their excessively long retention times. In the 
"glucuronide" fraction from a normal infant, three such compounds 
ygre detected and partially characterised.
The results presented in this thesis confirm the scope 
and potential of GC-MS in steroid chemistry. In particular, the 
technique affords a highly powerful means by which complex mixtures,/
3.
mixtures, such as steroid hormone metabolites in urine, may be 
examined. The sensitivity and selectivity of GC-MS in this 
area may be enhanced by single or multiple ion detection 
methods, and by the use of high-efficiency GLC solumns. The current
development of relatively lou-cost GC-MS systems could well 
provide the clinical chemist with an invaluable tool for both 
routine analysis^ and metabolic research purposes.
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Fig c1: The biosynthesis of cholesterol (6).
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1.1 GENERAL INTRODUCTION
1.1.1 STEROIDS: THEIR OCCURRENCE AND SIGNIFICANCE
Steroids belong to a class of organic compounds known
as terpenoids or polyisoprenoids, a vast family of substances
which have one common link: they are (or are presumed to be)
biogenetically derived from the same parent "building block",
1-3)
the five-carbon "isoprene unit" (l). The biosynthesis of
cholesterol (6), a key intermediate in the formation of almost
all naturally occurring steroids, has been studied in great 
4 5)detail. 9 The pathway (fig.l) has been shown to proceed in 
four phases: synthesis of (-) mevalonic acid (2) from thiol
esters (mainly acetyl-Coenzyme A), formation of squalene (3) - 
essentially a polyisoprene chain - via pyrophosphate derivatives, 
and then stereospecific cyclisation. These three steps result,' 
in animals, in the formation of lanosterol (4) (while the closely 
related triterpenoid cycloartenol (5) is produced in plants). 
Finally, loss of three carbon atoms (though oxidative eliminations)
5
from the tetracyclic skeleton, and formation of the A  -stenol 
system produces cholesterol.
Cholesterol is present in practically all living 
organisms, and further elaboration of its structure (or of the 
structure of its immediate precursors) by, e.g. oxidation and
side-chain cleavage, affords a host of compounds, which may be
6 7)
grouped according to their basic structure (Table l). *
One such group, the steroid hormones, is of particular importance, 
and a brief discussion of the main types is relevant to the work 
presented later in this thesis.
r-OH r— OH
Cortisone (E) Cortisol (F)
11-Dehydrocorticosterone (a )
OH
HO
Corticosterone (B)
i— OH
HO.
Aldosterone
OH ■OH
0
rn°0H
11-Deoxycorticosterone (DOC) Cortexolone (S)
Fig.2: The adrenocortical hormones.
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1.1.2 THE STEROID HORMONES
This group comprises progesterone, the corticosteroids, 
androgens and estrogens (Table l).
Progesterone is a key intermediate in the biosynthesis 
of steroids with 21 or fewer carbon atoms. It is closely 
associated with the reproductive process in mammals, creating a 
favourable medium for the implantation of the fertilized ovum and 
the maintenance of pregnancy.
Fig. 2 shows the seven adrenocortical hormones which 
are produced by the human adrenal gland. Of these, cortisol, 
corticosterone and aldosterone are the three principal 
corticosteroids secreted into the bloodstream. These compounds 
have profound effects on many metabolic processes in animals and 
possess two main types of activity: mineralocorticoid activity,
where the electrolyte balance is controlled through sodium 
retention, and glucocorticoid activity, which deals with protein 
catabolism. While aldosterone is the most potent mineralocorticoid, 
cortisol is the prominent glucocorticoid hormone.
The androgens are steroids and result from the 
complete removal of the side-chain attached to C-17 in cholesterol. 
They stimulate the development of the male reproductive organs 
and secondary sex characteristics, and also possess anabolic 
activity.
Finally, the estrogens are the corresponding female 
sex hormones. Their biosynthesis from Cig precursors involves 
oxidative elimination of the C-19 methyl group, followed by 
aromatisation of ring A. During pregnancy, estrogens act with 
progesterone to maintain gestation.
In addition to the naturally occurring hormones, a/
OAc  OH
AcO'
(7 ) (8 )
ROHO
(9)
“ OH
CO
HO O'HO
HO
Pregnanediol 3-glucuronide
0
O S O
Dehydroepiandrosterone sulphate
Fig.3: Steroid Conjugates.
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a large number of synthetic analogues have been produced by the
pharmaceutical industry for therapeutic use. The demonstration,
in 1949, of the anti-arthritic effects of cortisone acted as a
powerful stimulus to drug research. However, attempts to separate
the beneficial anti-inflammatory properties of corticosteroids
from their glucocorticoid activity have been largely unsuccessful.
In view of the undesirable side-effects associated with
corticosteroid therapy, the present trend in pharmaceutical research
is towards non-steroidal anti-inflammatory drugs. However, analogues
of progesterone, e.g. ethynodiol diacetate (7) have found widespread
use as ovulation inhibitors. When combined with a small amount of
an estrogen, such as the synthetic compound mestranol (8),
highly effective oral contraceptive preparations result.
Diosgenin (9), from Mexican barbasco root (Discorea tubers), is an
important starting material for the commercial preparation of
synthetic hormones. Degradation of this sapogenin affords 16-
dehydropregnenolone acetate (10: R=Ac) from which a variety of
8 )
C ^  and C^g steroid hormones can be prepared.
1.1.3 METABOLISM OF STEROID HORMONES
The metabolism of corticosteroids in man occurs primarily 
in the liver and takes place in two stages. Firstly, the hormone 
is inactivated by reduction of the 0C, J3> - unsaturated carbonyl group 
to yield predominantly the 3c* -hydroxy-5p-pregnane derivative. 
(Reduction at C-20 may also occur). Secondly, the 3rt-hydroxyl 
group is conjugated, through the action of a glucuronosyl 
transferase and uridine diphosphoglucuronic acid (UDP-glucuronic 
acid).9  ^ This yields the water-soluble glucuronide (fig. 3) 
which is finally excreted, via the kidneys, into the urine.
OH
Cortisol (F)Cortisone (E)/
DHE
THE
OH
OH
Cortolone
HO
H allo-DHF DHF
^0 H allo-THF ^ THE
OH
i-CortoloneP
A
Blood
Urine
Y
Cortol
u o
HO' ^
p-Cortol
Fig.4i The metaholism of cortisol.
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A minor fraction is also conjugated with sulphuric acid, transferred
from 3-phosphoadenosine 5-phosphosulphate (PAPS) by a sulphokinase 
9)
enzyme , while an even smaller amount of the parent hormone is 
excreted either unchanged, or as its 6^-hydroxylated derivative.
The major metabolites of cortisol (F), readily interconvertible in 
the body with cortisone (E), are shown in fig.4. Analogous 
metabolites are obtained from corticosterone (B) and dehydrocor­
ticosterone (A), while the principal aldosterone metabolite is the 
3a, 5^-tetrahydro compound.
An alternative pathway for the metabolism of 17-hydroxylated 
corticosteroids involves degradation to the corresponding
17-ketosteroid; this provides a route to the androgens, which are 
themselves metabolised by reduction and subsequent conjugation. 
Androgens with a 3^-hydroxyl group, such as dehydroepiandrosterone 
(DHA) are generally excreted as sulphate conjugates (fig.3).
The estrogens may be combined with sulphuric or glucuronic 
acid, or both. The sulphate group is invariably attached to C-3, 
but the glucuronide moiety may be conjugated with any of the free 
hydroxyl groups of estrogens.
1.1.4 THE ANALYSIS OF STEROIDS IN URINE
In order to obtain an indication of the rate of steroid 
production from a given endocrine gland, e.g. the adrenal gland, 
numerous methods have been devised for the estimation of hormone 
metabolites in urine. This approach, however, assumes the existence 
of a direct relationship between the level of active hormone in 
blood and that of its inert metabolite in urine,^^and it is 
essential for the validity of urinary assays that some fairly 
constant relationship does exist between the two. Furthermore/
9.
Furthermore a certain urinary metabolite may originate' from more
than one source; a given hormone may be secreted by various*
glands, while different hormones may ultimately give rise to the
same urinary metabolite. Consequently, results based on urinary
steroid levels should be treated with some cabtion when assessing
endocrine performance.
R. Borth"^ has suggested four criteria by which the
validity of a given analytical method may be judged. These are:
Precision - the measure of agreement between replicate
estimations.
Accuracy - the extent of agreement between the measured amount
and the actual amount of compound in the sample.
Sensitivity - the least amount of the substance which can be
measured.
Specificity - the extent to which the procedure measures only
the substance in question.
The use of modern analytical methods has greatly improved
specificity in steroid assays, although accuracy can still be a
problem due to uncertainties in the techniques used for sample
preparation.
Normally, procedures for the analysis of steroids in
urine entail three stages. Firstly, steroid conjugates are cleaved;
sulphate esters may be solvolysed, while glucuronides require a
hydrolysis step - this may be achieved either by treatment with
hot mineral acid, or, preferably, by incubation with a suitable
enzyme preparation. An advance in this area came with the
introduction of Amberlite XAD-2, a neutral, cross-linked polystyrene 
12)resin. On passing a urine sample through a column of this
material, free steroids and their conjugates are selectively 
retained, while other components e.g. urea and uric acid, are 
eluted. The steroid fraction is recovered by washing the 
column with an alcohol, such as/
Name of 
Reaction Substrate Reagent
Product and 
max.
Ref.
Kober estrogens hydroquinone in
aq. H SO,
H 2 4
oxidised form 
515-520nm
16,
17
Zimmermann 17-ketosteroids m-dinitro- 
benzene in 
alkali
N02
520nm
18,
19
Tetrazolium 20,21-ketols blue
tetrazolium
a formazan 
525 nm
20,
21
Porter-Silber 17 a,21-diol- 
20-ones
phenylhydrazine
in aq. H SO,
M 2-4
phenylhydra-
zone
410 nm
22,
23
Table 2: Principal colour reactions in steroid analysis.
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as methanol, and the conjugates are hydrolysed as before. This 
procedure thus eliminates many non-steroidal impurities at an 
early stage. Quantitative aspects of steroid losses on XAD-2, 
either by non-adsorption or by failure to elute, have been studied 
by 3.A. Luyten Using "^C-estriol and "^C-DHA, recoveries of
99% and 88^, respectively, were obtained from the column.
Secondly, a fractionation or purification step is often 
desirable to reduce the complexity of the mixture and to eliminate, 
as far as possible, material which may interfere with the subsequent 
analysis. Various chromatographic techniques have found widespread 
application in this connection, e.g. column chromatography on 
alumina or silicic acid, paper chromatography and thin-layer 
chromatography. A combination of some of these techniques 
is frequently necessary to obtain extracts of sufficient purity, 
depending on the analysis procedure chosen.
Thirdly, the individual steroids, or groups of structurally- 
related steroids of interest, are determined using an appropriate 
method. Host of the classical methods for steroid determination 
(many of which are still in routine use) centre on the colour reaction 
produced when some specific reagent reacts with a group of steroids, 
each of which possesses a particular structural feature. The 
intensity of the colour produced is directly proportional to the 
amount of substrate present, and may be measured by colorimetric 
methods. The four most important colour reactions in steroid 
analysis are summarised in Table 2.
Numerous variations on these basic procedures, aimed at 
increasing the sensitivity and specificity of the original method, 
have been published. For example, the Zimmermann reaction may be 
extended to determine the so-called "17-ketogenic" steroids,/
('1)
(1 2)
(13)
OH
OH
X
i j
OH
0
OH
J
BiO 0
(14)
liadi : Side-chain cleavage uith bismuthate,
BiO
no reaction
(15)
>
(14)
Fig-6 : Reduction - oxidation sequence for 20, 17-ketols.
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steroids, which possess 17c*,20-diol (ll), 17oC, 20,21-triol (12), or
17(X, 21-diol-20-one (13) side-chains (fig. 5). These compounds
undergo oxidation uith sodium bismuthate, uhich results in side-chain
cleavage and formation of the corresponding 17-ketones (14).25’26^
Thus, an analysis of the 17-ketosteroid content of aliquots of an
extract prior to, and after bismuthate oxidation affords an estimate
27 28)of these types of adrenal steroids. * ' A further elaboration of
this approach is described by Appleby et al.29\  uhere a sodium
borohydride reduction precedes the bismuthate cleavage. In this
determination, 20 , 17-ketols (15) are also included since they are
reduced to the 17c(, 20-diols and therefore also undergo subsequent
oxidation to the 17-ketones (fig.6). Furthermore, the 17-ketosteroids
present in the original extract are reduced to 17-hydroxysteroids, so
that in the final Zimmermann reaction one obtains a measure only
of 17-hydroxylated corticosteroids. Alternatively, 20,17-ketols
may be selectively determined by a three-step bismuthate/borohydride/
30)bismuthate sequence (fig.6.). The 17-ketosteroids so produced
originate only from this type of side-chain. Revieus of these
selective degradations of various corticosteroid side-chains are
31) 24)
given by O.K. Norymberski and in the textbook by A.I. Scott.
Ultra-violet spectrometry may be used to quantify
4
steroids possessing a suitable chromophore, theA-3-one being the
most common system, uhile methods based on fluorescence have been
32) 33)applied to the determination of e.g. cortisol and the estrogens.
However, all analytical procedures uhich depend on the measurement
of light absorption (or emission) suffer from the disadvantage that
trace impurities frequently interfere uith the determination.
Consequently, meticulous purification of extracts is often necessary
prior to the final estimation. Nevertheless, these classical /
12.
classical methods are considered to yield data sufficiently
accurate for diagnostic purposes in many cases.
Techniques based on radioisotopic dilution procedures
have proved valuable in the estimation of certain steroids which
are normally present in biological fluids at very low concentrations,
6»q. a l d o s t e r o n e . A  higher degree of sensitivity, and also
selectivity, may be achieved by this method. In recent years,
however, considerable interest has focused on assay procedures
which utilise the interaction between steroids and specific
binding proteins. These methods are known as saturation analysis
techniques; the term competitive protein binding (CPB) is used
where the protein is a natural binding protein, and radioimmunoassay
where the protein is an antibody. Minute amounts (l0-100pg) of
some hormones may be estimated in this way, and although the
procedures were initially developed for plasma samples, they have
been shown to be equally applicable to urinary extracts. A feature
which often complicates such analyses is the presence of interfering
binding proteins, or interfering steroids, in the sample under
study. Rigorous pre-purification of the extract is therefore
necessary, and chromatography on Sephadex LB-20 has been found
35 36)useful in this respect. ’ Thus, CPB and radioimmunoassay 
offer highly sensitive and selective methods for the determination 
of those steroids for which a suitable binding protein exists.
General details of these methods are given in reviews by
3 7 \ 38 )
Diczfalusy and Midgley and Niswender.
1.1.5 GAS-LIQUID CHROMATOGRAPHY (GLC) AMD COMBINED GAS CHROMATOGRAPHY - 
MASS SPECTROMETRY (GC-MS) IN STEROID ANALYSIS
39) /Although GLC was introduced in 1952, it was not /
not until several years later that the first application in
the steroid field was reported.40  ^ Significant early deve-lopments
in the technique were those of columns containing 1-3$ of
41)
thermostable polysiloxane stationary phases, 1 and the flame
42)
ionisation detector 7 for quantitative work with small
(jjig or sub-jj.g) samples. The introduction of derivatives,
4 3 )
particularly trimethylsilyl ethers, was found to overcome
many of the problems associated with the low volatility of steroids,
and their susceptibility to decomposition on GLC columns.
Accurately determined retention data were shown to be of great
value for characterisation and structural elucidation purposes,
and have been widely applied in the steroid field. These advances,
4 4 )
together with improved methods of column preparation, led to a
rapid increase in the use of GLC in steroid analysis.
Greater sensitivity has subsequently been achieved by
4 5 )
the use of the electron capture detector (ECD) in conjunction
yith suitable aromatic and halogen-containing derivatives, e.g.
phloroacetates, ^*^7) chioromethyl dimethylsilyl ethers ^®^and
49)heptafluorobutyrates. By this method, detection limits of
50)the order of 5pg may be attained. However, where such high 
sensitivity is desired, a more extensive sample pre-purification 
is necessary, together with a modified GLC injection system 
incorporating a by-pass valve to eliminate the solvent front.
The next major advance in the gas-phase analysis of 
steroids came with the development of the mass spectrometer as a 
GLC detector. In some aspects, the ^ fluent from a GLC column is 
suitable for study by a mass spectrometer i.e. the sample is eluted 
in a gaseous state, separated from other components of the mixture, 
and present in amounts (normally l-5^ ig) which are adequate to/
to yield interpretable mass spectra. However, the high gas flow
and relatively low sample concentration in the column effluent are
undesirable features. Some form of interface between the two
instruments was clearly necessary, particularly as the operating
pressure in a mass spectrometer ion source is in the region of 
-9
10 atmospheres. Further criteria for the mass spectrometer as a
GLC detector were that the scan must be fast enough (1-5 sec) to
be completed before the composition or concentration of the
effluent changed significantly. Also the accessible mass range
for steroid work had to be at least 1-750 atomic mass units (a.m.u.)
These problems were effectively overcome by the development of the
51)"molecule separator" and quick-scan system of R. Ryhage, which
resulted in the creation of the first practical GC-flS system for
steroids. Thus, the combined technique involves the separation of
a mixture and the study, by mass spectrometry, of its components.
By- the use of suitable internal standards, quantification and
positive identification of individual compounds may be achieved.
(The role of derivative formation in structural studies will be
discussed in section 3). The potential of the method, especially
for the analysis of complex mixtures such as one obtains in
52 53)
biological fluids, was quickly appreciated. * The mixed
JD-methyloxime-trimethylsilyl ether (HO-THS) derivatives, introduced
54)by Gardiner and Horning, stabilised the thermally-labile
"dihydroxyacetone" side-chain and hence permitted the direct 
analysis of corticosteroid metabolites in urine. By employing 
a temperature-programmed GLC separation, a urinary steroid 
"profile" could be obtained, affording a multi-component analysis 
of androgen, estrogen and corticosteroid (as well as drug) 
metabolites.55-57  ^This facility to determine simultaneously/
15.
simultaneously individual hormone metabolites is highly desirable 
for diagnostic purposes. Thus, while variations in the urinary 
levels of certain structurally-related compounds may indicate a 
certain pathological condition, group determinations based on 
colour reactions would fail to detect any alteration in the normal 
metabolic process where the total values lie within the normal 
range.
The sensitivity and specificity of a GC-flS combination 
may be greatly enhanced by the techniques of single ion 
monitoring (SIFl)^ and multiple ion detection (HID)
When used in the former mode, the mass spectrometer is focused to 
detect ions of a single m/e ratio, which are chosen to be sufficiently 
characteristic of the compounds concerned. Detection limits in the 
order of 15-20pg have been obtained by this method in suitable 
cases.^*67) jn multiple ion detection, two or more ions (within a 
moderate range of m/e values) may be measured by alternate focusing; 
when employing this mode of operation, one of the ions monitored is 
frequently the corresponding ion of a deuterated analogue introduced 
as an internal standard.
In conclusion, it may be said that the combined technique 
of GC-MS is one of the most powerful analytical tools available 
to the chemist. Currently its capabilities are being expanded by
the use of high-efjficiency capillary GLC columns,
71) 72)quadrupole-type mass spectrometers, chemical ionisation sources,
57 73, 74)
and data processing by computers.w*’ * Some applications of the
technique in steroid chemistry will be presented in the following 
sections.
16.
1.2 GENERAL EXPERIMENTAL METHODS
1.2.1 CHROMATOGRAPHIC AND SPECTROSCOPIC PROCEDURES *
Thin-layer chromatography (TLC) was carried out on glass
plates (20x20cm or 5x20cm), coated u/ith "Kieselgel-G" (E. Merck
AG, Darmstadt, Germany), using 0.25mm layers for analytical
purposes and 1.00mm layers for preparative use. The following
reagents were used for the detection of bands:-
5% (w/v) Ceric sulphate in 10^ sulphuric acid - after spraying
the developed chromatograms uith this reagent, the plates were
heated in an oven at 130° for 1-2 min. This gave rise to
coloured bands, the colours frequently being diagnostic for the
compounds present. Prolonged heating of the chromatograms,
however, caused the bands to turn black or brown.
2,4-Dinitrophenylhydrazine - this was used for the detection of
compounds containing free aldehyde or keto groups, which stained
yellow or orange without heating. The reagent was prepared by
suspending lg of powdered 2,4-dinitrophenylhydrazine in 30ml of stirred
methanol, and cautiously adding 2ml of concentrated sulphuric acid.
Iodine-vapour - brief exposure of the chromatogram to iodine
vapour was sufficient to locate the bands. This method was used
routinely in preparative TLC, being non-destructive in nature.
An alternative procedure for preparative work was to use
silica gel with an added fluorescent material - "Kieselgel ^ 254"*
In this case, bands were located by their quenching of the fluorescence
of the modified layer when viewed under an ultraviolet lamp. This
method is highly sensitive for compounds containing a chromophore,
4
and was found particularly suitable for the detection of A  -3-keto 
steroids.
* These details are generally applicable throughout this thesis.
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Gas-iiquld chromatography (GLC) was performed on one of the three
dual-column instruments listed in Table 3, each of which was fitted
with flame ionisation detectors. Columns were made up from Pyrex
glass tubing, 3mm i.d., and were 5ft, 6ft, or 12ft in length.
44)Packings were prepared by the methods of Horning et al_., ' using the
following stationary phases
1. 1$ OV/— 1 and 1$ SE-30 (Methyl siloxane polymers)
2. 1$ OV-17 (phenyl/methyl siloxane polymer (50$ phenyl) )
3. 1$ Dexsil -300 GC (poly - rn - carboranylene siloxane)
The 0V-1, SE-30 and OV-17 phases were obtained from 
Applied Science Laboratories Inc., State College, Pennsylvania, U.S.A., 
while the Dexsil - 300GC was supplied by Analabs Inc., North Haven, 
Connecticut, U.S.A. In all cases, the solid support used was Gas 
Chrom Q, 100-120 mesh (Applied Science Laboratories Inc.).
Samples for GLC were prepared, mainly in ethyl acetate 
solution, at a concentration of 1-3 mg/ml. Aliquots ranging from
0.2 - 5yj.1 in volume were injected by means of a lOjxl Hamilton syringe. 
Nitrogen was used as the carrier gas, with a flow rate of 40 ml/min, 
and the injection port heaters were maintained at temperatures between 
20° and 50° higher than that of the analyser oven.
n - Alkanes, co-injected with the samples, were used to
standardise the retention data of the steroids studied: the values
✓ . . .  75)are expressed as Kovats retention indices.
Mass spectra were recorded, at electron energies 22.5 eV 
and 70 e\/, using an LKB 9000 gas chromatograph - mass spectrometer 
(LKB-Produkter AB, Bromma, Sweden). This instrument is equipped 
with a two-stage jet separator of the Becker-Ryhage type which enables 
removal of 99$ to 99.5$ of the carrier gas (helium) and retention of 
50$ to 75$ of the sample eluted from the gas chromatographic column.
IS.
The separator and ion source were maintained at 250-270°, and a 
carrier gas flou rate of 25-35 ml/min was used. The trap current 
was 60jJ.A, accelerating voltage 3.5KV, electron multiplier voltage
2.1 KV; exit slit, 0.2mm; entrance slit, 0.12mm. Spectra uiere 
obtained using a recording oscillograph, and uith a scan time of 
approximately 5 sec. The gas chromatographic columns used in this 
instrument uere glass spiral columns, 6ft or 12ft in length, uith
i.d. 0.3mm.
Single ion monitoring uas carried out, at 22.5eV, uith a 
Rikadenki dual pen potentiometric recorder. An output from the 
galvanometer amplifier of the mass spectrometer uas connected via 
a 2.5cps filter (in the accelerating voltage alternator unit) to one 
pen set on the 10V fsd range and offset to the centre of the chart 
paper. The total ion current (T.I.C.) uas simultaneously monitored 
uith the second pen, set on the 10m\/ fsd range. The T.I.C. attenuation 
and electron multiplier voltage uere selected to give recordings of 
suitable amplitude on the chart paper. Much of the electrical 
"noise" originating in the electron multiplier uas filtered via a 
25,000yuF capacitor.
For samples unsuited to GLC, mass spectra uere recorded on
an AEI MS-12 mass spectrometer, at electron energy 70eV.
High resolution mass spectrometry uas carried out on an AEI MS9D2
instrument, uith direct probe sampling, at electron energy 70eV.
Infra-red spectra uere obtained using a Unicam SP1000 or 
Perkin-Elmer Model 257 spectrophotometer.
N.M.R. spectra uere recorded at 100 MHz uith the Varian 
Model HA-100 spectrometer, and at 60 MHz uith the l/arian Model T-60 
spectrometer.
Melting points uere determined on a Kofler micro hot stage.
19.
Thanks are due for the services of Mr. 3.M.L. Cameron and 
Miss F. Cowan for microanalyses, Mrs. F. Laurie (infra-red 
laboratory), Mrs. 3. Borthuick and Dr. R.C. Glass (GC-MS), and 
Mr. A. Heitzmann and Mr. 3. Gall (|\1MR). The line diagrams which 
appear in this thesis were drawn with the aid of a computer program 
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GENERAL CHEMICAL TECHNIQUES
1.2.2 PREPARATION OF MANGANESE DIOXIDE 76^
A solution of potassium permanganate (l5g) in water (200ml) 
uas added dropwise to a stirred solution of manganous sulphate (21g) 
in water (30ml), held at 90°. The addition took place over a period 
of l^h, during the last 30min of which aliquots (approx. 1 ml) were 
withdrawn from the reaction mixture, centrifuged and the supernatants 
examined. As soon as a faint pink coloration uas observed, addition 
of permanganate uas stopped, and the reaction mixture stirred for a 
further 15 min at 90° before being cooled to room temperature.
The chocolate-brown precipitate of manganese dioxide was 
collected by filtration, washed with hot water (500ml), then 
methanol (100ml) and finally ether (100 ml). The product was then 
dried overnight at 130°, and finely powdered prior to use. Total 
yield of manganese dioxide uas 17.5g.
1.2.3 PREPARATION OF 17fl, 20c* - AND 17o(, 20p> - DIHVDROXY - 4 - PREGNEN
77)-3- ONE 1
( a ) ^i^t^h^um^Al^umi^nijjrT^Jiily^dr^^^^^B^du^^^o^^o^^^^T^Hj^ ^^^^j/^r^g^st^cr^o^^
Lithium aluminium hydride (I74mg; 4.59 m mole) was placed 
in a 25 ml, three-necked, pear-shaped flask, equipped with dropping 
funnel and water condenser, and dry, redistilled tetrahydrofuran (THF;
5.5 ml) added. A solution of 17c* -hydroxyprogesterone/
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hydroxyprogesterone (97 mg; 0.294 m mole) in THF (3.0 ml) uas then 
added over a period of 5 min, uhen slight effervescence took place.
The contents of the flask uere heated under reflux for Tg- h, after uhich 
no starting material could be detected by analytical TLC (mobile 
phase: ethyl acetate/chloroform (1:1 v/v) ). Ethyl acetate uas
added to destroy excess reagent, folloued by saturated sodium sulphate 
solution (5 ml) and finally solid sodium sulphate (lg). The 
precipitated salts uere filtered off and uashed uith THF. Evaporation 
of the filtrate afforded the product (93 mg) as a colourless solid. 
Examination of this material by analytical TLC (Table 4) revealed tuo 
major spots (R^ 0.34 and 0.26), uhile GLC of the TMS ethers
(prepared by overnight reaction uith BSA) gave one broad peak on both
?3n° ?3n°
0V-1 and OV-17 aiumns (lQy  ^ = 29^5;  ^= 3095) and several minor
peaks uith louer retention indices. This mixture of reduction products
uas not separated at this stage, but uas used directly for the
follouing oxidation step.
(b) Manganese Dioxide Oxidation of the Reaction Product from (a).
The product from step (a) above (71mg) uas taken up in dry 
THF (3.8ml) and freshly prepared manganese dioxide (375mg) added.
The mixture uas then stirred at room temperature for 4h. The manganese 
dioxide uas removed by filtration through celite, uashed uith a little 
THF, and the combined filtrates uere evaporated yielding a pale yellou 
oil (60mg). This material again gave tuo major spots on TLC (Table 4), 
although these could nou be detected by both 2,4-dinitrophenylhydrazine 
reagent and ultraviolet light (X=254nm), confirming tho formation of 
a -3-one system. GLC of the TMS ethers (prepared as in (a) above)
23q°
gave a partly resolved doublet on 0V/-1 (igy  ^= anc ^2985) and a
23q°
single, broad peak on OV-17 (igy yj — 3315). Several early (minor) 
peaks uere also observed.
(c) Isolation of 17ft, 20ck - and 17oC, 20(5 -Dihydroxy -4-preqnen -3-one/
21.
The crude oxidation product from step (b) (50mg) was 
applied to two preparative TLC plates (20x20cm; 0.5mm Kieselgel
HF 5^)9 and the chromatograms developed using ethyl acetate/ 
chloroform (1:1 v/v) as mobile phase, uith a double elution. The
bands corresponding to 17<X, 20(X-dihydroxy-4-pregnen-3-one and the 
2 0 epimer were located with ultraviolet light ("X = 254nm) and 
extracted uith ethyl acetate. Evaporation of the solvent afforded 
22mg of the less polar (20 |5 ) isomer, and llmg of the more polar 
(20c* ) isomer.
17(X, 2Dft-Dihydroxy-4-preqnen-3-one, recrystallised from acetone, 
gave broad crystals (l9mg) m.p. 203-206° (lit. 204-205.5°). Infra-red:
^max (KBr) 3478 cm  ^ (broad, s), 1647 cm  ^ (vs) and 1614 cm ^(s).
225° +
GC-MS of the methylboronate ester (igy ^  = 3145) gave M * at m/e
356.
17cA ,20cA-Dihydroxy-4-preqnen-3-one, recrystallised from methanol, 
gave fine needles (5mg) m.p. 190-200° (lit. 208-210°). Infra-red:
■\) (KBr) 3427cm  ^(broad, s), 1658 cm  ^(vs) and 1610cm  ^(s).
fT )3X
225° +
GC-MS of the methylboronate ester (igy ^  =3170) gave M * at m/e 356.
1.2.4 HYDROLYSIS OF DIHYDR0XYACET0NE 21-flCETATES
In order to provide substrates for oxetanone formation 
(section 2.2), hydrolysis of the commercially available 21-acetates 
uas necessary in the cases of prednisolone and 9(X -fluorocortisol.
(a) Hydrolysis of Prednisolone Acetate (lift, 17CX ,21-trihydroxy-
78)
1,4 - pregnadiene - 3,20-dione 21-acetate)
Tuo solutions, one containing prednisolone acetate 
(201 mg, 0.502 m mole) in methanol (20 ml), and the other potassium 
bicarbonate (200mg) in distilled uater (2.0ml), uere bubbled (5min) 
uith nitrogen to remove dissolved oxygen. The solutions uere then 
mixed in a 100ml tuo-necked conical flask, equipped uith magnetic 
stirrer and nitrogen inlet. (At this point, some precipitation 
occurred, although this material re-dJ,ssolved as the reaction
22.
progressed.) The reaction mixture uas stirred, at room temperature 
and under a nitrogen atmosphere, for a period of 4h. (During this 
period, large aqueous globules formed in the reaction mixture, in 
agreement uith the reported heterogeneous character of this procedure). 
Analytical TLC of the product (mobile phase: ethyl acetate/light 
petroleum, b.p. 60-80°, (4:1 v/v) indicated complete hydrolysis of 
the acetate.
3.1 ml of a solution containing glacial acetic acid (3ml)
in ice-uater (60ml) uas then added, and the resulting mixture
concentrated iin vacuo, uithout heating, and left overnight in the
refrigerator (5°). This produced a crop of fine, yellouish
needles, uhich uere collected by filtration, uashed uith a little
ice-uater and dried overnight in a vacuum desiccator (yield=114mg).
A second crop of crystals, amounting to 24mg, uas obtained by further
cooling of the filtrate. Total yield of prednisolone: 138 mg
(0.384 m mole, yield: 77^); Infra-red: Vmax (Nujol) 3400 cm 1
(m, broad), 1708 cnf^(m), 1658 cm ^(s), 1612 cm '^ (m), and 1590 cm ^(m).
(b) Hydrolysis of 90C -Fluorocortisol Acetate (9cX-fluoro-11 fi ,17<* ,21-
trihydroxy-4-preqnene-3» 20-dione 21-acetate).
This uas carried out in a similar fashion to that described
above for prednisolone acetate. In this case, 198mg of the acetate
afforded 116mg of 9c*. -fluorocortisol as colourless crystals in 6h%
overall yield. Infra-red: \) (Nujol) 3450 cm (m, broad),msx
1720 cm ^(m) and 1655 cm "^(s).
1.2.5 SOLVENTS AND REAGENTS ?9^
For large scale preparative uork, solvents of analytical 
grade uere used, uhile "Nancgrade" solvents (Mallinckrodt Chemical 
Works, St. Louis, Missouri) uere employed for the handling of small 
(less than 2mg) samples, and urinary extracts.
Acetone (BDH AnalaR) uas dried by distilling from anhydrous/
23.
anhydrous potassium carbonate.
Acetonitrile uas dried by shaking uith Linde type 5A molecular sieve 
and distilling from calcium hydride (b.p. 82°).
Benzene (BDH AnalaR, 300ml) uas purified by shaking uith conc.
sulphuric acid (50ml), folloued by uater (100 ml).
It uas then shaken uith 2I\I sodium hydroxide (100ml) and 
finally uater (100ml). Drying uas accomplished by 
distilling from calcium hydride.
Dimethylformamide uas dried by prolonged storage over Linde type 
4A molecular sieve, and redistillation.
Dimethyl sulphoxide uas dried by prolonged standing over either Linde 
type 5A molecular sieve or calcium hydride, folloued by 
distillation under reduced pressure (b.p. 40° at 0.6mm Hg).
1,4-Dioxan (BDH AnalaR) uas purified by distilling from sodium 
borohydride.
Hexane (BDH Spectroscopic grade) uas redistilled from sodium hydride.
Methylene Chloride uas purified by shaking uith calcium chloride, 
redistilling and storing over Linde type 5A molecular 
sieve.
Pyridine (b.p. 114°) uas redistilled from potassium hydroxide pellets 
and stored over calcium hydride.
Tetrahydrofuran (b.p. 67°) uas redistilled from lithuim aluminium 
hydride.
Reagents
o >
Calcium Chloride uas made anhydrous by heating at 85 /0.5mm Hg for 
17h.
Methanesulphonyl Chloride uas distilled from phosphorus pentoxide 
(b.p. 160-161°).
Silylating Reagents uere redistilled and stored under anhydrous
■ conditions. HMDS had b.p. 124°, BSA 148° and TSIM 214 •
__p_-Toluenesulphonic Acid uas recrystallised from benezene, and
dried by heating at 100° for 4h under uater pump vacuum. 
Triethylamine uas redistilled from calcium hydride (b.p. 91°). 
Triphenylphosphine uas dried overnight in a drying pistol,
uith phosphorus pentoxide as the dehydrating agent. 
Conditions uere 60° at 0.25mm Hg.
SECTION 2
OXETANONES AS DERIVATIVES FOR THE GAS CHROMATOGRAPHY OF 
STEROIDS WITH THE DIHYDROXYACETONE SIDE-CHAIN.
HIO
C O H
OH
(16)
(14)
Fig. 7: Oxidation of the dihydroxyacetone side-chain.
INTRODUCTION
Among the types of adrenocortical hormones normally 
encountered in biological fluids, those possessing the 17ds,21-diol-
20-one (dihydroxyacetone) side-chain (partial formula 13) constitute 
an important group. Many synthetic corticoids exhibiting anti­
inflammatory activity also incorporate this s t r u c t u r e . A n  
investigation into the GLC properties of such compounds revealed
that decomposition to the corresponding 17-ketosteroid occurred in
8l)the flash heater zone of the gas chromatograph. An application
of- this finding uas made by Luetscher and Gould, uho determined
urinary tetrahydrocortisone (THE), allo-tetrahydrocortisone (allo-THE)
and tetrahydrocortisol (THF) as their thermal cleavage products, and
reported good agreement uith the values obtained from colorimetric
estimations. Houever, quantitative studies of this thermal
dissociation indicated that the yield of 17-ketone uas in the order
of 20 to 30^, although the exact value depended on both the nature
of the parent corticosteroid and, to some extent, on the amount 
83-85)injected. ” It therefore appeared that modification of the
dihydroxyacetone structure in some uay uas desirable prior to the
quantitative estimation of such steroids by GLC. Tuo approaches
have been developed for this purpose: oxidative cleavage of the
side-chain (a reproducible process knoun to proceed in high yield) and
stabilisation of the parent molecule through derivative formation.
The dihydroxyacetone structure may be oxidised (fig. 7),
either by periodic acid to yield an etiocholenic acid derivative
(partial formula 16), uhich may be chromatographed follouing
methylation,^^ or by sodium bismuthate uhich completely removes the
26 )
side-chain affording the thermally stable 17-ketosteroid (14).
Both of these procedures have been successfully applied to the
analysis of complex mixtures of cortiscosteroids, uhen the respective
87,93)
oxidation products are estimated by GLC. ’
0
H
( 1 7 ) (18)
Fig. 8: Acid-catalysed rearrangement of 17a ,21-oxido steroids.
' T  I— OH 
0 — CHF=0 0 - C H
Fig. 9: Stabilisation of aldosterone through acetal formation.
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Numerous derivatives have been used, or proposed, to
stabilise steroidal dihydroxyacetones for GLC. The most widely
used of these are probably the JO -methyloxime trimethylsilyl ethers
(MO-TMS) introduced by Gardiner and Horning in 1966.^^ ■ However,
96 97)cyclic boronate esters and dimethylsiliconides, ’ in which 
the oxygen functions at C-17<x and C-21 are incorporated into a six- 
membered ring, have proved useful in many instances. A survey of 
existing corticosteroid derivatives is presented in section 3.
Currently derivative formation is preferred to the side- 
chain degradation of corticosteroids, since in the former case the 
identity of the parent steroid is conserved to a greater extent.
However, when the derivatives are to be analysed by a GC-MS system, 
their molecular weights must be taken into account. Conversion of 
a 17(X, 21-diol-20-one to its 20-M0 17cA, 21-diTMS derivative increases 
the molecular weight of the steroid by 173 a.m.u., while still 
further mass increments result from the derivatisation of functional 
groups elsewhere in the steroid nucleus. Derivatives of high 
molecular weight (greater than 700 a.m.u.) are undesirable for study 
by common low-resolution GC-MS instruments. Furthermore, 
derivatisation of corticosteroids, as opposed to side-chain cleavage, 
increases the GLC retention time, although this is usually less 
severe a problem. Hence, a derivative which stabilises the 
corticosteroid side-chain, and which has a low molecular weight 
and short retention time, would clearly be a welcome addition to 
the existing range. The object of this stuoy was to evaluate 
17&, 21-oxido steroids (partial structure 17) as derivatives which 
might fulfil these requirements.
The change in molecular weight accompanying oxetanone/
OH
-  HX
(21) ( 1 7 )
Fig. 10: Synthesis of 17a ,21-oxido steroids,
**Br
HO 0
K O H /  M e O H  
 >
D M S O  RO
(22) (23)
Fiq.ii; Synthesis of ring-B cholestane 3-oxetanones.
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oxetanone formation is - 18 a.m.u. ; this is the only known 
dihydroxyacetone derivative which has a lower molecular weight 
than that of the parent corticosteroid, although aldosterone (19) may 
be stabilised for GLC as its 18->11:21 acetal (20) 84\  where a 
similar molecular weight relationship exists.
The 17(*, 21-oxido (or 17c*, 21-anhydro) derivative
possesses an ether linkage and a carbonyl group in a strained
four-membered ring. This structural unit is known as a 3-oxetanone
system. The first report of a 17<X, 21-oxido steroid was in 1955,
when Allen jrt aL claimed that an oxetanone of this type resulted from
98)the acid-catalysed hydrolysis of the corresponding ethylene ketal. '
99 100)This claim was proved erroneous, however, by two groups * , who
synthesised the true 17<X, 21-oxido-20-one structure (17) and showed 
that it rearranged to a five-membered tetrahydrofuranone (18) when 
treated with acid (fig.8). During the period 1958-65, several 
preparations of 17(X, 21-oxido steroids were reported, mainly by groups 
at Merck, Sharp and Dohme and at Upjohn, who observed moderate oral 
diuretic and anti-inflammatory activity in these compounds.
In all cases, the oxetanones were synthesised by internal displacement 
reactions involving the 17(*-hydroxyl group and a leaving group 
(mesylate, tosylate, iodide or diazo function) at C-21 (fig. 10).
Basic catalysts (potassium fluoride, silver phosphate, silver 
dihydrogen phosphate or potassium hydroxide) were employed in solvents 
such as dimethyl sulphoxide (DMSO), dimethylformamide (DMF), 
acetonitrile or 1,4-dioxan. The yields of oxetanones under these 
conditions were low (or not quoted). More recently, a synthesis of 
ring-B cholestane 3-oxetanones (23) was reported,^88^in which C-3 
substituted 7oUbromo-5p -hydroxy-6-oxocholestanes (22) acted as 
substrates for oxetanone formation (fig. 11). In suitable cases, when 
the ring-A substituent occupied the 3 -position, yields in excess of 
70% were obtained. However, in spite of the low yields of 17cC, 21- 
oxido steroids quoted in published syntheses, it was decided to f
29.
to adapt one of these procedures'^^ as an initial route to compounds 
of this type. Following an investigation of their GLC and mass 
spectral properties, studies aimed at improving the yields of 
oxetanones from steroidal dihydroxyacetones were undertaken.
2.2 EXPERIMENTAL
30.
PREPARATION OE OXETANONES (.17ft, 21-ANHYDR0 DERIVATIVES) FROM 
STEROIDAL DIHYDROXYACETONES.
The general method is exemplified for the case of 
Reichsteints Substance S (l7cx, 21-dihydroxy-4-pregnene-3,20-dione):
2.2.1 Substance S 21-mesylate (l7cx, 21-dihydroxy-4-preqnene-3,20-dione
21-methanesulphonate) ^
Substance S (lOOmg; 0.29 m mole) was dissolved in dry 
pyridine (l.4ml) and the solution cooled to 0°. Methanesulphonyl 
chloride (10(^1) was then added dropwise and the reaction mixture 
held at 0° for 4h. Dilution with ice-water (10ml) produced a fine 
white precipitate, which was collected by filtration, washed with 
ice-water (2ml) and dried overnight in a vacuum desiccator. This 
afforded Substance S 21-mesylate (117 mg; 27.5 m mole) (Yield =
95$).
Analysis of the product by TLC, using as mobile phase 
ethyl acetate/light petroleum, b.p. 60-80°, (1:1 v/v), indicated 
the mesylate to be only slightly less polar than the starting 
material. (R^ values were : Substance S, 0.23; Substance S 21- 
mesylate, 0.27). After two recrystallisations-from benzene/light 
petroleum, b.p. 60-80°, the mesylate had m.p. 170-171°. Infra-red: 
(KBr disc) 3490 cm  ^ (m, broad), 1735 cm ^(s), 1665 cm  ^ (s),
max
1610 cm-1(m), 1355 cm_1(s), 1165 cm“1(s) and 1040 cm“1(s).
(Found, C: 62.09; H: 7.58$. Calc, for C22H32°63: Ci °2,22’ H:7.61$.)
2.2.2 17(X, 21-Anhydro Derivative of Substance S (l7at21-oxido-4-preqnene-
3,20-dione) ^
A suspension of anhydrous potassium fluoride (85mg) in 
dry redistilled dimethyl sulpnoxide (2.2ml) was made into a slurry 
by stirring for 2h at 70 • Substance S 21-mesylate/
mesylate (92mg; 21.7 m mole) was then add-ed, whereupon the
reaction mixture turned deep yellow. Stirring was continued under
anhydrous conditions overnight (l6h), during which time the
reaction mixture was maintained at 85-90°. The reaction was
quenched by pouring into ice-water (25ml) and the resulting turbid
solution extracted with ethyl acetate (3x25ml). The combined
organic extracts were washed with water (1x20ml) and brine
(lx20ml), then dried and evaporated in vacuo, affording a yellowish
oil (70mg). Examination of this material by analytical TLC, using
the same mobile phase as employed in (a) above, indicated the
formation of two products with Revalues 0.46 and 0.57. GLC
225°
similarly revealed two peaks with I = 2505 (10^) and 2775 (90^).
JL" JU
275 °
The corresponding values on Dexsil were Iq£xsil = ^900 and 3120).
The early (minor) peak was identified as 4-androstene-3,17-dione by
comparison of retention data and mass spectrum (molecular ion at
m/e-286) with that of the authentic material. This compound would,
no doubt, be formed in the flash heater zone of the gas chromatograph
by thermal degradation of 21-fluoro-17& -hydroxy-4-pregnene-3,20-dione,
which is the major by-product, in this preparation. The later
(principal) peak gave a mass spectrum compatible with the desired
17ck ,21-anhydro compound (molecular ion at m/e 328).
Preparative TLC, using as mobile phase ethyl acetate/light
petroleum, b.p. 60-80°, (1:1 v/v), with a double elution, was used
to separate the two reaction products. Elution of the upper band
with ethyl acetate and evaporation in.vacuo afforded the oxetanone
(I2mg) as a solid. Two recrystallisations from acetone/light
petroleum, b.p. 60-80°, gave fine needles, m.p. 194-196 . Infra-red:
”0 (KBr disc) 1813 cm”1(s), 1667 cm”1(s), 1611 cm”1(m) and 
max
956 cm-1(s). GLC analysis of this purified material, however/
however showed that incomplete separation of the oxetanone from the 
contaminating fluoride had been achieved. The impurity peak had 
nevertheless, diminished in size to 2-3$ of that of the oxetanone 
peak.
Furthermore, vacuum sublimation of the recrystallised 
oxetanone using a 'cold finger1 apparatus (l25°/o.03mm Hg) afforded 
material which still contained an impurity, as shown by TLC and 
GLC. (Found, C: 75.28; H: 8.54$. Calc, for C21H28°3:
C:76.79; H: 8.59$.)
A small sample (400^ uig) of the 17cA , 21-anhydro derivative 
of Substance S was converted to its 3,20-di-Ckmethyloxime (di FlO), 
according to the method outlined in section 3.2.1.
KF /  
DMSO
0 5 0  Me  
2
K F /  DMSO
(17)
=  0
( 2 5 )
Fig. 12: Products obtained from reaction of dihydroxyacetone
21-mesylates with potassium fluoride in dimethyl sulphoxide,
2.3 RESULTS AND DISCUSSION
33.
2.3.1 GENERAL RESULTS
Fourteen representative steroidal dihydroxyacetones were 
converted to their oxetanone derivatives by the Upjohn procedure,104  ^
in which cyclisation of the 21-mesylates (24) was effected by 
treatment with potassium fluoride in dimethyl sulphoxide (fig.12).
In all cases, the corresponding 21-fluorides (25) were formed as 
by-products, resulting from the direct displacement of mesylate by 
fluoride ion. (The amount of 21-fluoride formed ranged from 5 to 
30^ of the total reaction product, as estimated by TLC and GLC.)
In each case, examination of the reaction product by analytical TLC 
revealed two closely separated spots, the less polar of which 
corresponded to the oxetanone. Even in the most favourable instance 
(Substance S), repeated thin-layer chromatography failed to remove 
completely the contaminating 21-fluoride, and despite three 
recrystallisations and one vacuum sublimation, analytical purity 
was not achieved.
For the purpose of discussion, the steroids studied have 
been divided into two groups, as follows:-
Group 1: Non-fluorinated corticosteroids, with varying degrees of
unsaturation in ring A and oxidation level at C-ll (Table 5).
Group 2: Fluorinated corticosteroids (Table 6). With the exception
of 6o(-fluoroprednisolone, these compounds all contained the 9&- 
fluoro-1113 -hydrin group present in many anti-inflammatory 
corticosteroid drugs. Introduction of fluorine substituents adds 
to the polar character of corticoids, and thus to the difficulty 
of achieving satisfactory gas chromatographic behaviour. Indeed, 
the analysis of such compounds by gas phase methods has received/
o
•H
-Pto
•H
P
CD
-P
a
co
p
CO
sz
u
tf-o
to
CD
oc
co
tdc
nXI
to
CD>
•H
-P
COi—I 
0 
p
TD
C
0
0 
0 
D <—I 
0 
D*
0Co•H
-P
C
0
E
ai
0
p
E|
CD
0 _X CO 
0 0 A 
0 0 0 
CD CL'>i
+ •
co•H
-P
c
a)
•p
0
ce
o in 
r- 
0 CM 
o i- 
o•H
XIc o •h in
CM
CM
•H CJ0 LD
X
0
a
a
to
iUJ
tn
CM CD 
•—I CD
CD '-x 
tO CD H CO
CD /-x 
XT CO 
i—I CO
Ch
CM
CM
CM
XT CM 
CM i—I
X} ^  
XT CD 
CM XT
CO ^in to 
CM i—I
Ch '
cd a  
CM CM
O '-X 
£x- CO 
CM CM
,m —
CM CM 
rH L-
[v. -^x
LO CMi—i in
in cm
<H XT
cm ^ -x 
in a i—l CM
tO
m  xr 
rH to
CD
CD
CM
CD
CM
CO
□
CM
CO
CM
CM
XT r—X 
CM XT 
CO rH
LO » in rH
CO CO
[x- <—I 
CO CM
CD r-N
cd a
CO □
CO
CM C- 
CM CO
CM ^  
XT CD 
CM CM
XT r-xr- co 
cm xr
XT '-x 
CD CO 
CM CM
CD '-x 
CD CO 
CM CM
CD r—' 
CM rH 
CO rH
Ch
CM
CO x_x
CO
CM CO 
rH CD
CD
CO CD 
t—I CD
LD -'“x
xj- in
r—I Xf
CO ^ -x 
CD CO 
H  Ch
XT
XT
CO CM CO
CD ^  
CO CD
r- r-x 
XT CD 
rH CM
cd inrH I—I
Ch
CD CO
CD '-xin r-
CM ^
CM ^ -x 
[x- CD 
CM--
xj" '-x 
CD CD 
CM--
□  /-x 
CD CO CO xr
CM
CMi—I
CM r-N 
Xj- CO 
CO '■—
CDa
CM
CO
oCO
CDCM
rH
CM CD 
rH XT
CO r— S 
CM CO
Xj- '—X
CO CMi—I i—I
O- ^ -~xxr co 
<— \ CM
LD ^ -x 
CD CM 
CM .H
CO ✓~x
CD Ch 
CM--
xr
CD CO 
CM '—
O r-s 
O  CM 
CO '—
CM '"x 
xr cm
CO >—
co in
rH CO
xr xr
>—I CD
□ r—N
CD Ch
<h  in
CO
CD [x-
xT ^  in co
CM CM
O ✓~x
i> xr
CM rH
co a
CM rH
CM /-x 
CD CO 
CM H
CD ^ -x 
Ch rH 
CM Ch
CO
Ch
CM
O  r-N
xr a
CO rH
in
CD
[X- r—x 
CD rH 
rH in
Ch r—-x 1—I rx 
rH CM
CM ^ -x 
CM CD 
H  CM
CO x-x 
CO O  
rH CM
[> r-x
XT CO 
rH CM
XT
O  o  
rH CM
O'! r-x 
CM CD 
CM rH
Xj- rr-x
xr cd
CM CO
O IH 
CM x_^
CM r-X 
O  CD 
CM CM
CO
CO
CD ^ -x
co xr
CO--
CM '"x
CM O'! 
rH CO
XT r"> 
CM CD 
rH CO
LD r-X 
CD C- 
i—I t—I
fx -^x
XT rH 
--I CM
Ch r'-V 
xr in
to ^  
co [>
Ch rH 
I—I xj-
XT r"'ex in 
cm ^
CD "X
cd in
CM rH
[X -^x
CD Ch 
CM CM
(x ^ -x
o  a
rH CO
Ch ^ -x 
CD f>
rH Xt
CM CM 
.H CO
Xj- ✓~X
xr to co '—
TOc
oCL
E
□
a
-p
c
0
p
0D.
I
O
CO
I
0
c
0
ccn
0 
p CL
1
xr
i
>  
x 
□ 
p TD 
X  JZ 
•H 
O  
I 0 rH C CM O 
"H 
O TD
Dj-cnj-
ICD
CM
CO
I
0c
0cCJl
0
pCL
IxT
I
XX
0
pTD '-x 
>> O  jz e:
■H -H 
Q T3
1H 0 
DJ C 
- O 
'H CH TD 
D-
CO
I
0
C
0cCJl
0
p
CL
I
xj
I
>.
X
a
p TD 
>« 
sz 
•H 
p 
I- I r-x rH 0 
CM C 
- O 
d  -H !>- TD 
rH I 
»- O  cDlcm
CO 
I 
0 c 
0 c cn
0
p 
Q.
1
xr 
i
x  
X
0
p TDXr-x 
SZ 0 
•H C 
Q  O1 -H rH P CM -P
*> I 
I I r^ CD HI ^  CN 
PID- 
OJrH C_Jf -
I
0c
0
•HTD
0Ccn
0 
p CL
1
xr
i
xxo
pTD>x
JZ
•H r x
P 0
0
corH
o
0•H
"D
0P
Q.
I- C 
I □rH *H 
CM TD 
1d CD[X- CM
CO-COrH
CO
I
0
L_
0•HTD
0
C
cn
0 
p CL
1
xr
i
>*-r-x
X 00 c 
p aTD -H >* P 
SZ -P •H I
a o1 cm
cn
CM *■>
0 
Co 
0 •H
CJ - rH 
D O  H  
0 O  
P W  
CL--
cn
i
0 p TD 
>| JZ •H
1
CO*.
m
£■ J
I
0
C
0c
cn
0
pCL
CO­
LD
I
>.
X
0pTD
>x
JZ
•Ha
1
0 
c o•HTD CM J - CD 
O CM 
£x-
CO
I0
c0c
cn
0 
p CL
1
CO.
in
i
>>
xopTD ^-x
0
JZ c •H O
•H 
P -P 
I- CDa cm
CM
Ta
bl
e 
5:
 
Re
te
nt
io
n 
in
de
x 
va
lu
es
 
an
d 
sa
li
en
t 
ma
ss
 
sp
ec
tr
om
et
ri
c 
da
ta
 
fo
r 
17 
a 
,2
1-
an
hy
dr
o 
de
ri
va
ti
ve
s 
of 
co
rt
ic
os
te
ro
id
s 
(G
ro
up
o I—1 P- f-•H CM CO o CO CD d
-P rH d t—1 d rH to0 V_' '—y v—■•H
P CO y-s d y—s COy--s COy—s y—s CMy—s0 CM rH CO cn CD CO CD i—1 d CO CM d-P rH CO i—1 in <—1 CM i—1 CM ■—i CM i—1 CMO V_r vy N_y v_y v—y s_y0P CO r-s '—l -^-s CDy—n rH y--\ rH y—s COy--s COy—s
0 CO CO CM l> d o CM rH CM CD r- in CM LO
JZ rH in i-l CD 1—i cn 1—1 CO i—1 in rH CM f—1 CM
u v—' —' v~^
4 - CO r-s in y-s y_S •d y--^ d i> COy-S
O CO CO CO d d rH CO CD CO cn co d CO COrH d i—i i—I i—l to i—1 i—1 ■—i '—y 1—1 CO 1—1 COv—/ N_y '—- sy >—y '—y
CO
0 CO ~^N p- /—s COy—n in y—s in y—n in y—s I> y--s
O rH d in CO cn CO P- to CO CO CO d [s-c rH CO i—I ■—i CM ■—i rH i—i i—1 CM f—1 ■—i CM
0 x_✓ v--/ n—y v_y _^* v_' —^XJ
c CO -^s CMy—s rH y--N r- y—s [S- y—\ CMy—\ r- y—s CDy—s
D in o CD CO CO CO d CO d CM cn LO o CO LO LOX) 0 CM CO i—1 CM CM 1—1 ■—i rH i—I i—1 CM LO i—i CO i—1 CO
0 C V_r V_/ '—' _ ' n_y s_y >_y 'O0 •rl CM r-s C"- y—-v COy—s o y—s CDy--v d y—\ COy—s. cn /—s
> cn o- CO cn CO CD CD CM CD l—1 cn O CD LD CO CO•H P CM CO rH CM i—1 i—1 rH i—1 1—1 CM rH i—1 d •—i dP cz s_y '—y '—y v—y v—y '—' ___
0 0
i—1 E CD CO_•. COy—S c- y—s l>- y—s cn y—v in y-s i> y—\ in y—s0 cn CD CM CO C^- cn CO CO o co cn CM CO rH rH cn in cn d
P 0 CO CM CMv_y CM CM 1—1 rH rH '—y CO cn i—1 CO CM i—i COP N_y v—y •>—y s— •—y >—yXJ Lu
c d  r—s i—1y—s i—1y—s in y--\ in y—s CDy—s rH y—s cn y--sCOy--s0 O  f- CO LO CD LD cn in cn i—1 CO d CM C^- cn LO CD LOCO rH CM i—1 CO'—y CM f—1 CM i—1 CO CM 1—1 in CM i—1 i—i LO
0 v_' '—y •>_y sy v—y v—y s—y0 •
u 0 CM y"s COy— COy—\ CMy—\ CMy—x CMy—\ CMy-s d y—\ cn y—\1—1 c d  CO cn CO i—1 in i—1 CO 1—1 CO CO CM CM LD rH cn CD CO
0 o CO '— CM—y CO■-—y CO 1—1 COv—' CO CM i—1 d CO i—i rH LO> •H "—1 v—
m| d  y~s CD CDy-^ d y—^ d y-^ CMyy^ COy-S LOy-S in y-Sd  d d in d in LO cn LO CO in CM CO CO d CO i—i LO
El CO s_y CO i—I CO—< CO-—y to 1—1 COV—y I—1 CM CO 1—1rH CO
v- ' v—'
CD ,
0 .X n
0 0 m| o CM cn CM CM CO CM
0 0 CM CM CO CM CM LO COCD CL E CO i—1 1—1 i—1 1—1 rH CO
CM -^s CD CO CDy—v d d d d CMys d ys
+ • co r^ CD • CO CO P- • [> • p- r- p- CO
EZ CO rH CO o COv_y co CD CO a co s_y co I—1
sy s_y s-y
* 1
rH CJ
•rl CD
O 0 CD LO in in CD CD in« LO X CD o C'- LO LO CO cn in0 P- 0 O d d d in in d dc 0 CM □ CO CO CO CO CO CO CO COo o (—i
•rl •rl
P XJ
c c o0 •rl O to CD CD LO in a in LOp LO 1 cn CM r- in CO i—i0 CM IP cn CD cn o o CD a
cr CM CD CM CO CM CO CO CO CO
t—l
XJ
cDo
CL
EO
CJ
P
c(D
P
(0a.
i—i
o
CO•HP
PO
a
o
p
ZJi—!
T
O
| Cnj
id
i5s
X
0p
XJ5S
jz
•H
P
-P
1<—I ' •> 
cm © 
•• c
0 or- -h
rH XJ 
- i 
CQ-CD
i—I CMi—I •-
1 to
Id
I>>
X0p
X)
5s
n
•H
P-p ©
1 c
•—I o
CM -H 
- XJ
G io- o 
rH CM
CQ-co
■—i i
ZJ XJ 
rH CO 
U_ C
Id
I
5s
X0p
XI 5s 
JZ 
•H 
P 
-P
rH 0 
CM C 
- Q
d -H
O  XJ
‘—I I
CQ_Si—| •*
rH CO
1 I□ 0 
P c □ 0 
D -H 
rH XJ 
Li- 0
I 0
G P
cn a. d d S G|a\ Q.t-hp-^
0
C
o
I -H
rH XJ 
CM„ I
0- Cm 
rH ~
- CO 
CQ_ i 
rH 0 
rH C 
I 0 
rH *H 
5s XJ 
JZ 0 
-P c
0 cn 
E 0
1 p 
COL?-co d1—i
i
op
oDi—I
I 0 c
CM O 
•* *H 
_ XJ0 i 
o o
rH CMfc *»
I
rH 0 
rH C
1 CD
rH -rl
5s XJ 
JZ 0 
-P c
0 cn 
E 0
1 p
G ?- 
.co d
cn G 0
CD p
i
G
jU J f    j
rH  
»
5s 
X
op
XJ 
X
ro|r} jz xj0 -H
or-
^S
0
c
o y-s
1 •H 0 1 0rH XJ —1 c
CM 1 c CM o
•sCD o •rl
CM 0 XJ
1o 0 G
r- CO JZ >- CD
i—i 1 p 1—ICM0 0 y y
CO.
c0
E0 _  COcQ-i
rH •H X i—i 0
0 i—1 P
0 i—i c
1 P XI i 0c rH 0 o rH •HO yS c p yS XJ0 JZ cn XJ JZ 00 p 0 p c
JZ 0 p JZ 0 cn
p E a 0 E ©0 1 i XD 1 pE0 O LOy*
1
Cs G a.i
X LO d LO LD0 i—i y* LD i—1 y
XJ 1 i—1 1 1 dO o 1 □ o ip p 5s P p 5sXJ o X XD □ X
CJ o IJ oJZ 1—1 p JZ i—1 pro 1 ■ -H XJ1 x ■—■ 1 >*
J
•
1-1
—
JZ
•rH CM 3
JZ
•r!
P y rs sVujv—yP - ----- Ta
bl
e 
6
: 
Re
te
nt
io
n 
in
de
x 
va
lu
es
 
an
d 
sa
li
en
t 
ma
ss
 
sp
ec
tr
om
et
ri
c 
da
ta
 
fo
r 
17
a 
,2
1-
an
hy
dr
o 
de
ri
va
ti
ve
s 
of
 
co
rt
ic
os
te
ro
id
s 
(G
ro
up
 
2)
.
34.
received little attention, although Kelly chromatographed a
96 97)fluorocorticosteroid as its dimethylsiliconide, ’ ' and Brooks
and Lawson characterised a number of fluorocorticoid drugs as their 
MO-TMS and bismuthate oxidation derivatives.
2.3.2 GLC PROPERTIES
Gas chromatographic retention data were recorded on two 
columns, SE-30 and Dexsil-300GC, and are presented in Tables 5 and 
6.
For those compounds in Groupl, good peak shapes were 
obtained, although the oxetanone peak was always preceded by that 
of the corresponding 17-ketosteroid, formed in the flash heater zone 
by thermal degradation of the aforementioned 21-fluoride (fig.12). 
Retention indices were, as expected, relatively low; the oxetanone 
from Substance S had a lower retention index (on SE-30) than any of 
the other derivatives commonly used to stabilise the side-chain for 
GLC (section 3.3).
The fluorinated oxetanones in Group 2 generally gave 
satisfactory GLC peaks, although in some cases tailing was observed. 
Peaks arising from the corresponding 17-ketosteroid were again 
present. In the two cases where a direct comparison could be drawn 
between fluorinated and non-fluorinated oxetanones (cortisol and 
prednisolone) the introduction of a 9$ -fluoro substituent increased 
the retention index (on both SE-30 and Dexsil phases) by 
approximately 45 units.
2.3.3 HASS SPECTROHETRIC CHARACTERISTICS
Salient features of the mass spectra of the oxetanones 
studied are summarised in Tables 5 and 6, which show that molecular 
ions were obtained in all cases. The oxetanone derivatives undergo/
+M
0
— I +
( M - 4 2 )
M
+ -
+  -
0
+
0
+
( M - 5 8 )
Fig. 13: Postulated fragmentations of the oxetanone ring,
HCH
m/e 123
m/e 124
m/e 134
X=H: 
m/e 160
+
t
t
m/e 158
tO v ^  ' C H 2X 
X=H: m /e  122
CHX
+
X=H: m/e 121 
X=F: m/e 139
Fig. 14: Postulated representations of ions resulting from the mass
spectral fragmentation of steroidal 4-en-3-ones and 1,4-dien- 
3-ones.
undergo distinctive fragmentations, notably the loss of ketene.
This gave rise to prominent ions at m/e (M-42) (or at (FI-hir-42) 
in the spectra of some of the fluorinated corticosteroids). Such 
ions afforded the base peak in six cases. The loss of 42 a.m.u. 
occurs in the spectra of A  -3-ketosteroids, through scission of the 
C-l/c-2 and C-3/C-4 bonds,  ^ although this process does not 
occur in ring-A saturated 3-ketones. However, the oxetanones 
derived from 5 j3-dihydro-S (DHS) and 5 j}-dihydrocortisone (DHE), 
both of which have a saturated ring A, exhibit the (N-42)+’ion as 
their base peak. Clearly, the origin of this ion in such spectra 
cannot lie in ring A, but appears to derive from the oxetanone 
moiety itself (fig.13). Another interesting feature of the mass 
spectra of oxetanones in the occurrence of ions at m/e (M-58) or 
(1*1-59) (or both). These apparently result from extrusion of the 
side-chain (fig.13).
The characteristic fragments arising from the cleavage of
ring B (at m/e 123 or 124 in 4-en-3-ones and at m/e 121 or 122 in
l,4-dien-3-ones) were prominent in most of the spectra, while
6 & -fluoroprednisolone yielded the corresponding fluorine-containing
ion at m/e 139 (fig.14). However, the base peak in the spectrum
of 17c* ,21-anhydro cortisone, which contains the 4-en-3-one grouping
lay at m/e 122 and not at JH/k 124; this feature is present in the
spectrum of cortisone itself, and has been rationalised in terms of
the absence of the llcA-proton, which is involved in a transfer proc
XXX ^X3}
leading to the m/e 124 ion.
Ions attributed to fragments containing rings A and B were 
present in the spectra of the 16-methyl corticosteroid derivatives. 
These ions were at m/e 160 in the spectra of betamethasone and its 
two isomers, and at m/e 158 in its 6,7-dehydro analogue (fig.14).
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Fig.15: Mass spectra (70eV) of representative oxetanone derivatives: 
(A) 1? Q j21—anhydro—cortisol'
(B ) 17 a ,21-anhydro-9 a-fluorocortisol.
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mechanism of cyclisetiQii and displacement reactions of 
corticosteroid 21-mesylates.
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Dexamethasone and betamethasone, differing only in the configuration 
of the 16-methyl group, gave practically identical mass spectra.
Loss of HF was commonly encountered in the spectra of the fluorinated 
derivatives', giving rise to ions at m/e (Fl-20). The mass spectra 
of 17ch ,21-anhydro-cortisol and its 9<X-fluoro analogje are shown in 
fig.15. The effect of introducing a fluorine substituent is 
evident in the mass shift of the major fragments.
The mass spectrum of the di-JD-methyloxime (di F10)
derivative of Substance S oxetanone (Table 5) furnished very useful
complementary information. As expected, the molecular ion became
much more abundant, and formed the base peak (at 70 el/). The high
mass region contained ions typical of HO derivatives, at m/e
(1*1-15) and m/e (M-31), resulting from losses of CH and CH 0
3 3
radicals respectively. A fragment at m/e 315 (fl-71) corresponded 
to the loss of 42 a.m.u. previously discussed, while the nring A" 
ion had shifted to m/e 153.
2.3.4 SYNTHETIC ASPECTS
The mechanism by which the dihydroxyacetone 21-mesylates 
are converted to oxetanone derivatives may be formally represented 
as shown in fig.16. Firstly, the base (in this case a fluoride ion) 
abstracts the proton from the 17c* -hydroxyl group (process (a) ) 
generating the oxy-anion (26). Secondly, an internal displacement 
reaction occurs, in which the leaving group (mesylate) is expelled, 
resulting in the formation of the spiro oxetanone system (17). In 
the competing reaction, the fluoride ion acts as a nucleophile, 
displacing the mesylate group by an S^2 process (route (b) ) and 
producing the dihydroxyacetone 21-fluoride (25). Therefore, to 
promote the cyclisation process - and inhibit the competing displacement 
reaction - two conditions must be satisfied:- (a) the base employed 
must possess low nucleophilicity but high basicity; and (b) the 
substituent at C-21 should be a moderately good leaving group ( a 
very labile substituent would tend to undergo rapid f
BASE SOLVENT TEMP. TIME COMPOSITION OF PRODUCT 
(BY TLC AND GLC)
KF DMSO 80° 18h Oxetanone -1- 21-fluoride
KF DMSO
ooCO 2h As above (no starting 
material remaining).
KF DMSO 58° 4h Oxetanone, 21-fluoride 
and 21-mesylate.
KF DMSO 25° 8h 21-mesylate only
KF DMA
ooCO 18ih Oxetanone + 21-fluoride
AgOMeS DMSO
o□CO 18h Oxetanone (?) + at least 
4 other products.
KBF,4
DMSO 00 o
o 17h Complex mixture of products 
- no oxetanone
Pyridine Pyridine 115° lh As above
Table 7; Effect of reaction conditions on the conversion of Substance 
S 21-mesylate to 17a ,21-anhydro S.
MeON
CH OSO Me
( 2 8 )
( 2 7  ) K F /  DM SO
CH F
( 2 9 )
Fig- 17: Reaction of Substance S S^O-diHO 21-mesylate with potassium 
fluoride in dimethylsulphoxide.
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rapid S^2 displacement). However, a feature which complicates the 
requirement for high basicity is that the use of strong bases can 
lead to undesirable D-homoannulationj this introduces a further 
limitation on the base chosen.
In an attempt to increase the yield of oxetanone, and at 
the same time reduce the amount of 21-fluoride formed, the effect 
of changing the following reaction parameters was studied: base,
solvent, temperature and time. The results of these experiments, 
using Substance S mesylate as substrate, are summarised in Table 7, 
which shows that with the system potassium fluoride/dimethyl sulphoxide 
(DMSO) a much shorter reaction time (2h at 80°) than that originally 
employed will suffice, although the same mixture of products is 
obtained. Dimethylacetamide (DMA) appeared to be interchangeable 
with dimethyl sulphoxide as solvent. The use of three different 
bases, all of low nucleophilicity, was investigated. These were 
fluoroborate ion (KBF, ), mesylate ion (CH SO ) and pyridine (which
J J
also acted as solvent). The mesylate ion appeared attractive as a 
possible base, since any displacement at C-21 would regenerate the 
substrate for the cyclisation. However, all three proved 
unsatisfactory in effecting the desired reaction.
A slightly different approach was then investigated, in 
which the diHO derivative of Substance S 21-mesylate (partial 
structure 27) was used as a substrate for the cyclisation (fig.17).
By derivatising the C-20 carbonyl function in this way, it was 
anticipated that its electron-withdrawing effect would be 
diminished. Consequently the susceptibility of the mesylate 
substituent at C-21 to direct displacement by fluoride ion might 
become electronically less favourable. Some degree of steric 
hindrance to approach of the fluoride ion at C-21 would also be 
expected from the -OMe group. It was hoped, therefore, that this 
substrate might lead to the diflO derivative of 17c* ,21-anhydro-S (28). 
However, this oxetanone derivative was not isolated from the reaction 
mixture, which vielded the diWO derivative of 21-fluoro-/
MeSCLO'
( 3 0 )
( 31 ) ( 3 2 )
Fig.18: Thermal cyclisation of cholesteryl mesylate.
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21-f luoro-17(* -hydroxy-4-pregnene-3,20-dione (29) as the major product. 
This compound, interestingly enough, was stable towards GLC, and was 
characterised by GC-MS.
2.3.5 THERMAL CYCLISATION OF CORTICOSTEROID 21-MESYLATES
Following the observation that the 21-mesylate of Substance
S gave, on injection onto a 1% SE-30 column at 225°, a single peak
with the same retention index as that of Substance S oxetanone, the
procedure was repeated for some other corticosteroid mesylates. Thus,
cortisol, cortisone and prednisone mesylates also gave peaks with
retention indices compatible with those of the corresponding 17 £X ,
21-oxides. However, in these three examples, an additional (minor)
peak was also present; retention data suggested that these additional
components were the respective 17-ketosteroids.
On re-examination of Substance S 21-mesylate by GC-MS,
the identity of the compound formed during gas chromatography —
presumably in the flash heater zone-was confirmed as the oxetanone
derivative by comparison of its mass spectrum with that obtained from
an authentic sample. Thus, a thermal cyclisation was indicated,
in which methanesulphonic acid was eliminated and the oxetanone
derivative produced. An analogous process was observed by
Vanden Heuvel et al., who studied the gas chromatographic behaviour
115)
of mesylates and tosylates of certain sterols. In the case of
cholesterol mesylate (30)several peaks were obtained on the 
chromatogram, one of which corresponded to 3,5-cyclo-6-cholestene (32). 
It was suggested that this compound arose from a thermally-induced 
i-steroid reaction, whereby intramolecular displacement of the 3£>-
5
mesylate took place with homoallylic participation of the A  -double 
bond. The intermediate carbonium ion (31) could not undergo 
solvation in the gas phase and was therefore saturated by loss of/
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Fin, 18A? Flame ionisation detector response to derivatives of Substance St- 
• 17 21-anhydro S;
*|* S 21-mesylate
Response measured as peak height, with adjustment for different 
amplifications.
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of a proton from C-7.
Quantitative aspects of the thermal cyclisation (in
the GLC flash heater zone) of Substance S 21-mesylate were
investigated, and the results are summarised in fig. 18A. A
linear relationship was demonstrated between peak height (under
constant GLC conditions) and mass of the mesylate and its
corresponding oxetanone. However, the detector response for
Substance S oxetanone resulting from the pyrolysis of the 21-
mesylate was only 16+ 2/6 of that obtained from a corresponding
mass of oxetanone. This result is very similar to that
previously reported for the thermal degradation of steroidal
83—85)dihydroxyacetones to their corresponding 17-ketones.
2.3.6 CONCLUSIONS
Oxetanones are potentially useful derivatives for the 
study of steroidal dihydroxyacetones by gas phase methods.
They possess good gas chromatographic properties, affording 
satisfactory GLC peaks even in cases where the steroid bears several 
additional functional groups. Their retention indices are 
generally lower than for other types of corticosteroid derivative 
(excluding the side-chain oxidation products), as their molecular 
weights are eighteen units less than those of the parent steroids. 
Furthermore, oxetanones afford informative mass spectra, exhibiting 
molecular ions, and a^so characteristic fragments of high abundance 
in the upper mass region. Such fragments provide a means of 
detecting particular structural types at high sensitivity by 
"single ion monitoring" (section 3.3).
The chief problem currently impeding the application 
of these derivatives to the study of suitable corticosteroids lies 
in the unsatisfactory method of preparation, whereby interfering/
40.
interfering 21-fluorinated compounds are formed by a competing 
reaction. It is hoped that a more practical preparative 
method will eventually emerge.
SECTION 3
A COMPARISON OF CORTICOSTEROID DERIVATIVES BY GAS
CHROMATOGRAPHY - MASS SPECTROMETRY.
r— OH r— OH
— OH ~ O H  ip O
k"*OH Jk -O H
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INTRODUCTION
The rapid increase, during the early 1960fs, in the use
of GLC in steroid analysis, was accompanied by a demand for suitable
derivatives. Through enhancing the volatility, and reducing the
polarity of steroids, such derivatives led to greatly improved
chromatographic behaviour and to the feasibility of analysing
complex mixtures of biological origin.
Trimethylsilyl (TflS) ethers, first described as derivatives
for alcohols in 1957^^, were later applied in the steroid field
43)by Luukkainen et al. ' These derivatives, which had excellent GLC
properties, rapidly found widespread use in steroid analyses, and
117-119)were applied, inter alia, to the study of estrogens,
120—126) 127)
androgens ' and bile acids. Acetates were also found to
128 )
be useful derivatives for hydroxysteroids, although their retention
times were somewhat higher than the corresponding TMS ethers.
Trif.luoroacetates, on the other hand, were found to have relatively
129)short retention times, and proved to be particularly useful 
when used as derivatives for electron-capture detectors.
However, considerable difficulty was experienced in the 
gas chromatography of certain steroids, notably those belonging to 
the corticosteroid family. These compounds comprise the adrenocortical 
hormones (fig.2), their immediate precursors and principal metabolites, 
and possess one of the six types of side-chain shown in fig.19.
Under the conditions necessary for steroid GLC, thermal decompositions 
and rearrangements were frequently encountered, particularly with the 
17-hydroxycorticosteroids (11-13, 15). For example, 20,17-ketols 
(15) could undergo D-homo steroid formation \  while dihydroxyacetones 
(13) suffered side-chain cleavage in the flash heater zone, affording 
the corresponding 1 7 - k e t o n e s . ( Some thermal/
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P i q .  20: Corticosteroid derivatives (i).
thermal D-homoannulation of the dihydroxyacetone structure has also 
13l)
been observed. ) Although chemical oxidation of corticosteroids
afforded products which wsre amenable to GLC (section 2.1), various
means of stabilising the side-chains through derivative formation
132)
were investigated. Particular attention centred on the labile
dihydroxyacetone grouping, for which the first derivative shown to
possess gas chromatographic stability was the bismethylenedioxy (BMD)
133)
derivative (35) of Kirschner and Fales . Gas chromatography of
the cortisone derivative was accomplished, but the reaction was not
found to be generally applicable. Cortisone 21-acetate (partial
structure 36) was studied by Uotiz _et al. and found to be somewhat
134)more stable to GLC than cortisone itself. However, some
133)decomposition (8 to 14$ ) and rearrangement were still evident.
13^ 13 6}17,21-diacetates (37) could be chromatographed intact, w’ '
although some elimination occurred on GLC to give the 21-acetoxy-
20-one derivative (38).
Following the introduction of the O^methyloxime (no)
137)derivative for ketosteroids , it was shown by Gardiner and Horning
that the 20-M0 21-TnS ethers (39) were effective in stabilising
54)
steroidal dihydroxyacetones. These, and the corresponding
20-F10 17,21-diTIvlS ethers (40) could be prepared in'a quantitativ
139)
fashion from microgram amounts of steroid , and possessed 
excellent GLC properties. In addition, the prior conversion of 
reactive ketone groups to their JD-methyloximes prevented the 
uncontrolled formation of enol-Tf'iS derivatives in the subsequent 
silylation step.^8  ^ Isomers of the syn/anti type were observed for 
some F10 derivatives, ^   ^ ^although when the ketone group
was located at C-17 or C-20, as is the case in most urinary/
( 4 1 )
r°v.
II— 0  S iM e .
( 4 2 )
( 4 3 )
o X
OSiMe,
•OSiMe
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Fiq. 21: Corticosteroid derivatives (II)-
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urinary metabolites, a single GLC peak was obtained.145>146) ThlJS>
TMS ethers and, where appropriate, nO-THS derivatives could be 
successiully employed to stabilise the various types of corticosteroid 
side-chain, and thus to permit the GLC analysis of complex mixtures 
of these compounds, such as one encounters in urinary steroid extracts.
A slightly different approach to the problem involved the 
incorporation of the 1,2 - or 1,3-diol system present in most 
corticosteroid side-chains into a cyclic derivative. Conversion 
of the dihydroxyacetone structure (a 1,3-diol) to such a derivative was 
effected by treatment with a suitable boronic acid, and the resultino 
six-membered cyclic boronate ester (41; R= alkyl or aryl) found to 
be stable towards GLC.94’ 95> 147  ^ 17, 20- and 20,21-diols formed 
analogous five-membered derivatives, while the unusually stable 
boronate ester obtained from 17,20,21-triol groupings has been 
shown to possess a six-membered ring, incorporating the oxygen functions 
at C-17 and C-21 (see appendix III). The cyclic dimethylsiliconide 
(42), introduced by Kelly, was also shown to stabilise the
dihydroxyacetone side-chain for GLC. Acetonides (43) have been 
prepared from steroidal 1,2-diol s y s t e m s , and have been shown 
to be useful derivatives for the gas chromatographic characterisation 
of natural, and drug metabolites possessing these structures.^49>
The use of boronate esters, dimethylsiliconides and acetonides has 
several advantages in the GLC of corticosteroids, notably the element 
of specificity involved in their formation; non-cyclic derivatives 
lack this feature.
More recently, TMS enol-TMS derivatives have been
described, and shown to possess excellent gas chromatographic properties
in favourable cases e.g. ring A - saturated metabolites with
151-154)
dihydroxyacetone or 20, 21-ketol side-chains. In each
type, enoli^ation of the 20-ketone affords a 20,21-double bond 
( cf . partial structure 44), and although formation of two/
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Fig.22: Characteristic fragmentations of steroid derivatives.
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two geometrical isomers is possible, only a single GLC peak is 
observed.
With the advent of combined GC-P1S, further criteria were
required of steroid derivatives, namely that they should yield readily
interpretable and structurally informative mass spectra. Fortunately,
the same derivatives as used for GLC have frequently been found to
be of value in GC-HS. This has certainly been true of TMS ethers,
which almost invariably afford spectra with clear molecular ions,
or indirect evidence thereof (e.g. loss of trimethylsilanol from the
molecular ion frequently occurs to give a peak (M-90)+* 52 )^.
Fragmentation generally proceeds via facilec£-cleavage, and ions
characteristic of the environment of the silyl group are often obtained
in high relative abundance. Thus the ion at m/e 191 is frequently
encountered in the mass spectra of compounds with vicinal TMS groups,
and arises by a rearrangement process. This fragment has been
employed for the determination of estetrol (45) by "single ion 
64)monitoring". The identification of ions in the spectra of THS
ethers may be facilitated by the use of perdeuterio-TMS derivatives,
when the silyl-containing fragments are revealed by an appropriate
. ... . 157)shift in mass.
In [3-methyloximes, the nitrogen atom stabilises the
molecular ion, and reduces the extent of fragmentation in the high mass
region. Characteristic losses of 15 a.m.u. (methyl radical) and
158 159)
31 a.m.u. (methoxyl radical ) * 'from the molecular ion are
observed in the spectra of HO derivatives, while Q-methyloximes of 
A 4-3-ketosteroids (partial structure 46) afford "ring A" fragments 
at m/e 125, 137, 151 and 153 (fig.22).114  ^ The cyclic boronate 
esters and dimethylsiliconides also show well-defined molecular ions, 
and in the case of the dihydroxyacetone derivatives (47), formation 
of the most abundant fragments (common to both types) involves loss 
of the heterocyclic ring through scission of the C-13/C-17 and 
C-15/C-16 bonds (fig.22)-
Although plentiful GLC and mass spectrometric data are 
available for individual corticosteroid derivatives, little material 
of a comparative nature has been published. In the survey 
described below, the gas chromatographic and mass spectrometric 
properties of a number of representative derivatives have been 
compared, and aspects of their preparation and stability are 
discussed. (Some products of side-chain degradation are also 
included for comparison.) The technique of "single ion monitoring" 
has been applied to the quantitative estimation of five derivatives 
of•Reichsteints Substance S and results on the linearity of response 
and lower limits of detection are reported.
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3.2 EXPERIMENT AL
PREPflRflTION OF DERIVATIVES
Derivatives were formed by conventional methods, normally 
using 0.4mg (ca. lj^ m mole) of steroid, except in the case of the 
17oC ,21-anhydro derivative of Substance S, which was prepared as 
outlined in section 2.2.
The derivatives studied may be divided into three groups:- 
Group A - Single Derivatives:- those prepared by a "one-step" 
procedure.
Group B - Mixed Derivatives:- those prepared by a "two-step" 
procedure, each step derivatising a different type of functional 
group.
Group C - Derivatives arising from the oxidative cleavage of the
corticosteroid side-chain.
3.2.1 Group ft - Single Derivatives.
J] - M e t h y l o x i m e s . T h e  steroid (400yU.g) was placed in a Pyrex
glass tube and methoxyamine hydrochloride (2-4mg) added. The
mixture was dissolved in dry pyridine (l00-200yxl), the tube stoppered,
and allowed to stand at room temperature overnight. (Alternatively,
the reaction could be carried out in 30min by heating at 60-70°.)
The solvent was then evaporated under a stream of nitrogen, and the
residue treated with ethyl acetate (2ml) and a 4^ H Cl - 10$£ Na Cl
solution (2ml). The aqueous layer was extracted with ethyl acetate
(2x2 ml), and the combined ethyl acetate extracts washed with a 5%
NaHCO -10^ b fviaCl solution (3x2ml) and dried. Evaporation of this 
o
final solution yielded the jD-methyloxime, which was taken up in ethyl 
acetate (200yul) for GLC. Samples were stored as ethyl acetate 
solutions at 5°.
Note: Keto .groups at C-ll do not form methyloximes under these
conditions.
Trimethylsilyl (TMS) ethBrs. Three different procedures were used;/
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used, according to the degree of steric hindrance of the hydroxyl 
group (s) to be silylated:
(i) Unhindered hydroxyl groups (e.g. at C-3, C-6, C-20 and C-21)162^
The steroid (400^g) was treated with 200^ ul of l\l,Q-bis-(trimethylsilyl)- 
acetamide (BSA) or N,D-bis-(trirr.ethylsilyl)-trifluoroacetamide 
(BSTFA). (Where necessary, one or tuo drops of dry pyridine were 
added to effect solution of the steroid). The reaction was found
to be complete in a feu hours at room temperature, or in 15 min on 
heating to 60-70°. The reagent uas then evaporated under nitrogen 
and the product taken up in ethyl acetate (200yul) for GLC. Samples 
uere stored as ethyl acetate solutions at 5°.
(ii) Moderately hindered hydroxyl groups (e.g. at C-llft jn this 
case, a catalyst, trimethylchlorosilane (TMCS) uas required. Thus 
the steroid (40(^ u.g) uas treated uith 200^1 of a mixture of BSA and 
TMCS (2:1) and alloued to stand overnight at room temperature. The 
TMCS and excess BSA uere evaporated under nitrogen, and the residue 
uas re-extracted into BSA (200yUl) for GLC.
(iii) Highly hindered hydroxyl groups (e.g. at C-17& in the pregnane 
series)'^'*' Again, a catalysed reaction uas necessary, using a 
silylating mixture comprising ^N-trimethylsilyl-imidazole (TSIM), BSA 
and TMCS (3:3:2). The steroid (400yug) uas placed in a screu-capped, 
Teflon-lined, "Reacti-Vial" (Pierce Chemical Co., Rockford, Illinois, 
U.S.A.) and the above silylating solution (200jjl) added. The tube 
uas then heated for 4h at 150°, and the reagents uere evaporated under 
nitrogen. The residue uas taken up in BSA (200^ 0.) for GLC.
Note: Many derivatives of this type uere found to be highly susceptible
to hydrolysis unless stored in a silylating reagent: BSA uas found
convenient for this purpose.
Deuterium-labelled trimethylsilyl ethers. These uere prepared, for 
unhindered hydroxyl groups, by the use of d-^^-N,0-bis-(trimethylsilyl)- 
acetamide (Merck, Sharp and Dohme of Canada, Ltd.) The method 
uas the same as that described in (i) above.
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95)
Nethylboronate The steroid (400pig) uas treated uith 300/ud. of a 
standard solution of methylboronic acid in ethyl acetate (0.5mg/ml) - 
this corresponded to approx. tuo molar equivalents of reagent. The 
mixture uas left at room temperature for 5-10min and an aliquot used 
directly for GLC.
Note: In cases uhere a single, free hydroxyl group uas present at
some other position in the molecule, only one equivalent of reagent 
uas used to prevent formation of a linear boronate ester at such a 
site.
A small-scale preparation of Substance S methylboronate uas
carried out as follous:- Substance S (4>pg) uas mixed uith a
solution of methylboronic acid (4 molar equiv.) in ethyl acetate
(6j j .l), and kept in a closed tube at room temperature for 15 miri.
An aliquot (^ ) uas used for GLC, uhich indicated that the boronate
had been formed in 85^ yield,as judged by the use of a reference
sample. The remainder uas diluted to lOOyul, and 2/Ul (equivalent to
60ng of Substance S) uas used for "single ion monitoringj'(section 3.3.4).
97 )Dimethylsiliconide The steroid (400yjig) uas placed in a Pyrex
tube (3x-|") uith a constriction in the neck. The sample uas then 
dissolved in a mixture of dry benzene and acetone, and the 
resulting solution taken to dryness under nitrogen. (This procedure 
ensured that the steroid uas quite anhydrous). 200yul of a solution 
of dimethyldiacetoxysilane (2%) and triethylamine (2%) in dry 
hexane uas then added, and the tube briefly flushed out uith nitrogen 
and sealed off in a flame. After a period of 4h at 45° the tube 
uas broken open and the mixture injected directly into the gas 
chromatograph.
Notej Both the derivatives and the reagent, dimethyldiacetoxysilane, 
uere found to be extremely susceptible t o hydrolysis.
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Consequently, fresh solutions of reagent uere prepared at regular 
intervals and stored in tightly capped vials under anhydrous 
conditions.
Acetonides  ^ Anhydrous conditions uere also necessary for the 
effective preparation of acetonides. Thus, the steroid (400jug) uas 
placed in a screu-capped Pyrex tube (4xJ") and dried by the method 
described above for dimethylsiliconide preparation. The sample 
uas then dissolved in dry acetone (2ml) containing jd -toluenesulphonic 
acid (2mg), anhydrous calcium chloride (50mg) uas added, and the 
mixture shaken for 4h. The calcium chloride uas removed by 
filtration, and the filtrate treated uith tuo drops of pyridine.
This solution uas taken to dryness under nitrogen and the residue 
extracted uith dry benzene (20ml). This extract uas then uashed 
successively uith I\1 sodium hydroxide (2ml) and distilled uater 
(2ml), and the combined uashings uere back-extracted uith benzene 
(15ml). Finally, the combined benzene extracts uere dried and 
evaporated iji vacuo to yield the acetonide, uhich uas taken up in 
ethyl acetate (200yjil) for GLC.
3.2.2 Group B- Mixed Derivatives
O-Nethyloxime-trimethylsilyl ethers (P'lO-TMS)'^'^ These derivatives 
uere prepared by a tuo-step process, in uhich the ketone groups uere 
first converted to their jD-methyloximes, as outlined above, and 
the hydroxyls subsequently derivatised using the appropriate silylating 
method.
O-Hethyloxime dimsthylsiiiconides (flO-dimethylsiliconides) Steroid 
0-methyloximes, prepared in the normal manner, uere converted to this 
mixed derivative using dimethyldiacetoxysilane, as described above. 
Anhydrous conditions uere again found to be essential for this reaction.
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O-Methyloxime heptafluorobutyrates (HO-HFB)163  ^ The steroid 
^O-methyloxime (200^ jg) was placed in a "Reacti-Vial" and dissolved 
in acetonitrile (60y^ l). _N-Heptafluorobutyryl-imidazole (HFB-imidazole; 
10t}ul) was added, and the mixture held at room temperature for 30 min.
The reaction mixture was then extracted with hexane (3x150^1) and the 
combined hexane extracts were evaporated to dryness under nitrogen.
The residue was extracted with ethyl acetate (IOO j^lL) at -5°, and 
this solution used for GLC.
Oxetanone 0-methyloxime (Oxetanone-FIQ) A sample of the 17c*,21-anhydro 
derivative (oxetanone) from Reichstein*s Substance S (section 2.2) was 
converted to its di-£-methyloxime by the normal procedure.
Q-flethyloxime methyj-boronate (MO-methylboronate). Treatment of 
steroid 0_-methyloximes with a slight excess of methylboronic acid, as 
outlined above, resulted in smooth conversion of suitable diol 
groupings to the corresponding MO-methylboronates.
Flethylboronate-trimethylsilyl ethers (flethylboronate-TMS). In some 
instances, boronate ester formation yielded a derivative still 
retaining one or more free hydroxyl groups. In favourable cases, 
where the boronate moiety was relatively stable (e.g. boronates from 
pregnane 17,20,21-triols), these hydroxyls could subsequently be 
derivatised using the appropriate silylating method. Thus,
17<X, 20p, 21-trihydroxy-4-pregnen-3-one formed a 17c*, 21-methylboronate 
(see Appendix III), which was then converted to the 17c*,21-methylboronate 
20^-trimethylsilyl ether by overnight reaction with BSA at room 
temperature.
GROUP C - Side-chain Oxidation Products
Oxidation with Periodic Acid  ^ The steroid (400^ ig) was placed in a 
10ml Pyrex centrifuge tube and 400j^ l of a solution of periodic acid 
in 50% aqueous dioxan (lOmg/ml) added. The tube was corked 
and the reaction allowed to proceed for 3h at room temperature. The 
reaction mixture was then diluted with distilled water (2ml) and 
extracted with methylene chloride (3ximl). Emulsification oi mio /
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the two phases was accomplished by agitating the stoppered 
centrifuge tube for approx. 20 sec. on the Hicromixer. The emulsion 
was broken by a brief centrifugation, and the (lower) methylene 
chloride l’ayer withdrawn with a Pasteur pipette. The combined 
extracts were evaporated to dryness and the residue taken up in 
ethyl acetate (400yul).
Where the substrate for the oxidation was a 20,21-ketol or 
a 17&,21-dihydroxy-20-one, a carboxylic acid function resulted at 
C-20. In this case, the acid was methylated by treating the above 
ethyl acetate solution with an excess of a freshly prepared ethereal 
solution of diazomethane (prepared from bis-(N-methyl-N_-nitroso)- 
terephthalamide ^ ^ ) .  A persistent yellow colour indicated the 
methylation was complete. Finally, the reaction mixture uas taken 
to dryness under nitrogen and the residue re-dissolved in ethyl acetate 
for GLC.
Oxidation with Sodium Bismuthate. T h e  steroid (400^ ug) was 
placed in a screw-capped Pyrex tube (10cm x 1cm), together uith 
sodium bismuthate (4mg) and 50% aqueous acetic acid (400pil).
The tube was wrapped in aluminium foil to exclude light, and shaken 
at room temperature for 3 h. A saturated solution of sodium 
bicarbonate (1.0ml) was then added, and the resulting mixture filtered 
into a clean centrifuge tube. The product was extracted (in a similar 
manner to that outlined above for the periodic acid cleavage) using 
dry methylene chloride (3xlml), the combined extracts washed, first 
with N sodium hydroxide (1.0ml) and then with water (2.0ml), and 
finally dried and evaporated. The residue uas taken up in ethyl 
acetate (200yul) for GLC.
( 4 8 ) ( 4 9 )
( 5 0 ) (51)
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Fiq«23: Representative corticosteroids studied in section 3.
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RESULTS AND DISCUSSION
The following steroids, which were used in this study, were 
taken to be representative of the six types of corticosteroid, 
classified according to their side-chain:-
(i) Dihydroxyacetone:
Reichstein's Substance S (17&,21-dihydroxy-4-pregnene-
3,20-dione; 48).
(ii)20,21-Ketol:
Deoxycorticosterone (21-hydroxy-4-pregnene-3,20-dione; 49)
(iii) 20,21-Diol:
20 ^  ^ 21-Dihydroxy-4-pregnen-3-one (50).
(iv)l7, 20-Diol;
17oc,20^ -Dihydroxy-4-pregnen-3-one (51).
(v) 17,20,21-Triol:
17c*, 20J3,21-Trihydroxy-4-pregnen-3-one (52).
(vi)20,17-ketol:
17oC -Hydroxyprogesterone (l7oUhydroxy-4-pregnene-3,20-dione; 53). 
The structures of these compounds are given in fig.23. 
PREPARATION OF DERIVATIVES
flO TflS Ethers. The results confirm the general efficacy of the
54)i^ tfo-stage procedure , whereby reactive ketonic groups are
•converted to 0-methyloximes and these products are trimethylsilylated,
 ^o-u u  ^ i 138,152,161,162,165)with or without reaction of the 17(X-hydroxyl group.
Thus study was limited to 11-deoxysteroids, but conditions have already
been well established for the trimethylsilylation of llp-hydroxycorticos-
teroids.152’162  ^ 11-Ketones are highly resistant to methoximation,1^
while their conversion to enol-TMS ethers occurs only slowly even
182,161)
under vigorous conditions.
flethylboronates. The preparation of these derivatives was effected 
by mixing the steroid with methylboronic acid in an organic solvent.
This extreme simplicity allowed the formation of methylboronates 
from as little as 4tfjg of steroid diol. (The presence of additional/
IV .  OV-1 , 5 2 0 *
2775
lo
2M0
20
time (minutes)
1% OV-1. 220■
MeON*
100100
MeON
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100
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24: Gas chromatograms of representative single and mixed
derivatives of Substance S.
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additional hydroxyl groups complicates the reaction.95 )^
Dimethylsiliconides. These derivatives uere satisfactorily obtained 
only from a dihydroxyacetone and from a 17, 20-diol: conditions
suitable for the formation of a 20,21-dimethylsiliconide 97  ^ were 
not found. Both the reagent (dimethyldiacetoxysilane) and the 
derivatives uere extremely susceptible to hydrolysis. This 
finding contrasts with the reported stability towards hydrolysis 
of dimethylsiliconides from 16c(, 17&-dihydroxycorticosteroids.
Acetonides of Diols. The method of Bailey 9 where £-toluenesulphonic 
acid is employed as a catalyst, was found satisfactory for the 
small-scale preparation of acetonides from both 17,20- and 20,21-diols. 
The use of perchloric acid as a catalyst would doubtless be
superior for the formation of 17,20-diol acetonides in larger 
quantity. The acetonide obtained from the 17, 20,21-triol is 
assumed to be the 20,21-derivative.150)
Oxetanones from Steroidal Dihydroxyacetones. These derivatives uere 
prepared from large amounts (lOOmg) of steroid, as outlined in 
section 2.2.
85 )
Side-Chain Degradation Products. Oxidation with periodic acid
9l)or sodium bismuthate resulted in the formation of an aldehyde 
or carboxylic acid function at C-20, or removal of the side-chain 
to yield the corresponding 17-ketone. Carboxylic acids were 
methylated with diazomethane for gas chromatography.
GAS CHROMATOGRAPHIC PROPERTIES
Gas chromatographic retention indices for the various 
derivatives are listed in Tables 8-14. Satisfactory peaks were 
obtained in all instances; chromatograms of representative single 
and mixed derivatives of Substance S are illustrated in fig.24.
It should be noted that although the Dexsil-300GC column has been/
1% Dexsil - 300GC 260
3020
3110
3265
3135
15105 min
B
-os
O BMe
BMeTMSO
Fj-9* 25; Separation of four corticosteroid types as their boronate 
ester derivatives.
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betin found suitable for certain steroidal tertiary alcohols, it would 
not be generally applicable to compounds containing free hydroxyl 
groups, since adsorption and/or decomposition has been observed in 
such cases.
While the retention data obtained are insufficient for 
detailed correlations, several general effects may be observedj-
(i) Nethoximation of carbonyl groups increases the retention on
OV-1 (cf. fig.24) but decreases it on Dexsil.
(ii) Among the derivatives formed without side-chain degradation, 
the methylboronates have the lowest retention indices, with the 
exception of the oxetanone from Substance S (on OV/— 1) and
the HO trims ether of 17ft,20p>,21-trihydroxy-4-pregnen-3-one 
(on Dexsil). The latter exception arises because of the
cumulative effects of the three m s  groups and the O-methyloxime
function in reducing the retention time on the more polar phase.
(iii)Trimethylsilylation of the 17(X-hydroxyl group is advantageous in 
reducing the retention times to values which are comparable (on 
Dexsil) with those of methylboronates.
(iv) It is evident that the only practical derivatives for the 
analytical separation of all six corticosteroid types are the 
1*10 TNS ethers. For the four types containing or 0_-diol 
groupings, the methylboronates provide a possible alternative 
with the advantage of lower retention times (cf. fig.25): thus 
the 4-pregnen-3-ones possessing the dihydroxyacetone, 20j3,21-diol, 
17c*,20p>-diol and 17<*,20f>,21-triol side-chains yield NO
(full-) TNS ethers with I ± 3070, 3140, 2985, and 3160 
respectively, while the corresponding methyl boronates have 
I x 2820, 2850, 2795 and 2970.
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IMo marked differences were noted at the 1 j j .g level in 
the response of the flame ionisation detector to the various 
derivatives. The important question of the lower limits of 
detection is discussed below in relation to mass spectroscopic data 
(section 3.3.4).
3.3.3 HASS SPECTROMETRIC CHARACTERISTICS
Salient features of the mass spectra of the compounds 
studied are cited in Tables 8-14. Ions below m/e 80 have been 
disregarded in assignment of base peaks. Molecular ions were 
generally prominent, although two derivatives failed to give one, 
namely the MO-HFB derivative obtained from Substance S (Table 8) 
and the 20|5,21-diol diTMS ether (Table 10.) In the former case, 
an intense ion at m/e (M-18) was obtained, indicating loss of the 
17c* -hydroxyl group and presumptive formation of the corresponding 
16-dehydro derivative. This elimination may have occurred in the 
ion- source, but it is more likely (from the low retention index 
value) that dehydration took place during derivative preparation.
No molecular ion was obtained from the 20j3,21-diol diTMS ether 
because of the supervention of oUcleavage of the TMS ether.
Similar dominance of ether fragmentation accounted for the low 
abundance of the characteristic "rirg A" ion of m/e 124 (cf. fig.14) 
in the TMS ethers of the 20,21-diol, 20,21-ketol and in the
20,21-diTMS ether of the 17,20,21-Triol. The fragmentations of 
other types of side-chain derivative competed more evenly with 
those characteristic of the nucleus: compounds retaining the
4-en-3-one group yielded ions of m/e 124, and the corresponding 
jD-methyloximes gave ions at m/e 125, 137, 151, and 153  ^ (fig.22).
The mass differences between the various derivatives, and their 
individual fragmentation modes, together provide a wide range/
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range of mass spectroscopic ions suitable for analytical 
characterisation.
PIHYDROXYACETONE (Table 8) Mass spectra of the five principal 
types of single derivative of Substance S are shown in fig.26. The 
di-MO mono TNS ether and its _dg analogue gave closely similar 
fragmentation patterns (with the expected mass shifts): the base peak
in each case was at m/e 386, representing loss of the trimethylsilanol
moiety. The diMO diTNS ether, in contrast, gave no significant peak 
at m/e (M -90); the dominant fragmentation proceeded via loss of a 
methoxyl radical. The characteristic"^^ ion at m/e 273 doubtless 
comprises rings A, B and C with C-14 and C-18, and corresponds to the 
well-knoUifragment of this type (m/e 244; fig.22) observed for cyclic 
boronates^’ ancj dimethylsiliconides^^with the added 29 mass 
units due to the NO group. The dimethylsiliconide gave a particularly 
intense molecular ion: the base peak at m/e 91 is structurally
insignificant. A notable feature of this spectrum is the peak at 
(N-28)+*: a similar ion was recorded by Kelly98  ^ for cortisol 11- 
dimethylsilyl ether 17,21-dimethylsiliconide. The nature of this 
elimination has not yet been firmly established, but it probably 
represents loss of CO. No corresponding peak occurs in the spectrum
of the methylboronate, which in other respects parallels the
dimethylsiliconide. The mass spectrum of Substance S oxetanone is 
described elsewhere (section 2.3.3). Previously reported mass 
spectra related to those discussed above include those of tetrahydro-S
NO diTNS ether,169^cortisol dimethylsiliconide^, the diNO (full-)
152) 17q )
TMS ethers of cortisol, cortisone 'and dexamethasone, , and
MO-TNS derivatives of various fluorinated cortiscosteroid drugs.108^
CO
c
o
•H
o
•H
-P
CO
•H
P
CD
■P
O
ca CJ
p CD
co Q
JO '— '
o
0
<4- C
o o
p
CO CO 0
0 O  CD -p
CJ t— 1 VO m
c  CO V,_/ o
CO C O
*o o to X-N in •H
C  -H O  vt cm in -P
3 iH LO 1— 1 St P
XI -P '— y v_/ O
co c O
(0 to ' in ^ >.
CO E sj- ai O- r-1 X
>  cn <— I sd rH CO o
•H co V_✓ v_' 0
+J p a
fll Lu c  ^ CO
*— 1 O ’ CO CD CM Cj-
CD rH ^r -H O' o
p __' V_✓
m
TD to /-N CO ^ 1—1 " ^ 0
O LO <0- r~- to cn cd >
CO cm in CM S3- i— i •HV_/ N_<» v_< -P
CO 0
0) 1— 1 '— ^ VO ^ sj- > >
3 c  o CD rH cm co •H
rH cm cn CM 'd i—iv— P
CO N_✓ '— y 0
> -a
c  ^ cn ^ cn ^
0| CD CM CO CO CO p
ro in st r>- co — o
El v ■” u-
0
-P
0
~ CD •a
01 ^  CD cn o a
co ro a . cn VO >H o
(0 (D 0) CM 'd- i— 1 •H
m a > l
P
-P
0czd
o
• p
+ CM ^ o  ^ Sf -p
. e: O  CM VO CD in cd CJ
•sj- >.— sd- a CO rH 0
i—i V_! Q.
>•— ’ m
i m •
rH CD .— .
•H CJ o o in 0 cn
O  10 G CM CO c^ E 'd'
ID X  O to rH a
Is- 0  a CO CO CO -P
w a n C 0
c m  hh 0 c
O  0 •H o
•h  a rH •H
-P -H 0 TD
C O  O  i—1 CD 1
0  C  O  1 in a in O
-p  *-< in r=> a to CO TD CM
0  CM o □ CD cn C
CO »-H to CO CM 0 CO1
m
1
0
0 o
3 0
jH
0 ai
> 0
p
X CL
0 i
TD -d"
C 1
•H >s
X
C o
o p
•H TD
-P X
0 C SO
-p 0 1
0 -P rH
TD c 0 CM
c cn □ CO
3 e: p
O h o • «a. i X) cn
E rH 1—1
O CM 0
CJ SZ rH
CD -p XI
■* Sr- 0 0
•rl E 1-
cn -n !
£1 T i—1
J- o CM
1 CM
i—i •* CD
CM CO CM
( 5 4 )
i-OSiMe
=0
^ c h 2
m/e 1 A3
0SiM e;TI+ ‘
NOMe
( 5 5 )
pOSiMe3
P=NH~OMg pd/e
CH
OSiMe
NH-OMe m/e175 
+  •
CH
— j + ♦
+
0"BMe 
/
0
( 5 6 )
Fig. 27; Fragmentations of 20,21-ketol derivatives,
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The methylboronate and the corresponding 3,20-diNO 
methylboronate "mixed" derivative afforded similar mass spectra 
in that the major mode of fragmentation in each case was the cleavage 
of ring D and expulsion of the boronate ring. However, in the diflO, 
ions characteristic of the O-methyloxime grouping were also prominent, 
the net result being a superimposition of fragmentation patterns.
A similar effect was encountered in the spectra of the diHO 
dimethylsiliconide and the diflO oxetanone. The mass spectrum of the 
diMO HFB derivative was dominated by the typical "ring A" fragments 
(fig.22), and contained prominent fluorine-containing ions at m/e 
69 (CF3+), 119 (C2F5+) and 169 (C3F?+).
20,21-KETQL (Table 9) The 21-TflS ether of deoxycorticosterone
(partial structure 54) underwent the expected major cA-cleavage of
the C-20/c-21 bond, with charge retention on either of the fragments.
This led to ions at m/e 103 (fig.27) and m/e (N-103); such ions
are.typical of TMS ether derivatives of primary alcohols ^^such
171 172)as 21-hydroxysteroids, * although they have also been observed 
in the spectra of TflS ethers of steroids with vicinal hydroxyl 
groups. The abundant ion at m/e 143 is noteworthy: an ion of
this mass was observed in about 30$> relative abundance in the
171)
spectrum of 11 j5 ,21-dihydroxy-5c*-pregnane-3,20-dione diTMS ether.
The mode of fragmentation may be as depicted in fig.27. The
spectrum of the diMO TMS ether (partial structure 55), in agreement
152 171)
with data previously reported, ’ included strong peaks at 
(M-174)+* and (n—187)"*" and quasi-complementary peaks at m/e 175 and 
m/e 188 - the latter representing the side-chain with one and two
ring D carbon atoms, respectively, as proposed by Gustafsson and
171} 95)
Sjflvall (fig.27). The 20,21-methylboronate, for which evidence
favours a A 1<7^ 2°-structure (56), yielded a spectrum dominated by
the "boronate" fragment at m/e 110. This feature is characteristic
of the boronates of 20,21-ketols, which all afford prominent ions
at m/c (95+R), where *R* is the alkyl group attached to boron.
Boronate derivatives of other types of cortiscosteroid side-chain,/
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side-chain, on the other hand, give spectra with abundant nuclear 
fragments, and fewer boron-containing ions.^^
The three derivatives compared here illustrate well the 
manner in which the base peak can be directed to various regions 
of the spectrum.
20,21-DIQL (Table 10) The diTMS ether of 20 ,21-dihydroxy-4-
pregnen-3-one gave no discernible molecular ion because of the
predominance of C*-cleavage and elimination of trimethylsilanol,
affording the base peak, (M-193)+. Methoximation of the 3-ketone
stabilised the molecular ion, as expected, and a peak at m/e 505
(n+*) was evident in the MO di TMS spectrum. A more balanced
fragmentation occurred with the methylboronate (partial structure 57)
leading to the "ring A" ion (m/e 124) as base peak, and to prominent
ions M+* and (M-42)+#, the latter arising through loss of ketene
from ring A (cf. fig.14). Fragmentation of the boronate ring
afforded the ion at m/e 85 (fig.28). The acetonide (partial structure
58) exhibited yet another mode of fragmentation, giving the (M-15)
ion as base peak; this ion is formulated as a tertiary carbonium
ion, stabilised by the two neighbouring oxygen atoms of the acetonide
ri n g ^ ^  (fig.28). Loss of the elements of acetic acid (60a.m.u.)
from the (M-15)+ion affords the prominent peak at m/e 297,
*jhile the intense ion at m/e 101 is doubtless due to the
dimethyldioxolenium ion C5Hg02+, paralleling the fragment of m/e
85 from the boronate. The ion at m/e 101 is prominent in the
spectrum of 20c*-dihydroprednisolone acetonide recorded by Bailey,
and in the spectrum of the 20,21- acetonide from a pregnanetetrolone
171)
studied by Gustafsson and Sjflvall.
17,20-DIOL (Table 11). The mass spectra of the monoTMS ether,
the M0 monoTMS ether and the M0 diTMS ether were all dominated/
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60.
dominated by ions arising from the fragmentation of the C-17/C-2G 
bond, with charge retention in either fragment. Such cleavage 
gives rise to ions at m/e 117 and m/e (1^—1 1 7 ) 51V5, 179) 2g).
The spectra of the two monoTMS ethers reveal ions at m/e (M-45).
This feature has been rationalised^*"^ in terms of a rearrangement 
uh ereby the trimethylsilyl moiety is first transferred to the 
1 7 & -hydroxyl group. This is followed by cleavage of the C-17/C-20 
bond, with the expulsion of the radical species CH CHOH. The
J
three cyclic derivatives exhibited individual breakdown patterns,
although each afforded an intense ion comprising the side-chain
moiety, at m/e (99+X). In addition, the methylboronate and
dimethylsiliconide gave strong peaks at (85+X); these could arise
by cleavage at C-13/C-17 and C-15/C-16 with hydrogen transfer to
the nuclear fragment, although an alternative mechanism is
/  4" •
illustrated in fig.29. The prominent ion at m/e 86 (CgH^O ’) ,
in the acetonide spectrum evidently arises from the 1,3-dioxolane
ring; a possible mode of formation is shown in fig.29.
17,20,21-TRIQL (Table 12) The diTMS ether (partial structure 62)
yielded the base peak at m/e 116, characteristic of such derivatives
and an intense ion (M-133)+. This loss of 133 a.m.u. has been
noted by Rosenfeld^^ and by flrinqer et al.~^^. although a
■satisfactory explanation of its origin was not presented. A
proposed mechanism for the formation of the (M-133)+ ion is given
in fig.30. (It should be borne in mind that, in view of the ease
of migration of TMS groups, structures such as (62) may not be
correct - see also comments below on the methylboronate-TMS ether
“mixed" derivative. Some information on this problem might be
18l)
gained by "mixed" silylation studies. ). In the spectra of 
the 3-MO 20,21-diTMS ether and the 3-MO 17,20,21-triTMS ether, the 
base peaks were due to the corresponding ion from direct cleavage/
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Fig.30: Fragmentations of 17a,20 p ,21-triol derivatives.
cleavage of the C-17/C-20 bond.
As in previous examples, the cyclic derivatives displayed 
modes of fragmentation markedly different from those of TMS ethers.
The methylboronate gave an intense molecular ion together with the 
"ring A" ion (m/e 124), and a nuclear fragment (m/e 287) resulting 
from the loss of the (rearranged)boronate side-chain"^^. Boronates 
from 17,20,21-triols are formulated as six- membered esters, 
involving the 17- and 21-hydroxyl groups9^’1^7^(Appendix III). 
Trimethylsilylation of the triol boronate thus yields the 
methylboronate 20-TMS ether "mixed" derivative. However, the 
spectrum of this compound had, as its base peak, m/e 103, an ion 
normally characteristictof TMS ether derivatives of primary 
hydroxyl groups (cf. fig.27). It is therefore proposed that the 
side-chain rearranges to a 17,20-methylboronate 21-TMS ether structure, 
which then undergoes scission of the C-20/C-21 bond to give the 
m/e‘103 fragment. In the acetonide, the aforementioned "nuclear" 
fragment (m/e 287) dominated the spectrum, while prominent ions in 
the low-mass region at m/e 43 and m/e 59 may be ascribed^7^to the
_l_ +
species CH C= 0 and (CH )_C=0H,respectively, deriving from 
3 3  ^ •
the acetonide ring.
20,17- KETOL (Table 13). The spectra of the diMO and diMO TMS 
ether both gave as base peaks (M-3l)+. The latter spectrum also 
contained a series of even-mass ions comprising the side-chain M0 
group rather than the ring A M0 groups114*1^  detailed assignments 
would require mass measurements combined with a study of labelled
/ iss)
derivatives. The characteristic ion at m/^ 273 has been 
mentioned above with respect to the dihydroxyacetone analogues.
No stable cyclic derivatives were obtained from/
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from 17o( -hydroxyprogesterone. This finding agrees with the 
observed resistance of 20,17-ketol groupings towards enolisation 
to give a A   ^ ^ -structure.Enolisation of the isomeric
20,21-ketols occurs much more readily, resulting in the more 
favourable A^^-double bond (see above).
SIDE-CHAIN DEGRADATION PRODUCTS (Table 14). Each corticosteroid 
type, with the exception of the 20,17-ketol, underwent side-chain 
cleavage on treatment with periodic acid or sodium bismuthate 
(fig.31); etiocholenic acid derivatives were methylated prior to 
study by GC-MS. The mass spectra of these oxidation products 
yielded abundant molecular ions, while the major fragmentations 
were those characteristic of the 4-en-3-one group'*'11 ^ (cf. fig.14).
The aldehyde (67) afforded two ions, at m/e 244 and m/e 229, which 
apparently resulted from cleavage of ring D, and an ion (M-85)+, 
presumed to comprise rings B,C and D, analogous to the fragment at 
m/e (M-85) in the spectrum of testosterone111  ^ (fig.32). Similar 
ions at m/e 244 and m/e 229 were present in the spectrum of the 
17o( -hydroxyetiocholenic acid derivative (64), which also afforded 
a peak at m/e (M-59) corresponding to loss of the carbomethoxy 
group via c(-cleavagb. The 17-deoxy analogufl(66) yielded a prominent 
ion at m/e 147, which may be formulated111  ^ as a fragment containing 
rings C and D, plus C-7.
The spectra of the MO and MO-TMS derivatives of the
114)
side-chain oxidation products were dominated by the well-defined 
"ring A" ions typical of A^-3-ketosteroid D-methyloximes (fig.22). 
Molecular ions were again abundant, and the "nuclear" fragment
m/e 273 uas evident in most cases.
3.3.4 DETECTION OF CORTICOSTEROIDS BY "SINGLE ION MONITORING".
The detection of particular compounds by means of a/
(66) m /e  1A7
CHO
H — I+*
. < v  c h o i
+-
m /e 244
CHO
n +
!+*
CHO
m /e  229
pjq, Fragmentations of side-chain degradation products.
a small set of characteristic ions in their mass spectra is now a 
well-established technique.58>60,61,73,182) jn suitable instances, 
the very simple technique of focusing at a single m/e value may
afford a satisfactory means of detecting and estimating steroids
4-t 4- 4.- 63,66,183,184) TU ^at low concentrations. 7 7 1 The success of such
procedures depends critically upon a number of factors, the
relative importance of which must be assessed experimentally. The
principal considerations in respect of corticosteroids (for which
derivative formation is a prerequisite) are as follows
(i) The ease, reliability, selectivity and completeness of 
derivative formation.
(ii) The stability of the derivatives.
(iii)Their retention times, and the quality of the chromatographic 
peaks.
(iv) The degree to which the derivatives may be lost by adsorption 
• or destruction during gas chromatography.
(v) The character of the ions to be selected for monitoring.
(The choice of fragment will depend on the structural 
features that it is desired to detect).
(vi) The nature of probable interference by ions from other compounds 
in the sample, and its avoidance - as far as possible - by 
optimal selection of the sample preparation method, type of 
derivative, stationary phase and chromatographic conditions.
(vii)The m/^ 3 values at which similar interference may arise from 
impurities constantly or frequently present in the "background" 
of the GC-NS system. ( In some cases, sample fragment ions 
coincide with prominent "background" peaks, and thus prove 
unsuitable for single ion monitoring purposes. Consequently, 
a different derivative, yielding an ion of more suitable/
re
sp
on
se
100
10-
1-
0-1
10-1 0*2 0-4 2 10 40 1,0004 20 100 200 400
sample size (ng)
Fig.33: "Single ion monitor" response to derivatives of Substance S.
+17,21-anhydro derivative (m/e 286); □ 17,21-methylboronate (m/e 370); 
o 17,21-dimethylsiliconide (m/e 402); A 3,20-diflO 17,21-diT(vlS 
(m/e 548); • 3,20-diMO 21-TMS (m/e 386),
Electron multiplier voltage 1.7-3.7kV.
Response measured as peak height, with adjustment for different 
amplifications (Logarithmic scales).
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suitable m/e value, may have to be employed. JD-rings, septa 
and solvent impurities contribute to the "background", as does 
"bleed" from the GLC column - this latter source of 
interfering ions may be avoided to some extent by the use of 
alternative stationary phases, although most of the high 
temperature phases used for steroid work are silicones which 
give a number of common ions.)
(viii) The relationship of the actual m/e values selected for
monitoring to the degree of mass resolution, as well as to 
the sensitivity of the electron multiplier system in the 
region of the spectrum concerned.
In this survey, particular attention was given to five 
representative derivatives of Reichstein*s Substance S. In each 
instance, ions of even mass were selected for monitoring: the
majority of strong "background"peaks are of odd mass. For the 
diMO TMS ether, the base peak (M-90)+* was chosen; for the diMO 
diTMS ether, dimethylsiliconide and methylboronate, the molecular 
ions were used; and for the oxetanone, the base peak (M-42)+* was 
employed. In each instance, the lower limit of detection was 
explored, with the results summarised in fig.33. All the derivatives 
.were satisfactorily applicable for detection and estimation of 
quantities above 100 ng. Below this level, marked differences in 
behaviour were noted, and only the oxetanone remained clearly 
detectable at the 400 pg level. It appeared probable that the loss 
of response was due to adsorption of the derivatives on the 
chromatographic column.
It may be observed that the derivatives which were most 
easily prepared (methylboronate; diMO 21-TMS) were also those most 
susceptible to loss at low sample sizes, whereas the more/
65.
more difficulty accessible oxetanone and dimethylsiliconide yielded the 
best results under these conditions. The derivative of choice with 
respect to convenience of preparation and range of detectable 
concentration would appear to be the diMO diTMS. This result is 
in agreement with the current trend towards the use of fully- 
silylated derivatives for the gas-phase characterisation of steroids. 
152,161,162) introduction of O.-benzyloximes (BO) and BO-TMS
ethers'*"^’ ranks as an important complementary development in 
this area, while the use of other O-alkyloximes is discussed in 
sections 4 and 5.
The data in Tables 8-14 suggest that derivatives
suitable for detection by single ion monitoring should be obtainable
from all types of corticosteroid. In certain instances,
apparently suitable peaks might be inappropriate: for example,
m/e values of 124,125 and 157 represent ions which are relatively
abundant in the "background" spectra of the instrument used in this
work at the temperatures (for OV-l and Dexsil) required for steroid
derivatives.Untoward coincidences of this kind can be
circumvented either by selecting an entirely different derivative,
or by using simple homologues to shift the masses of the desired
ions without any undue alteration to the fragmentation mode.
Examples include d_-TMS ethers, chloromethyl (dimethyl)silyl ethers,
“9
O-ethyloximes and other CJ-alkyloximes, O^trimethylsilyloximes and 
JD-benzyloximes.
The extent to which mass spectrometric detection is likely
to prove useful in the analysis of urinary corticosteroids is by
no means fully explored. Single ion monitoring has been found
suitable for the study of certain steroidal drug metabolites, and is
particularly effective for steroids which occur in unconjugated/
66.
unconjugated form, such as Dianabol (17jS-hydroxy-17 (A -methyl-1,4-
187 )androstadien-3-one) and its 6 |3 -hydroxylated metabolite.
Recently, a procedure for the estimation of both cortisol and estriol
im plasma or urine has been developed, in which single ion monitoring
is employed to detect prominent fragment ions in the diflO-triTHS
188 )
ether and tri (cl^THS ether derivatives, respectively.
3.3.5 CONCLUSIONS
The results of this survey indicate that the majority
of derivatives which have been developed for the gas chromatography
of corticosteroids also have qualities useful for GC-MS. The
range of compounds examined is, of course, very limited, and some
derivatives of proved utility - particularly the enol-THS ethers 
151-154)
- have not received attention, while others await evaluation. 
Examples of known derivatives of steroidal dihydroxyacetones which 
have not, apparently, been applied to gas-phase studies are the ,
17,21-formals,^9  ^ a c e t o n i d e s , o ther  17,21-acetals,'L9^  and
, 192,193)
orthoesters.
The variety of fragmentation modes displayed by the 
different classes of derivative is of obvious value in the 
identification of corticosteroids. In addition, ions characteristic 
of individual compounds (or common structural features) are frequently 
produced, and permit the detection of their parent molecules by 
monitoring the ion current at a single m/e value or a few such 
values. The practicability of the mass spectrometric estimation 
of corticosteroids in the sub-nanogram range is clearly foreshadowed 
by the data presented here.
SECTION 4
0-ALKYLOXIMES AS DERIVATIVES FOR THE STUDY OF KETOSTEROIDS
BY GAS CHROMATOGRAPHY
68.
INTRODUCTION
A variety of derivatives have been employed for the study
of ketosteroids by gas chromatography. These include thioketals,
195)
enol esters, x hydrazones and oximes. Enol-trimethylsilyl ethers
(enol-TMS ethers) have been shown to be suitable derivatives for
corticosteroid metabolites with 20,21-ketol or dihydroxyacetone
s i d e - c h a i n s , a l t h o u g h  4-en-3-one groupings may give rise to
a mixture of p r o d u c t s , w h i l e  only partial reaction occurs with
1 7 - k e t o s t e r o i d s . N -Dimethyl hydrazones  may be readily
prepared from reactive ketone groups,*^^although they have been
shown to lack stability on exposure to light and air; the
pentafluorophenylhydrazone has been applied to the estimation of
197)estrone, using GLC with electron capture detection.
The derivative of choice in most cases, however, has been
a substituted oxime. Simple (unsubstituted) oximes are of limited
value due to their high polarity, although they may be readily
converted to the non-polar JD-trimethylsilyl oximes (TMS oximes) or 
175)
^0-acetyl oximes. TMS oximes were first applied in the carbohydrate
198)
field by Sweeley jrt al., and later shown to be suitable for the
gas chromatography of ketosteroids.146,175,199) O-Methyloxime (MO)
137)
derivatives, originally introduced by Fales and Luukkainen in 1965 ,
have proved to be of great use owing to their ease and completeness
of formation, stability and excellent GLC properties (see section 3).
54)
The "mixed11 MO-TMS derivatives of Gardiner and Horning have been
widely applied to the study of urinary steroid profiles by gas •
55,200-202) , ..
chromatography and mass spectrometry. The retention
increments (on non-selective stationary phases) associated with
the formation of MO derivatives or £-ethyloximes (E0)146^are small,
and do not lead to gas chromatographic group separations of/
69.
of ketosteroids from related hydroxysteroids and steroids
54)possessing unreactive keto groups. The analogous _0-benzyloximes
(BO derivatives)^^’ readily afford complete separations of
this type because of their much longer retention times. However,
the large retention increments accompanying BO formation preclude
the analysis of most diketonic steroids; furthermore, the late
elution of BO derivatives of ketosteroids leads to some
21
difficulties because of the abundance of "background" ionisation 
in mass spectrometry.
In the present investigation, aimed at extending further 
the range of substituted oximes, four JD-alkylhydroxylamines 
have been selected which afford oximes with retention times (and 
molecular weights) intermediate between those of MO and BO 
derivatives: these are 0-sec-butoxyamine, 0_-isobutoxyamine,
Cl^n-pentoxyamine and ^O-isopentoxyamine. It was envisaged that 
the new alkyloximes would complement the established derivatives, 
by preserving to some extent the group separating power of the 
benzyloximes but also allowing (like the methyloximes^^)the 
elution of diketone derivatives. The availability of a range of 
O-alkylhydroxylamine reagents would permit the recording, from 
complex mixtures of hydroxy- and ketosteroids, of comparative steroid 
profiles which should simplify interpretations based on gas 
chromatography - mass spectrometry.
70.
4.2 EXPERIMENTAL
4.2.1 PREPARATION OF O-ALKYLOXIME DERIVATIVES
Analytical samples of [)-alkyloximes uere prepared in 
pyridine solution, using 0.5mg of reference steroid, according 
to the general procedure of Sakauchi and Horning^^ (cf. 
J]-methyloximes; section 3.2). Reactive hydroxyl groups were 
(in some cases) subsequently converted to trimethylsilyl (TMS) 
derivatives, according to the method of Chambaz and Horning"^^ 
(section 3.2).
Pregnenolone _0-isopentyloxime (from 40mg of pregnenolone)
was obtained in 95$ crude yield as a product giving only a single
GLC peak, and, after two recrystallisations from ethanol/water, gave
flaky crystals, m.p. 116-117° (Found, C:77.67; H:10.78; N:3.45$.
Calc, for C26H4302N: C:77.75; H:10.79; N:3.49$.).
N.M.R. (100MHz) gave:- 9.34X singlet (3H (C Me-group);
18
9*07^ 1:1 doublet (3=6Hz, 6H (two terminal Me-groups in isopentyl
chain) ); 8.97X singlet (3H (C^g Me-group) ); 8.19x singlet
(3H (C^ Me-group) ); 5.93t: 1:2:1 triplet (3=6.5Hz, 2H (methylene
protons Ok to oxygen function in isopentyl chain) ); 4.62X1:1
doublet (broad, 3=5Hz, 1H (Cg) ).
Progesterone (60mg) was similarly converted to its di-0- 
isopentyloxime in 92$ crude yield. After three recrystallisations 
from methanol, it had m.p. 86-88 (Found, C.76.58; H:10.82;
N:5.98$. Calc, for C31H5202N2! C:76#81» H:10.81; N:5.78$. )
SYNTHESIS OF DEUTERIUM-LABELLED REAGENTS
4.2.2 Synthesis of Isopentoxyamine-l-d^ Hydrochloride
(i) Isoamyl alcohol-1-d^. To a stirred suspension of lithium 
aluminium deuteride (1.092 g; 28.8 m mole) in anhydrous/
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anhydrous ether (40 ml) under a nitrogen atmosphere, was added
a solution of isovaleraldehyde (5.006 g; 58.2 m mole) in
anhydrous ether (10 ml). Complete addition took 35 min, and
was accompanied by gentle reflux of the reaction mixture.
Work-up afforded 5.8 ml (4.736 g; 52.6 m mole) of isoamyl
alcohol-l-d.. (Yield = 90%). Infra-red:- ^ at 
—1 max
3350cm  ^ (s, broad) ( \) (0-H) ); 2170cm  ^ (s) (-0 (C-D) ).
N.M.R. (100 MHz) gave :- 9.08X 1:1 doublet (3=6Hz, 6H (two 
Megroups) ); 8.5x triplet (0=7Hz, 2H (C^) ); 8.31X multiplet
(1H (C^) ); 6.96x singlet (1H (-0JH) ); 6.41x1:2:1 triplet
(3=7Hz, 1H (Cx) ).
(ii) Isoamyl bromide-l-d .^ This was prepared according to the
203)method of Wiley et al. . To a stirred solution of dry
triphenylphosphine (11.88 g; 45.4 m mole) in dry 
dimethylformamide (50 ml) held under a nitrogen atmosphere was 
added 5.0 ml (4.08g; 45.4 m mole) isoamyl alcohol-l-d^.
Bromine (2.4 ml: 1.03 molar equivalent) was then added dropwise, 
the temperature of the reaction mixture being maintained 
below 50°. Two successive distillations at atmospheric 
pressure yielded isoamyl bromide-l-d^, b.p. 117-120° (2.9 ml; 
3-28 g; 21.4 m mole). (Yield=47.3$). Infra-red:-^ max
at 2235 cnf1(m) (%>(C-D) ). N.M.R. (100MHz) gave:- 9.07x 
1:1 doublet (3=6Hz, 6H (two Me-groups) ); 8.25x1:1 doublet
(broad, 3=6Hz, 3H (C2 and C3) ); 6.62x1:2:1 triplet
(0=6Hz, 1H (Cx) ).
(iii) Isoamyl 1-d^-benzhydroxamate^^ . Benzhydroxamic acid 
(2.686 g; 19.6 m mole) was dissolved in AnalaR methanol 
(25 ml), and the resulting solution vigorously stirred 
while a solution of sodium hydroxide/
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hydroxide (0.784 g; 19.6 m mole) in water (2.6 ml) was 
added. Isoamyl bromide-1-d^ (3.0 g; 19.7 m mole) was then 
added, and stirring continued for 24 h. The reaction mixture 
was kept at room temperature for 3 days, after which it was 
evaporated to dryness under reduced pressure. The residue 
was dissolved in ethyl acetate/water (10 ml : 10 ml), the 
organic layer washed with water (3x5 ml), and the washings 
back-extracted with ethyl acetate (5 ml). The combined 
organic extracts were dried, filtered and evaporated under 
reduced pressure, to yield the benzhydroxamate (1,557 g;
7.49 m mole) as a pale yellow oil. (Yield=38^.) Infra-red:- 
\) at 3475cm ^(w) and 3410cm ^(w) ( \)(l\I-H) ); 3025cm  ^ (w)
f f id X
(^)(aryl-H) ); 2155cm‘1(w) (^(C-D) ); 1650-1705cnf 1(s)
(0(C=0) ). N.M.R. (lOOMHz) gave:- 9.11x1:1 doublet 
(j=6Hz, 6H (two Me-groups) ); 8.44X 1:1 doubled (broad,
3=6Hz, 3H (C and C ) ); 6.05rl:2:l triplet (3=7Hz, 1H (C ) );
Z J X
2.66x multiplet (3H (jn and £-aromatic protons) ); 2.27X 1:1
doublet (J=8Hz, 2H (o^aromatic protons) ).
204)(iv) Isopentoxyamine-l-d^ hydrochloride. The crude benzhydroxamate 
(1.50 g; 7.21 m mole) obtained above was treated with 15 ml of 
a mixture of 12N-HCl/methanol (1:3), and the resulting clear 
solution refluxed for a period of 3 h. The solvent was 
evaporated on a rotary evaporator, yielding an oil, which 
slowly solidified. This residue was treated with ether (15 ml), 
and the solid product collected by filtration, washed well with 
more ether (15 ml) and dried under vacuum, affording a 
colourless, amorphous solid (0.779 g; 5.5 m mole), (Yield= 
76,6%), which on recrystallisation from ethanol/ether, gave 
large translucent plates, double m.p. 115-117° and/
73.
and 143-145°. Infra-red:- 'O C^H C13^  at 2165cm"1(w)
max v
(^(C-D) ). N.M.R. (100 MHz) gave:- 9.18*1:1 doublet 
(3=5Hz, 6H (tuo Me-groups) ); 8.44X 1:1 doublet (broad,
3=6Hz, 3H (C2 and C ) ); 5.67x 1:2:1 triplet (3=6Hz, 1H
(cx) ).
Synthesis of Isopentoxyamine-l-d^ Hydrochloride.
(i) Isovaleric acid. A mixture of isovaleraldehyde (7.144g;
83 m mole) and AnalaR acetone (5ml) was placed in a 50ml two- 
necked flask, equipped with pressure - equilibrated dropping 
funnel and thermometer. The mixture was stirred magnetically 
and cooled in an ice-bath to approx. 10°. 3ones reagent 
(20ml; prepared by dissolving 13.36g chromium trioxide in a 
mixture of conc. sulphuric acid (11.5ml) and water (20ml), and 
making the resulting solution up to 50ml with water) was then 
added dropwise, maintaining the temperature of the reaction 
mixture below 30°. Complete addition took 2h, after which 
the reaction product was poured into water (50ml) and extracted 
with ether (3x50ml). The combined ether extracts were then 
treated with IN sodium bicarbonate (2x50ml), and the bicarbonate 
washings were acidified by careful addition of dilute (2N) 
hydrochloric acid (40ml). The resulting cloudy solution was 
ether-extracted (3x150ml) and the combined ether extracts 
finally dried and evaporated iri vacuo to yield isovaleric acid 
(4.4g; 43 m moles; Yield=52^).
Note: The acid isolated contained some dissolved C r ^  salts, as
evidenced by a pale green coloration.
(ii) Methyl isovalerate. Isovaleric acid (4.4g; 43 m mole) was 
dissolved in anhydrous ether (20ml), and the solution placed 
in a 500 ml round-bottom flask. A solution of /
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of diazomethane (approx. 60 m mole) in anhydrous ether (250ml) 
was then added in portions, with swirling, and the final 
solution evaporated to give the product as a pale green liquid 
(the colour arising from the aforementioned chromium salts).
The crude ester was finally distilled, using a "Quickfit" 
micro-distillation apparatus, and the methyl isovalerate 
collected as a clear liquid (Yield=l.966g; 17 m mole; 40^).
(iii) Isoamyl alcohol-l-d .^ This compound was obtained by the 
reduction of methyl isovalerate with lithium aluminium 
deuteride, in a similar fashion to that previously described 
for the preparation of the mono-deuterated alcohol from 
isovaleraldehyde (section 4.2.2). The isoamyl alcohol-l-d^ 
(0.77g) so obtained had the following constants: Infra-red:-
^  at 3380cm 1 (broad, s) (V(O-H) ); 2170cm ^(m) and 
max
2115cnf1(s) (n>(C-D) ). N.M.R. (100MHz):- 9.05* 1:1 doublet 
(3=6Hz, 6H (two Me-groups) ); 8.50* 1:1 doublet (broad,
3=7Hz, 2H (C2) ); 8.31* singlet (broad, 1H (0-Hj); 8.27t:
multiplet (3=6Hz, 1H (C3) ).
(iv) Isoamyl bromide-l-d^. Bromination of isoamyl alcohol-l-c^
(0.764g) was carried out according to the method previously 
described (section 4.2.2). In this case, however, the reaction 
product was distilled, and the distillate which had been 
collected below 150° was treated with water (lml) and 
extracted with light petroleum, b.p. 30-40° (4x10ml). The 
combined petroleum extracts were washed with water (5ml) and brine 
(5ml), then dried and evaporated to yield isoamyl bromide-l-d^
(0.397g) as a colourless liquid. Infra-red:- ^ max at 
2290cm“1(w) and 2180cm”1 (m) (>)(C-D) ).
Isoamyl 1-d^-benzhydroxamate. Condensation of isoamyl/
isoamyl bromide-l-d^ (0.393g; 2.56 m mole) with
benzhydroxamic acid (0.354g; 2.58 m mole) was carried out as
outlined above (section 4.2.2). liiork-up afforded the
benzhydroxamate ester (0.254g; 1.21 m mole) in 48$ yield.
Infra-red:- at 2230cm ^(m), 2165cm ^(m) and 2120cm ^
max 7
(m) (V (C-D) ).
(vi) Isopentoxyamine-l-d  ^hydrochloride. Using the same procedure
as described above (section 4.2.2), isoamyl-l-d^benzhydrox-
amate (0.254g; 1.21 m mole) was hydrolysed to give
isopentoxyamine-l-id^ hydrochloride, which crystallised from
ethanol/ether as colourless plates (yield= 53.5mg; 0.39 m mole;
32$). N.M.R. (lOOHHz) gave:- 9.21t: 1:1 doublet (0=5Hz, 6H
(two Me-groups) ); 8.47t: unresolved multiplet, 3H (C and C ) ).
Preqnenolone-isopentyloxime(-1-d^)-Tlv15 and (l-d^)-TIY15.
These derivatives were prepared as indicated above
(section 4.2.1) using the appropriate labelled reagents. They gave
250°
single gas chromatographic peaks (igy  ^= 3130), and mass spectra 
consistent with the incorporation of one and two deuterium atoms, 
respectively (lYl+# : m/e 474,475) (see Appendix II).
5#-Androstan-17-one (A) 
and Oxime Derivat ives
M O
E O  s e c B u O
i P O
B O
r T T TT T
O IO 20 30 4 0  50
T I M E -  M I N .
Fig. 34: Separation of 5a -androstan-17-one (A) and its JD-methyloxime (MO), 
O-ethyloxime (EO), O-sec-butyloxime (s ecBuO), O-isopentyloxime 
XiPO) and fr-benzyloxime (BO) with a 9ft 1% OU-1 column by temperature 
programming at 1 ,/min from 17G°* Retention indices ere: 219*5.
2275, 2335, 2470, 2600 and 2980 respectively.
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4.3 RESULTS AND DISCUSSION
4.3.1 PREPARATION AND GLC PROPERTIES OF D-ftLKYLOXIFlE DERIVATIVES
All four _0-alkylhydroxylamine hydrochlorides reacted with 
a number of representative ketosteroids to give the expected 
derivatives, provided the reagent was present in large excess 
(20: 1 or greater). Reaction could be affected either at 70°
for 4 hr, or overnight at room temperature; the latter procedure
was found convenient. Under these conditions, no unreacted
starting material could be detected by GLC.
The resulting oximes were found to have good gas
chromatographic properties and possessed the expected increments in
retention time relative to the corresponding free ketones:
these were approximately 270 retention index units for the 
_0-butyloximes and approximately 410 units for the 0-pentyloximes, 
with a 1% 0V-1 phase. (The increments on the 0V/-17 phase were 
less, being about 200 and 365 retention index units, respectively.) 
These properties are illustrated in fig.34, where five oxime 
derivatives of 5c^-androstan-17-one are compared.
Initial experiments indicated that the two isomeric JD- 
butyloximes had very similar properties to each other, as also had
the corresponding J3-pentyloximes (Tables 15 and 16). Two of the
reagents, sec-butoxyamine hydrochloride and isopentoxyamine 
hydrochloride, were selected for more detailed investigation. Their 
reactions were examined with representative ketosteroids possessing 
3-one, 4-en-3-one, 16-one, 17-one and 20-one groupings. Quantitative 
conversion (as judged by GLC) to the JO-alkyloxime derivatives was 
observed under the conditions cited above. 3&-Hydroxy-5 j6 - 
androstane-ll,17-dione yielded only the 17-mono isopentyloxime/
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C Pregnanolone 
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Fig.35: Separation of steroids as TMS and MO-THS derivatives (upper), and 
the same mixture as TMS and iPO-TMS derivatives (lower). The 
chromatogram was obtained on a 9ft 1% 01/-1 column with 
temperature programming at 1 /min from 190°.
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isopentyloxime, as indicated by mass spectrometry of the corresponding 
"I" •
TMS ether (M *at m/e 461). The formation of syn/anti isomers was
observed in some cases (see Tables), notably with 4-en-3-ones, and
with 16-ones unsubstituted at C-17. Similar results have been
145)reported earlier for the HO derivatives. ' Steroids with a 3-one 
17-one or 20-one structure, however, gave rise to only one GLC 
peak on derivative formation, although Dray and Ueliky 
reported the formation of two MO isomers from 17 -hydroxy-5d- 
androstan-3-one and its 5|3-epimer.
The usefulness of the isopentyloximes (iPO) in effecting 
chromatographic separation of mono- and diketosteroids from hydroxy-
%
steroids is illustrated in. fig. 35. The upper chromatogram (a) 
shows a mixture of steroids as MO-TMS derivatives, and the lower 
(b) the same mixture as iPO-TMS derivatives, showing the improved 
separation from pregnanediol diTMS.
4.3.2 MASS SPECTROMETRIC CHARACTERISTICS
All the derivatives studied by mass spectrometry gave 
molecular ions in moderate abundance. It was expected that the 
fragmentation modes of the O-alkyloximes would parallel the well-known 
processes observed for MO-TMS derivatives, and comparison of the 
representative mass spectra in figs.36 and 37 confirmed this in some 
respects e.g. in the characteristic loss of the J^-alkoxy radical, 
affording a prominent peak at m/e (M-31) in spectra of methyloximes, 
158,159)a£ (m-73) in spectra of butyloximes and at m/e (M-87 )
for pentyloximes. The £-alkyloximes from 20-ketosteroids yielded 
the expected ions by cleavage of ring thus the ion at
m/e 244 in the mass spectrum of 21-hydroxypregnenolone iPO diTMS 
(fig.36, *Bf) comprises the side-chain together with the oxime 
grouping, C-16 and C-17, and corresponds to the fragment at m/e 
188 in the MO diTMS derivative (cf. fig.36, 'A1). Similarly, in/
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in the spectra of the two O^-alkyloxime derivatives of 3 |3 , 17|3 - 
d.ihydroxy-5-androsten-16-one depicted in fig.37, abundant ions 
retaining the alkyloximino group are present at m/e 216 and m/e 
230. These fragments, which comprise C-15, C-16 and C-17 (with 
their substituent groups), arise from scission of the C-13/C-17 and 
C-14/C-15 bonds, with hydrogen transfer from the nucleus; a 
corresponding ion at m/e 174 occurs in 95^ relative abundance in 
the spectrum of the MO diTMS derivative (not illustrated), and 
a similar ion at m/e 145 appears in the spectrum of the diTMS 
e t h e r . T h e  various oximes thus afford some common and some 
distinctive fragment ions, both types being useful in the recognition 
of ketosteroids in the analysis of mixtures by GC-MS.
The mass spectrum of the iPO - diTMS ether of 3j3,17j3> - 
dihydroxy-5-androsten-16-one (fig.37, fBt) revealed a prominent 
ion at m/e 503, corresponding to the loss of 30 mass units from 
the molecular ion. Examination of other data indicated that 
(M-30)+’ions were absent from the spectra of sec-butyloximes 
and isobutyloximes, but were formed by many isopentyloxime and 
rnpentyloxime derivatives. A further complicating feature was noted 
in the occurrence of (M-44)+* and (M-45)+ ions, as exemplified in 
fig.36, *Bt. The incidence and abundance of (M-30)+*and 
(fl-44)+* ions were markedly dependent on the structures of the 
ketonic substrates, as indicated in Table 17. 17-0xosteroid iPO 
derivatives yielded strikingly prominent ions, especially at 
(M-30)+*; 20-oxosteroid isopentyloximes unsubstituted in ring D 
gave lesser amounts; and in 1 6 or 1 7 & -trimethylsilyloxy-20- 
oxosteroid iPO derivatives, no ions of either type were detected.
High resolution mass spectrometry gave the exact mass 
of the (M-30)+*ion from pregnenolone iPO (molecular weight: 401)/
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(molecular weight: 401) as 371.3189. This indicates a molecular 
formula of ^25^41^ (calculated mass: 371.3188), corresponding
to the loss of CH^O from the molecular ion. It appeared probable 
that the CH^O unit originated from the alkoxy group, and this was 
confirmed by data recorded for derivatives labelled by the route 
indicated (fig.38) with one and two deuterium atoms, respectively: 
ions at (M-31) * and (FI-32) *were observed (see Appendix II).
The simplest mechanism for the production of these ions would 
appear to be as in fig.39: their absence in the case of 16- and
17-trimethylsilyloxy-derivatives is presumably due to steric 
inhibition of the cisoid conformation of the N-O-CH^-R grouping.
From models, this is clearly very likely with 17d-substituents, but 
the effect of a 16 dv-trimethylsilyloxy group would be expected to 
be less marked.
The identity of the ions at m/e (M-44) and (H-45), 
which occur in the spectra of many iD-pentyloximes, particularly 
those of 17-ketones (Table 17), has not yet been established. However, 
they appear to be associated with a fragmentation of the alkyloxime 
group, similar to that described above leading to the (lvl-30)+* 
species. Thus, in the labelled pregnenolone-(l-d^JiPO-THS ether 
and fjrfegnenolone-(l-d^2)i>P0-TlvlS ether derivatives, the (M-44)+* 
and (M-45)+ions had shifted to (M-45)+*and (M-46)+, respectively.
In the spectrum of dehydroepiandrosterone iPO TflS ether 
(DHA iPO TMS), a trio of ions of moderate intensity, at m/e 
(fl-43), (fl-44) and (M-45) was noted; in the corresponding (1-d^) 
iPO derivative, these ions had likewise shifted to m/e (M-44),
(M-45) and (N-46), respectively.
The possibility that the observed loss of 45 mass units 
from the molecular ion might represent a combination of losses/
80.
losses of 15 a.m.u. (CH radical) and 30 a.m.u. (CH 0) was
3 2
investigated in the case of DHA iPO TMS ether, by examining the
corresponding d^-TMS derivative. Should the methyl radical
involved in such a process originate from the trimethylsilyloxy
group, the original loss of 45 a.m.u. would become a loss of 48 mass
units in the deuterated derivative. However, no peak at m/e
(M-48) was present in the spectrum of DHA iPO cL-TMS ether.
— y
Nevertheless, this spectrum did serve to illustrate the dual origin 
of the (M-15)+ peak, a common ion in the mass spectra of steroid 
TfiS ethers: although still present for the deuterated TMS ether,
the intensity of this ion had dimished, while a new peak at m/e 
(1*1-18) had appeared. Therefore, this (fl-15)+ion must coirespond 
to loss of a methyl radical from the steroid nucleus, while the 
(N-18)+ fragment results from elimination of a CD^ radical from 
the TMS group. (This phenomenon has previously been described by 
Diekman and Djerassi.^^). It was concluded that the above 
(l*l-45)+ion could conceivably arise from the combined losses 
of 30 a.m.u. (CH^O) and a methyl radical (from the steroid nucleus), 
although an analogous mechanism to that postulated for the formation 
of the (lYl-44)+’ ion (fig.39) is favoured.
4.3.3 CONCLUSIONS
The butoxyamine and pentoxyamine hydrochlorides were 
found to react readily and quantitatively with a series of 
representative ketosteroids. The resulting derivatives were stable, 
and had good gas chromatographic properties, displaying retention 
times conveniently intermediate between those of the corresponding 
1*10 and BO derivatives. They were also suitable for study by 
gas chromatography-mass spectrometry, giving molecular ions and/
and informative fragmentation patterns.
These reagents therefore appeared very promising for 
the study of mono- and diketosteroids by gas phase methods, and 
their application to the study of urinary steroid profiles is 
discussed in section 5.
SECTION 5
COMPARISON OF ISOPENTYLOXIME AND BENZYLQXIME 
TRIMETHVLSILYL ETHERS IN THE CHARACTERISATION OF
URINARY STEROIDS OF NEWBORN INFANTS.
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5.1 INTORDUCTION
5.1.1 THE URINARY STEROID PROFILE
An important application of GLC and GC-MS in clinical 
chemistry is in the determination of urinary steroid profiles.
This technique permits the simultaneous qualitative and quantitative 
estimation of the various hormone metabolites in urine, and thus 
affords a means by which endocrine function may be indirectly 
assessed, e.g. many disorders of the adrenal glands give rise to 
markedly altered profiles, which may return to a more normal 
pattern following drug therapy. Basically, three strikingly 
different types of human urinary steroid profile can be distinguished: 
adult male, pregnant female and newborn infant.
The principal components in the adult male (and non- 
pregnant female) profile are reduction products of the adrenocortical, 
hormones (fig.2), e.g. tetrahydrocortisone (THE), tetrahydrocortisol 
(THF), cortolone and cortol (fig.4), the 17-ketosteroids androsterone 
and etiocholanolone (together with their 11-oxygenated analogues), and 
dehydroepiandrosterone (DHA). With the exception of DHA, which is 
excreted as its 313-sulphate, these metabolites are rendered water- 
soluble mainly through conjugation with glucuronic acid (fig.3).
The urinary steroid profile associated with pregnancy 
differs from that described above in that elevated levels of certain 
steroids - notably estriol and pregnanedio 1 - are apparent. The 
excretion of these two compounds rises steadily throughout pregnancy, 
and their urinary levels attain values of the order of 25mg/24h^^ 
and 35mg/24h,^^ respectively, at term. The involvement of the 
fetus in the production of estrogens has long been appreciated, and
the urinary estriol level may be taken as an index of fetal
2D9 210)viability. • * The other important estrogens, estrone and
estradiol, are found in pregnancy urine in much lower concentration.
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Pregnanediol is the principal metabolite of progesterone which,
in turn, is secreted in large amounts by the placenta. (it has
been estimated that some 250mg of progesterone are secreted per
211)
24h at term. ) Both pregnanediol and the estrogens are excreted 
mainly as their glucuronides, although some conjugation with 
sulphuric acid may also occur.
The pattern of urinary steroids obtained from newborn 
infants, however, is strikingly different from those described 
above. Extensive investigations into the nature of steroid
excretion in early infancy were carried out mainly by Mitchell and
212-219) 220-223)his colleagues and by Reynolds. The separation
methods employed by these authors were largely those of TLC and
paper chromatography; colorimetric and fluorometric determinations
of isolated fractions were used for the quantitative estimation
of the compounds present. The steroids identified in newborn
infant urine differed from those normally encountered for adults
in several respects:- (i) the major metabolites possessed a
A^-3^-ol structure, as opposed to the ring-B saturated compounds
which predominate in adult urine. However, additional saturated
metabolites, mostly of the 5 jj-pregnane series, have been more
224)
recently described in infant urine by Shackleton ert al;
(ii) many of the "newborn1' steroids possessed an oxygen function at
C-16, usually a 16cC -hydroxyl group;^,2^9,22‘^  (iii) sulphate
conjugation was found to be quantitatively more important than
225)conjugation with glucuronic acid ; (iv) the proportion of
urinary steroids excreted in unconjugated form, particularly polar
225 226)metabolites of cortisol, was higher for infants than for adults 9 ;
(v) among the ll-deoxy-17-ketosteroids, DHA, etiocholanolone and 
androsterone (which form most of the group in the adult) were
212)
present in infant urine in only trace amounts, if detectable at all ;
(vi) the urinary levels of THE and THF, excreted in large amounts
214)
by adults, were low in infant urine. Quantitatively, the
most important steroids excreted in the urine of newborn infants/
Umbilical Artery
Umbilical Vein
Urine
9)
Fiq.40t Diagrammatic representation of the feto-placental unit.
Fi = maternal compartment 
P = placenta 
F = fetus 
AF = amniotic fluid.
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infants were identified as:-
5-androstene-3 ,17c* (and 17(3 ) -diol,217’232^,
5-androstene-3 p*, 16c/. ,17f3 -triol,218,223,228,229\
16 c* -hydroxy-DHA,221,227\
16^3-hydroxy-DHA,205^,
221)16-Ketoandrostenediol ,
16 c* - hydroxy pregnenolone2'*'8’228 ’222 ^ , and 
21-hydroxypregnenolone.58 ’ 2^4-216)
5The excretion of these 3^ -hydroxy- A  -steroids was
observed to persist until the sixth month of life, when a more
222 230)"adult" steroid pattern began to emerge. ’ '
Clearly, steroid metabolism in early infancy differs 
considerably from that obtaining in later life, and the study of 
urinary metabolites affords an indirect means by which the 
biosynthetic processes operating i_n utero may be investigated.
5.1.2 STEROID MET ABOLISH Il\l THE FETO-PLACENTAL UNIT
The fetus and the placenta are physically distinct, and 
may be thought of as separate entities. During gestation, the 
fetus derives its nourishment via the placenta, which acts as a 
"barrier" between fetus and mother. Certain compounds may cross 
this placental barrier e.q. glucose, fats, amino acids, vitamins 
and certain steroids. However, during intrauterine life, the fetus 
and the placenta function together, and, particularly with respect 
to steroid biogenesis, they are advantageously thought of as two 
specialised compartments of an integrated functional unit. The 
term "feto-placental unit" is used to emphasise the important inter­
relationship, which is illustrated diagrammatically in fig.40.
Steroid metabolism in the feto-placental unit has been 
investigated extensively by means of both iji vitro and _±n. vivo
231-233)
experiments, and a number of reviews have appeared on the subject. 
Basically, the feto-placental unit is responsible for the synthesis of the 
large quantities of estrogens and progesterone necessary for the 
maintenance of pregnancy. While progesterone production is/
OH
" 0  SO 
3
HO
(68  ) ( 6 9 )
(71) ( 7 0 )
Fig.41: Placental synthesis of progesterone from cholesterol 
sulphate.
is essentially limited to the placental compartment, the fetus 
plays an important role in the formation of estrogen precursors..
The synthesis of these tuo types of compound will be dealt 
with separately:-
Progesterone: Although fetal tissues have been demonstrated to be
capable of the cte novo synthesis of cholesterol from acetate (cf. 
234-236)
fig.l) , the major precursor of progesterone is believed
to be cholesterol from the maternal bloodstream, where it is
237)
present as the 3j& -sulphate. Placental synthesis of progesterone
(71) from cholesterol sulphate (68) (fig.41) has been shown to
proceed via removal of the sulphate group (through the action of a
sulphatase enzyme), cleavage of the cholesterol side-chain
238 239}
probably via cholesterol 20^, 22R-diol (60) * , and finally
conversion of the pregnenolone (70) so produced by the combined
action of two enzyme systems, 3j5 -hydroxysteroid dehydrogenase 
A 4-5
(3|3-HSD) and a A  isomerase. This last step, the formation of
4 5A  -3-ketosteroids from 3 -hydroxy- A  -steroids, is an important
reaction in placental tissue. The progesterone formed is
distributed between maternal and fetal compartments; in the former,
it is mainly reduced to pregnanediol in the maternal liver prior to
conjugation and urinary excretion, while hydroxylation at various
sites (e.g. 6£ ,llj?> ,15<X ,16(X ,17oC and 21) takes place in fetal 
231)
tissues, along with partial reduction to e.g.the 20c^-dihydro 
derivative.
Estrogens; Whereas the placenta lacks the enzyme system (a 17,20-
desmolase) required for complete removal of the cholesterol
side-chain (Table 18), the fetus actively converts pregnenolone (70)
234 241)
to dehydroepiandrosterone sulphate (DHAS; 72), * thus
providing a source of estrogen precursors. The first steps in the 
synthesis of estrogens from C^g steroids are the removal of the
5
sulphate ester function and the conversion of the 3 |3-hydroxy- A  
system to a 4-en-3-one grouping. The fetus, however, has a 
deficiency in the two enzymes required to bring about these/
Enzyme system Placenta F etus
/ 4-5
3|3-HSD/ A  isomerase High Lou
Aromatisation High Lou
Sulphatase High Lou
Sulphokinase Lou High
16c* -Hydroxylase Lou High
17c* -Hydroxylase Lou High
17,20-Desmolase Lou High
Steroid synthesis from acetate Lou High
232)
Table 18: Enzyme activities in the placenta and fetus.
00 \ 0
(72 )
V 0 \ / 0
(74) (76)
OH
OH V OH
OH
(75) (77)
lia .42: Najor pathuays for the synthesis of estrogens in the feto­
placental unit.
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these conversions; the placenta, on the other hand, possesses a high
/ 4-5activity of the requisite sulphatase and 3|5-HSD/A isornerase 
enzyme systems, and can therefore utilise fetal DHA^, which it 
converts to androstenedione(73). Aromatisation of ring-A then
takes place, again in the placental compartment, via oxidative
242-244) , v
elimination of C-19, and estrone (74) is finally produced
(fig.42). Placental reduction of estrone is believed to be the
major route to estradiol (75), while estriol (77), quantitatively
the most important estrogen in pregnancy, is synthesised in the
placenta mainly from 16&-hydroxy-dehydroepiandrosterone sulphate
(l6cC-hydroxy-DHAS; 76).^^ This latter compound is formed in
large amounts by the fetus, whose, liver tissue possesses a highly
active 16(X-hydroxylase enzyme (Table 18).
The estrogens produced by the placenta are distributed 
between both fetal and maternal compartments. In the fetus, 
sulphurylation rapidly takes place, followed, to some extent, by 
further hydroxylation (e.g. at C-15&^^ 2^8)> estrogens are then 
re-cycled to the placenta. Estrogens entering the maternal 
circulation are eventually conjugated, mainly with glucuronic acid, 
although sulphate and "mixed" sulphate-glucuronide conjugates are 
also found in pregnancy urine. The general picture is therefore one 
of an estrogen/estrogen sulphate cycle between fetus and placenta, 
which results in estrogens being steadily transferred to the maternal 
compartment from the pool of estrogen sulphate in the fetus. The
above scheme of estrogen biosynthesis illustrates well the
complementary nature of steroid production in the feto-placental 
unit; tissues in fetal and placental compartments act sequentially 
because the requisite enzymes are present in one compartment, but 
absent from the other. The relative activities of various enzyme
systems in the placenta and fetus are shown in Table 18.
G8.
5.1.3 STEROID MET ABOLISH Il\l EARLY INFANCY.249^
At birth, three populations of steroids may be considered
to exist in the infant: (l) those arising from the metabolism of the
large amounts of estrogen and progesterone received from the placenta;
(2) 3 -hydroxy-A steroids produced in utero as precursors of
estrogen; and (3) cortisol and other steroids normally found in
adulthood. From all three groups, steroids or their metabolites
might be expected to be excreted in the urine of the newborn infant.
Metabolites of the compounds in group 1 would be excreted after
birth in rapidly decreasing quantities, since their source has been
eliminated; indeed, the level of urinary estriol has been found to
fall to barely detectable levels after the fifth day of life.^^
Excretion of the 3 -hydroxy-A steroids (group 2), on the other
hand, may actually increase rather than decrease during the first 
230)
month , and compounds with this structure predominate over all
218) A5
others in early infancy. This increase in A-steroid output
might be explained by the continued adrenal secretion of these
estrogen precursors after birth, and the relative inability of the
infant liver to deal with them in the same way as does the placenta 
251)
in utero. However, it would be reasonable to assume that the
A  -steroids fulfil some particular biological role, although the 
nature of this function remains unclear at the present time.
By the sixth month after birth, the excretion of 3p>-hydroxy-
5
A  steroids has generally fallen to a negligible level; this decline 
5
in A  steroid output has been correlated with physiological changes
in the infant adrenal glands, and with the accompanying maturation of 
/ a 4-5the 3p>-HSD/A isomerase enzyme system which is responsible for 
the production o f  A^-3-ketosteroids (cf.fig.41). Interestingly 
enough, of the adult-type steroids considered in group 3, the newborn 
infant produces adequate supplies of corticosteroid hormones from/
89,
252 253)from birth onwards. ' * " Since these compounds possess the 4-en-3-
/ 4-5
one grouping, it has_been suggested that the 3 jb-HSD/A isomerase
system necessary for their formation does exist in certain fetal
254 255^tissues, but that it is substrate-specific. ’ ' Thus, compounds
such as DHAS, 16c/\ -hydroxy-DHAS and pregnenolone sulphate, present
in Ugh concentration in the fetal circulation, might remain
unaffected, whereas various hydroxylated pregnenolone derivatives
might act as corticosteroid precursors in certain fetal tissues.
This theory was initially favoured by Mitchell and co-workers, who
a 4 5proposed that, in the newborn, 3 -HSD/ A  isomerase acted subsequent
218 ^
to 17ot-,21- and 11^-hydroxylase such a pathway might
explain the presence of 21-hydroxypregnenolone in infant urine.
However, a later investigation of polar steroids in plasma from 
human umbilical cords and in human infant urine failed to detect
5
any of the 3 ^  -hydroxy- A  analogue of cortisol, i.e. 3j$ ,llj$ , 17 ,
95 ft \
21-tetrahydroxy-5-pregnen-20-one. '
DHA, a 17-ketosteroid commonly encountered in adult urine,
212)is not normally detected in that of newborn infants, probably
due to the high activity of 16cC -hydroxylase in fetal and infant
liver (Table 18); 16q(,-hydroxy-DHA is, as previously mentioned,
a major infant urinary steroid. The high activity of 16oC-
hydroxylase is apparent in the first few months of life, and could
be a remnant of its necessary function _iri utero concerned with
the production of estriol (cf. fig.42). It may, however, be
involved with the important problem of electrolyte balance at
birth, and in early independent life, since natriuretic properties
257)
have been attributed to 16C\-hydroxylated C^^steroids.
Steroid metabolism and, consequently, the pattern of 
urinary steroid excretion in early infancy is thus highly complex, 
and undergoes a period of continuous change during the first six 
months of life. It is against this background of constant change, 
and of variations in the steroid excretion pattern often observed 
between individual infants,202^that any deviation from the/
90.
the "normal" metabolism has to be recognised. Such a deviation arises
in cases of congenital adrenal hyperplasia, the effects of which
on steroid metabolism are discussed below.
5.1.4 CONGENITAL ADRENAL HYPERPLASIA
Congenital adrenal hyperplasia results from an inborn
error in steroid metabolism involving defects in the enzyme
systems required for the formation of corticosteroid hormones.
The inadequate level of hormone in blood causes corticotrophin to
be secreted by the pituitary in increasing amount which, in turn,
causes hyperplasia of the adrenal glands with overproduction of
those steroids not affected by the enzyme block. The most common
deficiency is in 21-hydroxylase, but deficiencies have also been
reported in infants and children of 3p-HSD, 1113-hydroxylase and
cholesterol 20,22-desmolase.* 259)
In cases of 21-hydroxylase deficiency in infants, the
excretion of 3 jS -hydroxy- A^-steroids is usually much higher than
n o r m a l , and large amounts of 16 c(-hydroxy-DHA and 16ciL -hydroxy-
261 ^
pregnenolone are normally found in the urine. ' Furthermore,
pregnanetriol and the 11-keto derivatives of androsterone,
etiocholanolone and pregnanetriol may be excreted in the urine;
these compounds are more commonly encountered in older infants with
this defect, however, since their formation requires the action of
a ring-A reductase which is deficient in the liver of newborn 
262— 264)infants. " Thus the diagnosis of a defect in 21-hydroxylase
in infants through a study of the urinary steroid excretion is 
generally easier and more reliable when the infant is over six 
months old. At this age, an "adult" type of steroid metabolism 
has been assumed, and abnormal compounds e.g. pregnanetriol, are 
clearly visible in the urinary steroid profile.
5.1.5/
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5.1. 5 DERIVATIVE FORMATION IN STEROID PROFILE ANALYSIS.
GLC and GC-MS methods have been extensively employed 
by Horning and co-workers in the study of urinary steroid 
profiles from newborn infants.5^>56,175,200,265-267) jn ^he first
week of life, the excretion of corticosteroids of dihydroxyacetone 
and 20,17-ketol types is very limited, only tetrahydrocortisone 
(THE) being frequently observed. Accordingly, the major urinary 
steroids may be studied after simple trimethylsilylation. Under 
these conditions the principal components are readily identified 
by GC-MS, but there is considerable overlap of ketonic and hydroxylic 
steroid derivatives. The MO-TMS ethers provide a more convenient
%
mass spectrometric distinction between the two groups, but show 
fortuitous coincidence of retention times on non-selective phases 
(e.g. SE-30 or OV-l), as for example of 5-androstene-3 j3 ,16 ot , 17j3 - 
triol triTMS with 3o( , 6 -dihydroxy-5p -pregnan-20-one MO-diTMS.
BO-TMS ethers, on the other hand, give rise to a distinct "group 
separation" of hydroxy- from ketosteroids, due to the large molecular 
weight increments accompanying their formation. Thus, a BO-TMS 
profile will generally contain two distinct regions: hydroxysteroids,
or steroids possessing unreactive keto groups (e.q.at C-ll) are 
eluted first, followed by a group of peaks representing steroids 
with reactive ketone functions. Group separations of this nature 
are clearly desirable in simplifying the overall steroid profile, 
although the high temperatures (290-300°) required for the elution 
of many BO-TMS derivatives lead to high GLC column "bleed", and so 
to elevated levels of "background" ionisation in the mass spectrometer. 
Furthermore, the large retention increments accompanying BO formation 
preclude the analysis of most diketonic steroids. In view of the 
favourable results reported in section 4 for O^alkyloximes with 
retention times intermediate between those of the MO-TMS and BO-TMS 
ethers, it was decided to apply one of these, the iPO-TMS derivative, 
to the study of infant urinary steroid profiles. It was/
was envisaged that the iPO-TMS ethers would complement existing 
derivatives, and that their use would minimise the practical 
difficulties, outlined above, associated with the use of BO-TMS 
ethers in steroid profile analysis.
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5.2 EXPERIMENT flL
5.2.1 EXTRACTION OF STEROIDS FROM URINE
All urinary steroid extracts studied in this work were 
kindly supplied by Dr. E.M. Chambaz (Laboratoire dtHormonologie,
CHR de Grenoble, France). Urine samples were collected from 
both male and female newborn infants during the first five days 
of life. A fraction of each urine sample was used to constitute 
a pool.
The procedures used by Dr. Chambaz for the extraction 
of urinary steroids were as follows
"Total" steroid extracts were obtained after enzymatic 
hydrolysis (5 to 50ml of urine) with a mixture of |5-glucuronidase 
and sulphatase for 48 h at 37°C in a shaking bath, after addition of 
0.1 volume of acetate buffer (0.2 M, pH 5.2). The hydrolysed 
urines were extracted with 2 volumes of ether and 2 volumes of 
ethyl acetate; the pooled organic phases were washed with 0.1 
. volume of 0.IN sodium hydroxide and with distilled water, filtered 
through anhydrous sodium sulphate and evaporated to dryness in a 
rotary evaporator: the residues were suitable for derivative
formation.
Steroid extracts corresponding to the sulphate and 
glucuronide - conjugated metabolites were obtained by a two-step 
differential hydrolysis:
The urine was first extracted with 1 volume of methylene chloride
and the organic phase discarded. The aqueous phase was brought to
pH 1 with concentrated sulphuric acid and extracted twice with
o
1 volume of ethyl acetate. The organic phase was kept at 37 
for 24 h, then washed with 2 volumes of IN sodium hydroxide,
0.1 volume 10j£ acetic acid, distilled water and finally evaporated 
to dryness. This afforded tha "sulphate" fraction.
The IN sodium hydroxide washings (above) were quickly 
diluted by 1 volume of water, neutralised and buffered at pH 5.2/
94.
5.2 for enzymic hydrolysis, as previously described. Extraction 
and work-up, carried out in the same manner as for the "total” 
steroids, afforded the "glucuronide" fraction.
5.2.2 PREPARATION OF DERIVATIVES
(a) JD-Alkyloximes of reference compounds
JD-Isopentyloximes (iPO) were prepared by adaptation of the 
method previously described (section 3.2.1) for O-methyloximes.
JD-Benzyloximes (BO)^^j- The steroid (400yU.g) was placed 
in a screw-capped "Reacti-l/ial" and benzylhydroxylamine hydrochloride 
(8mg) added. The mixture was dissolved in pyridine (200^1) and the 
vial placed in an oven at 60-70° overnight. The solvent was 
evaporated with the aid of a stream of nitrogen and the residue 
extracted and worked up in a similar fashion to that previously 
described for 0-methyloximes (section 3.2.1).
(b) Trimethylsilyl (TNS) ethers of reference compounds
Unhindered hydroxyl groups were converted to TMS
167 T
derivatives by the non-catalysed reaction with BSA or BSTFA 
outlined in section 3.2.1.
Hindered hydroxyl groups were silylated with TSIN, 
either by the non-catalysed procedure of Devaux £t al.^^or by 
the catalysed reaction described by Thenot and Horning^^ 
Non-catalysed reaction: The steroid (50(Jug) was placed in a
"Reacti-Vial" and TSIM (250yul) added. The reaction mixture was 
then heated at 150° for 4-J h, and examined directly by GLC.
Catalysed reaction: This was used in cases where reactive
ketone groups had previously been converted to oxime derivatives. 
Here, the steroid oximes were not extracted from the residue 
obtained by evaporation of the solvent (pyridine), but the crude 
oximation product was treated directly with TSIfl (lyul reagent 
per 2j j q  steroid) and the mixture heated at 100° for 2h. The/
95.
The resulting oxime-TMS derivatives were examined directly by 
GLC.
(c) BO-TMS and iPO-TMS derivatives of urinary steroid extracts
These were prepared under the conditions described for 
MO-TMS derivatives by Thenot and Horning"^^
The urine extract (approx. 500^) was placed in a "Reacti-l/ial" 
and the appropriate alkoxyamine hydrochloride (8-10mg) added.
The mixture was taken up in dry pyridine (200^1) and heated at 60° 
for 30 min. The solvent was then removed under a stream of 
nitrogen and the residue treated with TSIM (lO^ul). After a 
period of 2 h at 100°, the reaction mixture was examined directly 
by GLC.
5.2.3 GLC AND GC-MS CONDITIONS
Gas Chromatography. A Carlo Erba Model G\J was used, with U-shaped
12ft (3mm I.D.) glass columns, packed with 1% 0V—1 on silanised'
100-120 mesh Gas Chrom Q. Flame ionisation detectors were used,
with nitrogen (40ml/tbin) as carrier gas. Separations were carried
out with temperature programming from 190° to 275°for iPO-TMS
ethers, and from 190° to 300° for BO-TMS derivatives. £-Alkanes
(C to C ) were used to standardise the retention data for the 
v 24 38
steroids studied. Cholester.yl decylate was added to BO-TMS 
analyses as an internal standard, while cholesteryl butyrate was 
used (to some extent) for corresponding iPO-TMS runs.
Gas Chromatography - Mass Spectrometry. This was carried out using 
an LKB9000 instrument, with the operating conditions previously 
described (section 1.2.1). A 12ft spiral column was employed, 
with a packing identical to that used for GLC (above). Urinary 
steroid samples were injected in silylating reagent (TSIM or 
BSTFA), and the dual valve was kept closed for approximately/
95.
approximately 5 to 10 min following injection. Under these 
conditions, the solvent front was diverted from the mass 
spectrometer, resulting in a considerably reduced level of 
"background" ionisation throughout the run.
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5.3 RESULTS AND DISCUSSION
5.3.1 GAS CHROMATOGRAPHIC CONSIDERATIONS IN URINARY STEROID PROFILE 
ANALYSIS.
Two modes of operation are routinely employed in the
gas chromatography of steroids, namely isothermal analyses and
132)
linear temperature programmed (LTP) separations. Under
isothermal conditions, members of a simple homologous series
e.g. n-alkanes, are eluted with a geometrical progression of
retention times. The retention behaviour of a compound may be
related to that of a series of n-alkanes using the method of 
75 268^
Kovats; 9 under this system, which is based on a logarithmic
scale, compounds are allocated retention index (i) units. In 
temperature programmed separations, the temperature of the GLC 
oven is increased continuously, at a predetermined heating rate, 
throughout the run. However, the carrier gas flow rate (at 
constant inlet pressure) decreases with increasing column 
temperature. Consequently, in temperature programmed analyses, 
continuous changes in two variables, flow rate and temperature, 
take place during the separation. During temperature programming, 
the elution of successive members of a simple homologous series is 
approximately linear with time, and the retention behaviour of 
compounds may again be related to that of a series of n-alkanes.
Isothermal procedures are used when relatively few 
components of a mixture are under study and when the separation 
can be accomplished in a short time. For the examination of 
urinary steroid profiles, temperature programmed separations 
(employing heating rates of 1 to 3°/min) are necessary for the 
simultaneous determination of estrogen, androgen and corticosteroid 
metabolites, which have widely differing retention/
R/
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Fiq.43r Characteristic ions in the spectra of oxime-THS ether derivatives 
of urinary steroids.
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retention characteristics. Caution should be used, however, when
comparing retention indices of reference steroids, determined under
isothermal conditions, with those of components of the urinary
steroid profile, since retention indices frequently exhibit some
degree of temperature dependence. Thus, 1^ values determined
isotnermally commonly differ slightly from the corresponding
retention indices measured under LTP c o n d i t i o n s . I n  a
temperature programmed run, the retention indices of compounds
eluted in the earlier stages are generally lower than the
corresponding isothermal values; I values of compounds eluted in
the later stages, however, agree well with those determined
isothermally. This effect, which has also been observed for
13)steroids chromatographed on capillary GLC solumns, yis evident 
from a comparison of the data presented in Appendix I (reference 
steroids) with those in Tables 19-21 (urinary components). Thus, 
while direct comparison of a retention index determined from an 
LTP separation with standard isothermal values is inadequate 
£er se for structural identification, it is nevertheless very useful 
in narrowing down the range of possible alternatives.
5.3.2 Mass Spectral Fragmentations of iPO-TMS and BO-TMS Derivatives 
of Infant Urinary Steroids,
Steroidal 0_-benzyloximes afford characteristic ions in 
185 186)
their mass spectra. ’ Cleavage of the l\l-0 bond results in
the formation of a prominent ion (M-107)+, paralleling the loss 
of 31 a.m.u. in JD-mothyloxime, and of 37 a.m.u. in 0_-isopentyloxime 
derivatives. In addition, peaks at m/e (M-91) and m/e 91
are observed; the latter fragment, which corresponds to the 
reasonance - stabilised benzyl or tropylium ion (fig.43), often 
affords the base peak of the spectrum. The principal fragmentations/
99.
fragmentations of _0-isopentyloxime derivatives have been outlined 
above (section 4.3.2) and the origin of the ions at m/e (M-30),
(M-44) and (M-45) in their spectra discussed.
In both BO-TMS and i_P0-TMS spectra, prominent fragment 
ions result from the well-established losses of trimethylsilanol; 
elimination of this moiety may take place from the molecular ion 
to give a peak at m/e (M-90), or from suitable fragment ions.
TMS ethers of steroids possessing the 3 -hydroxy- A  grouping, 
which is the predominant structure in steroids of the newborn 
infant, afford a characteristic ion at m/e 12g.52»132»175»178»270»271) 
The genesis of this fragment has been investigated by Diekman and
• 9nfz \
Djerassi ' and its structure is shown in fig.43. The mass spectra 
of BO-TMS and iPO-TMS derivatives may provide information about the 
location of oxime and neighbouring functional groups. Thus, oxime- 
TMS ethers of 16 c*-hydroxy-pregnan-20-ones afford an ion comprising 
the side-chain, together with C-16 and substituent groups"^^
(fig.43) - this occurs at m/e 264 for BO-TMS ethers and at m/e 244 
for i_P0-TMS derivatives. Isomeric 16& 9 17c* and 21-hydroxy-pregnan-
20-ones may therefore be distinguished from one another by 
examination of the mass spectra of their oxime - TMS ethers; the 
derivative of the 20,21-ketol gives rise to characteristic peaks 
at m/e 103 and (M-103) (section 3.3.3), while the 1 7 -hydroxyl 
group of the 20,17-ketol does not form a TMS ether under non- 
catalysed silylation conditions, and may be readily distinguished 
on this basis.
5.3.3 The Urinary Steroid Profile from a Normal Newborn Infant
By employing the differential hydrolysis procedure outlined 
above (section 5.2.1), two urinary steroid fractions are obtained, 
corresponding to metabolites excreted through conjugation with 
sulphuric or glucuronic acid. Following derivatisation, individual 
steroid profiles may be recorded from these "sulphate" and/
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and "glucuronide" fractions. ("Mixed" conjugates, such as estriol
3-sulphate 16-glucuronide, would afford the free steroid in the 
"glucuronide" fraction from the abov/e solvolysis/hydrolysis 
procedure.)
The urinary steroid excretion from a normal newborn infant 
is discussed below for the example of "Baby DE". A 24 h urine collection 
afforded, after cleavage of conjugates, 11.8mg of steroid extract; 
of this total, the sulphate fraction comprised 6.8 mg, while the 
glucuronide fraction accounted for 5.0mg. Samples of each 
fraction (0.5-lmg) were converted to iPO-TMS and BO-TMS derivatives, 
and the gas chromatograms obtained from these derivatised extracts 
are illustrated in figs. 44-47. Approximate retention parameters 
were measured for the major components of the mixture, and combined 
GC-MS yielded mass spectra for each main metabolite. Several GLC 
peaks appeared as a mixture of metabolites. Identity of retention 
parameters and mass spectra allowed tentative identification of 
some of these steroids, but others could only be partially 
characterised. For the positive identification of steroids in 
extracts, it is necessary to compare results from more than one 
type of stationary phase. However, in the exploratory work 
described in this chapter, urinary profiles were recorded only on 
a 1% 0V-1 column.
Sulphate fraction: The iPO-TMS and BO-TMS urinary profiles are
shown in figs.44 and 45, respectively. The pattern of peaks in the
two chromatograms is closely similar, although a more pronounced
separation between hydroxy - and ketosteroids is evident in the
BO-TMS case. The longer analysis time - and, consequently, the
higher final temperature - required in the BO-TMS run is also
apparent in fig.45. The GC-MS data (Table 19) confirms the
a 5preponderance of metabolites with the 3J5 -hydroxy- Zl structure, 
the major component being 16 & -hydroxypregnenolone. The/
iPC-TMS (fig.44) BO-TMS (fig. 45.) Structure Proposed for 
Parent Steroid
Spectrum
No.
I0U-1
m+‘ Spectrum
l\lo. 10\l-1
M+*
2 2835 522 2 2835 522 5-A*-3j3,16* ,17p -triol.
3 2870 504 3 2872 504 Estriol.
5 2955 610 5 2963 610 5-A*-3 p ,15,16,17-tetrol.
- - - 9 3085 566 5 p -P-3* ,20* ,21-triol-ll- 
one.
- - - 9 3085 548 P"-triol.
- - - 9 3085 458 Cholesterol .
7 3023 533 12 3380 553 16* -Hydroxy-DHA .
8 3033 533 13 3410 553 16 p>-Hydroxy-DHA .
9 3078 621 13 3410 641 5-A*-3 p ,11p ,16-triol- 
17-one .
9 3078 550 - - - 5-P«-3j0 ,20* , 21-triol.
10 3113 533 15 3470 553 16-Keto-AD.
12 3153 621 15 3470 641 5-A*-3j3 ,15,16-triol-17-one.
13 3184 649 16 3515 669 5_pt_3 jS,lip> ,17* -triol-20- 
one.
14 3212 621 16 3515 641 5 - A * - 3 ,15, 17-triol-16-one.
14 3212 563 - - - 5*-P-3jS,6* -diol-20-one.
15 3233 561 17 3580 581 16 ck -Hydroxypregnenolone.
- - 17 3580 641 S-A^triol-one.
Table 19: Urinary steroids - Baby DE; Sulphate fraction.
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The co-occurrence of the three isomeric androstenediolones, namely
16& -hydroxy-DHA, 16 j5 -hydroxy-DHA and 16-ketoandrostenediol is
regularly observed in newborn infant urine (section 5.1.1). While
the role of 16o( -hydroxy-DHA in the biosynthesis of estriol is well 
245)
established, an explanation for the presence of 16 jb -hydroxy-DHA 
in quantity in infant urine, and its use by the fetus, is not 
immediately apparent. Furthermore, 16£>-hydroxy-DHA has been shown to 
undergo spontaneous isomerisation under certain conditions to the 
more stable 16-ketoandrostenediol.^^ This might therefore 
indicate that the latter compound is produced from 16|3 -hydroxy-DHA 
during extraction and purification, as an artefact.
Comparison of the GC-MS data for ^iPQ-TMS and BO-TMS 
derivatives in Table 19 demonstrates the complementary nature of these 
two derivatives. The molecular weights of benzyloximes are 20 a.m.u. 
higher than those of the corresponding isopentyloximes, while the 
difference in their retention index values is around 335 units 
(on 0V/—l) • These regularities assist in the identification of
unknown metabolites, particularly where the "unknown" spectrum for 
one type of oxime derivative is complicated by the presence of a 
second "overlapping" compound in the same GLC peak. Such interference 
from accidental coincidences in retention time may often be eliminated 
by recording the corresponding profile for the other oxime derivative . 
Glucuronide fraction: The pattern of compounds excreted as glucuronide
conjugates is quite different from that occurring in the sulphate 
fraction. The major glucuronide components (Table 20) are ring-B 
saturated metabolites of the pregnane series, mainly pregnanetriols 
and dihydroxy - and trihydroxy-pregnan-20-ones. These compounds 
are presumably end-products of the metabolism of placental 
progesterone received before birth. Pregnanediolones and 
pregnanetriolones have been detected previously in various/
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iPO-TFIS (fig.46) BO-TMS (fig.47) Structure Proposed for
Spectrum
Wo. I0U-1
. i *
n Spectrum
No. I0U-1
nt* Parent Steroid
5 2760 464 6 2758 464 5 -P-3c* ,20<* -diol.
- - - 7 2785 522 5-A*-3 p , 11 p> , 17 J3 -triol.
6 2788 552 - - - 5 ft -P-3 ck , 17c* ,20ot-triol.
7 2843 522 - - - 5-A*-3 ft ,16 ok ,17j3 -triol.
9 2875 504 9 2875 504 Estriol.
10 2898 552 10 2900 552 5 ft -P-3c* ,6 c* ,20 ft -triol.
i 12 2987 552 11 2987 552 5 oC-P-3 ft , 16 c* ,20 c* -triol.
; - - 12 3085 550 5-P*-3 ,20c< ,21-triol.
; - - i it 458 Cholesterol.
j; 16 3152 563 16 3477 583 5 £-P-3c* ,16 c* -diol-20- 
one.
1 17 3168 563 17 3495 583 5 ft -P-3 c* ,6—diol—20—one.
ir
! 18 3199 649 18 3515 669 5-P*-3 (3»,11^  ,17^-triol- 
20-one.
i;
S' 18
!•
3199 563 18 3515 583 5 ft -P-3 c* ,6-diol-20-one ,
« 19
1
3252 665 - - -
THE
; 20 3285 563 22 3623 583 5 c* - P-3 ft ,6-diol-20-one.
•j----
21 3318 651 23 3655 671 5 /3-P-3c* , X,16<* (or 17cC ) 
rriol-20-one.
22 3338 651 - - - ii
23 3348 662 - - - P-diol-3,20-dione.
:! ° 
f ■
3513 572 - - - Hydroxynrogesterone,
26 3587 572 - - - ii
<ji
f Table 20: Urinary steroids - Baby DE; Glucuronide fraction.
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224)various biological fluids, e.g. the urine of normal * and
anencephalic2^2^infants, faeces from infants,273^meconium,2^4)
275) 276 279)fetal int estinal contents and pregnancy urine.
An interesting feature in the glucuronide iPO-TMS profile
(fig.46) is the presence of three peaks at the upper end of the
temperature programme(nos. 23,25, and 26), which afforded mass
spectra with even-mass molecular ions (n+*at 662, 572, and 572,
respectively). These molecular weights correspond to the di-i^ PO
diTMS ether, of a pregnanedioldione (niii=662) and to the di-iPO
TMS ether of a monohydroxy-pregnenedione (MW=572). Peaks
corresponding to these compounds do not appear in the BO-TMS
profile (fig.47) since steroidal di-benzyloximes are not detected
owing to their high retention indices (>3800). A possible structure
for the derivatives with nU/572 would be a hydroxyprogesterone
di-iPO TMS ether, since fetal tissues (particularly the adrenals)
are known to hydroxylate progesterone at various sites, e.g.
ctt280) . 281) . 280,282,283) , .. ... , . ...6 6 , 16c* and 17ck , and the resulting metabolites
may undergo urinary excretion during the first few days of life. 
a4Furthermore, A  -3-ketosteroid oximes afford two GLC peaks, corresponding 
to syn/anti isomers, and it appeared feasible that the two urinary 
components with Mlii 572 might represent isomers of this type, their 
mass spectra being very similar. However, the spectra of the 
"unknowns" differed from those of reference 16c* -, 1 7 -and 18- 
hydroxyprogesterone di-iPO TMS ethers. A further possibility for the 
M+*572 peaks was the di-iPO TMS ether of 16-ketopregnenolone, a 
derivative which also shows evidence of syn/anti isomers on GLC; 
this structure was also eliminated on the basis of its mass spectrum. 
Hence, these "unknown" diketonic steroids still await identification.
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Spectrum
No. 1 G \1 -1
r+* Proposed Structure
20 2706 522 5-A!-triol triTRS
21 2730 550 5-P*-triol triTRS
21 2730 464 5 /3 -P-3oC , 2 0 -diol diTRS
23 2803 552 5/3 -P-3 t* ,17* ,2G<*-triol triTRS
24 2843 522 5-A*-3 £ ,160c ,17/5 -triol triTRS
24 2843 566 11-Keto-P-triol triTRS
24 2843 478 5 /I-P-3 cC , 20/3-diol-ll-one diTRS
25 2877 552 P-3,X,20-triol triTRS
26 2904 552 5 p - P - 3 d  ,11/3 ,20/5 -triol triTRS
26 2904 480 5/3-P-3oC ,11 j3 ,20/3 -triol 3,20-di TRS *
28 2968 566 P-3,17<*,20-triol-ll-one triTRS
28 2968 494 P-3,17oC,20-triol-ll-one diTRS *
28 2968 552 5/3 -P-3*,11/3 ,20* -triol triTRS
29 3005 494 5oC-P-3, 17* ,20-triol-11-one 3,20-diTRS *
30 3042 550 5-P<-3/3 ,11/3 ,20/5 -triol triTRS
30 3042 478 5-P l-313 ,11^ ,20(3 -triol 3,20-diTRS *
31 3070 550 5-P *-3/3 ,20,21-triol triTRS
31 3070 478 5-P*-3,11(3 ,20* -triol triTRS
32 3088 458 Cholesterol TRS
33 3130 568 5* -P-3/5 ,15 (orl6), 17* ,20-tetrol 3,15 (or 16), 
20-triTRS*
36 3268 581 5-Pt-diol-one BO-diTRS
37 3290 481 11-Ketoetiocholanolone B0-TRS
40 3343 671 P-triol-one BO-triTRS
40 3343 583 5 |3 -P-3 & ,X-diol-20-one BO-diTRS
* *
41 3375 671 P-triol-ons BO-triTRS
43 3442 671 11 ti
43 3442 597 5/3-P-3/3 ,X-diol-11,20-dione BO-diTRS
44 3476 671 P-3,X,21-triol-20-one BO-triTRS
46 3520 671 P-3,\16^(or 17ck )-triol-20-one BO-triTRS
47 3530 671 11 11 11
47 3530 685 THE BO-triTRS
48 3756 581 16cC-Hydroxypregnenolone BO-diTRS
49 3620 581 21-Hydroxypregnenolone BO-diTRS
50 3640 671 P-3, X, 16c/. (or 17cl )-triol-20-one BO-tri TRS
Table 21: Urinary steroids - Baby LO; "Total" steroids as BO-TRS derivatives
(cf. fig.48).
* These compounds resulted from incomplete silylation of the sample*
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5.3.4 The Urinary Steroid Profile from an Infant with a 
21-Hydroxylase Deficiency.
The urinary steroid profile (BO-TMS) of a "total"
steroid extract from an infant ("Baby L0") with a defect in
21-hydroxylase is illustrated in fig.48. GC-MS data (Table 21)
a 5indicate, somewhat surprisingly, that 3 j3-hydroxy-A steroids 
are relatively unimportant in this profile, whilB the principal 
components are ring-B saturated pregnane derivatives, e.g. 
pregnanetriols, pregnanediolones and pregnanetriolones.
Comparison of the data in Tables 20 and 21, however, indicate that 
these ring B - reduced metabolites in the pathological profile ace 
different from those encountered in the glucuronide fraction 
from the normal newborn infant. Numerous 11 £> -hydroxy - and 11- 
ketosteroids are also evident in the pathological sample; this 
feature is commonly observed in cases of 21-hydroxylase deficiency, 
when- the effect of the 11 £> -hydroxylating enzyme is greatly 
enhanced. Pregnanetriol, a characteristic urinary steroid in older 
infants with this disorder, is present as a minor peak in the 
profile. 16 0^-Hydroxypregnenolone is the only prominent 3^ - 
hydroxy- A^steroid, although small amounts of androstenetriols and 
pregnenetriols are present.
Despite the deficiency of 21-hydroxylase, however, the 
GC-MS data indicate the presence of four steroids bearing a 
hydroxyl group at C-21 viz.5-preqnene-3^3 ,20<X ,21-triol, a pregnane- 
3, X, 21-triol-20-one, tetrahydrocortisone and 21-hydroxypregnenolone. 
This latter compound was also identified as a urinary steroid from 
an infant with a 21-hydroxylase defect by Mitchell et_ al.
Hence,the occurrence of 21-hydroxylated metabolites in the urine 
cannot, in itself, be taken as evidence that there is no inborn 
error in 21-‘hydroxylase.
104.
5.3.5 CONCLUSIONS
Both jLPO-TMS and BO-TMS ethers are useful derivatives 
for the study of urinary steroid profiles. iPO-TMS ethers do not 
afford the complete group separation of hydroxy - from ketosteroids 
obtained with the benzyloximes. However, di-isopentyloxime 
derivatives may be eluted under normal operating conditions, whereas 
the BO of steroidal diketones have retention times too long to 
permit their study by gas-phase methods. The two types of 
oximes give rise to individual fragmentation patterns, while 
structurally informative mass spectra with clear molecular ions, are 
usually obtained. The combined application of iPO-TMS and BO-TMS 
derivatives to the study of urinary steroid profiles thus provides 
useful complementary data which facilitates the identification 
of metabolites of unknown structure.
APPENDIX I
GAS CHROMATOGRAPHIC DATA
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MU
434
522
522
522
522
445
533
533
533
533
621
462
550
550
550
550
473
561
561
561
649
737
737
484
572
572
572
RETENTION INDICES ON 1% OV-1 (250°) AND 1% DEXSIL-300GC (275°) 
FOR TMS AND iPO-TMS DERIVATIVES OF REFERENCE STEROIDS
Parent Steroid
TMS or 
OV-1
iPO-TMS
Dexsil
5-A 
5-A 
5-A 
5-A 
5-A 
5-A 
5-A 
5-A 
5-A 
5-A 
5-A
5-P
5-P
5-P
5-P
5-P
5-P
5-P
5-P
5-P
5-P
5-P
5-P
4-P
4-P
4-P
-3 (3 ,17(3 -diol 
-3(3 ,11(3 ,17(3 -triol 
-3 fi ,16d ,17c* -triol 
-3 (3 ,16c* ,17(3 -triol 
-3 |3 ,16 (3 ,17(3 -triol 
-3 (3 -ol-17-one (DHA)
-3 |3,11 (3 - diol-17-one (11 £>-0H-DHA)
-3/3 ,16<*-diol-17-one (16c*-OH-DHA)
-3 , 16 (3 - diol-17-one (16 -OH-DHA)
-3^ 8 , 1713-diol-16-one 
-3/3 ,11|3 ,16c*-triol-17-one
-3/3 ,20/3 -diol
-3 ,16cjE ,20c*-triol
-3 j3 ,17c* ,20c* -triol
-3 (3 ,17 c* ,20 (3-triol
-3 (3 ,20 c* , 21-triol
-3 (3-ol-20-one (Pregnenolone)
-3(3 ,16c*-diol-20-one (l6c*-0H- 
Pregnenolone)
-3 (3 ,17 c* -diol-20-one (17c*-0H- 
Pregnenolone)
-3 p ,21-diol-20-one (21-OH-Pregnenolone)
-3 ^ ,17c* ,21-triol-20-one
-3 (?> ,11 (3 ,17cE ,21-tetrol-20-one
-3 ,16^. ,17 c* ,21-tetrol-20-one
-3,20-dione (Progesterone)
-16c* -ol-3,20-dione (16&-0H- 
Progesterone)
-17c*-ol-3, 20-dione (I7c*-0H- 
Progesterone)
4-P*-18-ol-3,20-dione (18-OH-Progesterone)
2633
2770
2847
2868
2877
2948
3100
3070
3104
3125
3187
2830
3008
2989
2941
3044
3132
3253
3200
3303
3307
3452
3480
3502/
3530
3600/
3626
3543/
3587
3606/
3640
NW
572
471
447
447
447
535
535
461
461
464
552
552
552
728
728
475
563
563
563
563
563
563
563
651
651
651
651
739
739
654
Parent Steroid
TFIS or 
DV-1
ipo-ins
Dexsil
5-P!-3 (i-ol-16, 20-dione (16 Keto- 
pregnenolone) 3560/ 3627/
3600 3665
5,16-PM-3 |3-ol-20-one 3093 -
5 d-A-3d-ol-17-one (Androsterone) 2861 2958
5d-A-3 (3-ol-17-one (Epiandrosterone) 2938 3054
5 p -A-3d-ol-17-one (Etiocholanolone) 2863 2977
5d-A-3 d ,11|3 -diol-17-one (ll|3-0H- 
Androsterone) 3000 3356
5 |?>-A-3d , llj?> -diol-17-one (ll^-OH- 
Etiocholanolone) 3000 3367
5d -A-3d-ol-ll,17-dione (ll-Ketoandrosterone) 2958 3110
5 & -A-3d-ol-ll, 17-dione (ll-Ketoetiochola- 
1 nolone; 2958 2948
5 -P-3d ,20d-diol (Pregnanediol) 2796 3050
5^-P-3d,6d, 20j&- triol 2887 2892
5|?>-P-3d , 17d,20&-triol (Pregnanetriol) 2824 2851
5f> -P-3 |i ,20(3> ,21-triol 3034 3060
-P-3d ,lip ,17d ,20d ,21-pentol (Cortol) 3144 3063
5 (2>-P-3d ,11(3 ,17d ,2010> ,21-pentol (jS -Cortol) 3100 3010
5 ($-P-3 d-ol-20-one (Pregnanolone) 3059 3167
5 (3 -P-3d ,6d-diol-20-one 3187 3196
5d -P-3 (J ,lip*d.iol-20-one 3304 3378
5d-P-3 , 16d-diol-20-one 3320 3295
5(3 -P-3(3 ,16d-diol-20-one 3202 3177
5d -P-3 p ,17d -diol-20-one 3217 3244
5j?> -P-3d ,17d-diol-20-one 3050 3018
5 (3 -P-3d,21-diol-20-one (TH-DOC) 3172 3192
5d -P-3 d , 1113 ,21-triol-20-one (allo-THB) 3284 3242
5d-P-3 (3 ,11(3 ,21-triol-20-one 3546 3428
5jS -P-3d ,11 ft ,21-triol-20-one (THB) 3264 3273
5jS-P-3d ,l7dv ,21-triol-20-one (THS) 3146 3096
5d -P-3 d , 11/3 ,17 d , 21-tetrol-20-one 
(allo-THF) 3292 3194
5£ -P-3 d  ,1113 ,17d ,21-tetrol-20-one (THF) 3270 3188
5^-P-3d,17<d ,20d , 21-tetrol-ll-one (Cortolone) 3083 3060
108.
Parent Steroid TMS or 
OV-1
iPO-TMS
Dexsil
MW
5(3 -P-3cA ,17d ,20 p> ,21-tetrol-ll-one 
( ji-Cortolone) 3104 3104 654
5ci-P-3o( ,21-diol-ll,20-dione (allo-THA) 3305 3377 577
5 -P-3 c^,21-diol-ll, 20-dione (THA) 3283 3340 577
5^-P-17d ,21-diol-3,20-dione (DHS) 3502/
3535
3494/
3538
662
5c£ -P-3(i , 17 oC , 21-triol-11,20-dione 
(allo-THE) 3234 3237 665
5 p -P-3c/. ,17c/ ,21-triol-ll, 20-dione (THE) 3234 3236 665
Cholesterol 3100 3218 458
1,3,5(lO)-Estratriene-3, 16c£ ,175 -triol 
(Estriol) 2904 2943 504
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MASS SPECTRA
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APPENDIX III
• THE CRYSTAL STRUCTURE OF CYCLIC BORONATE ESTERS 
FROM PREGNANE-17CX ,20,21-TRIQLS.
115.
INTRODUCTION
Cyclic bcronate esters are useful derivatives for the
gas-phase characterisation of compounds with various suitably
147)orientated bifunctional groupings. The derivatives may be
simply and rapidly prepared, in essentially quantitative fashion, 
while hydrolysis of the resulting boronate - and regeneration of 
the parent compound - may often be achieved by the addition of 
several equivalents of propane-1, 3-diol.^^
Corticosteroids (with the exception of 20, 17-ketols)
94 95)may be stabilised for gas chromatography as their boronate esters. ’
These derivatives possess good GLC properties, and provide informative
mass spectra which usually exhibit molecular ions in moderate
abundance. The degree of stability of corticosteroid boronates
towards hydrolysis depends primarily on the nature of the steroid
95)
side-chain involved. Thus, while boronates of the dihydroxyacetone
type of side-chain may be hydrolysed relatively easily, those of
corticosteroid 17(X ,20,21-triols are much more resistant to hydrolysis,
and are amenable to study by TLC and to further derivatisation
reactions. The structure of these triol boronates may be formulated
as either a five-membered (l7cX ,20- or 20,21-boronate) or six-
membered (17(X, 21-boronate) cyclic ester, since examples of each
type are encountered in boronates of sugar 1,2,3-triols.^^’^ ^
Evidence which favours a six-membered structure was obtained by 
147)
Anthony et al., who acetylated the jn-butylboronate of 17cX ,20j3 , 
21-trihydroxy-4-pregnen-3-one, and then selectively hydrolysed the 
boronate moiety. The resulting triolone monoacetate differed in 
its chromatographic behaviour from the 21-acetate, prepared by 
direct acetylation, and was tentatively regarded as being the 20- 
monoacetate derivative. Further evidence for a 17 <X ,21-boronate/
116.
95)boronate structure was provided by Brooks and Harvey who 
demonstrated that the tert.-butylboronates of both 17ck,20 &,21- 
and 17ck , 20 , 21-trihydroxy-4-pregnen-3-one were oxidised with
dimethyl sulphoxide - acetic anhydride to the corresponding ester 
of 17ck,21-dihydroxy-4-pregnene-3,20-dione. However, attempts 
to effect the reverse reaction, by reduction of the steroidal 
dihydroxyacetone boronate with sodium borohydride, were unsuccessful, 
due to hydrolysis of the boronate ester. Certain of the mass 
spectrometric data for triol boronates appear to indicate a five- 
membered ester (section 3.3.3), although the possibility that this 
arises during fragmentation must be borne in mind.
In view of the difficulties involved in the study of this 
problem by chemical and chromatographic methods (notably the ease of 
hydrolysis of derivatives and of functional group migrations) it 
was decided to investigate the crystal structure of 17 ok ,20,21-triol 
boronates by X-ray anaylsis. Introduction of a "heavy atom" was 
accomplished by the use of £-bromophenylboronic acid, and the 
crystalline derivatives were prepared as outlined below.
Preparation of £-Bromophenylboronate Esters
17c*. ,20c*. ,21-Trihydroxy-4-pregnen-3-one (50.2mg; 144yimole) 
was treated with £-bromophenylboronic acid (28.9 mg; 144yu.mole) and the 
mixture dissolved in AnalaR ethyl acetate (10ml). The reaction was 
allowed to proceed at room temperature overnight (l6h), and the 
product examined by analytical TLC (mobile phase: ethyl acetate/ 
chloroform (1:1 v/v) ). This indicated that the triolone (R^ . 0.07) 
had been completely converted to the £-bromophenylboronate ester 
(R^ 0.60). The solution was then taken to dryness under nitrogen, 
affording a pale yellow oil. Vacuum sublimation was carried out 
at 255°/0.02mm Hg, using a "cold finger" apparatus, and yielded the 
£-bromophenylboronate as a colourless glass (m.p. 126-130°)
Elemental analysis (Dr. A. Bernhardt, Mikroanalytisches Laboratorium, 
Elbach, West Germany) gave:- C: 63.00; H: 6.52; Br: 15.79^.
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(Calc, for C _H O.BBr: C: 63.19; H:6.68; Br: 15.57#.) A
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portion of this material was crystallised from ethyl acetate, 
by allowing the solution to evaporate slowly to a small volume 
over a period of several days. The colourless prisms so obtained 
had m.p. 204-212°.
1 7 , 2 0  |3 ,21-Trihydroxy-4-pregnen-3-one (52.4mg); 150yomole) 
was similarly treated with £-bromophenylboronic acid (30.2mg; 150yUmole). 
Analysis of the reaction product by analytical TLC (solvent system 
as above) again showed quantitative conversion of the triolone 
(R^ ,0.09) to its boronate ester (R^0.60). Vacuum sublimation 
(249°/o.02mm Hg) afforded the £-bromophenylboronate as a amorphous 
solid, which crystallised slowly from ethyl acetate as colourless 
prisms, m.p. 245-249°. (Found, C: 63.23; H: 6.56; Br: 15.
Calc, for C27H34°4BBr: C: 63*19> H: 6*68» Br; 15.57#.)
RESULTS
Only the crystals obtained from 17o\ ,20^ ,21-trihydroxy- 
4-pregnen-3-one were suitable for X-ray analysis purposes. The 
crystals of-this compound mere very small, however, and the limited 
data which were collected led to high standard deviations for 
the parameters involved. Dr. P.D. Cradwick was responsible for 
solving the structure by Patterson techniques and by applying 
tangent formula calculations to the phases of partial structure 
factors. Dr. P.D. Cox completed the refinement of the atom paramete 
Crystal data
Molecular formula 
Molecular weight 
Crystal, system 
Space group 
Cell dimensions
Cell volume (u)
Density (obs.)
Density (Calc.)
Molecules per unit cell (z)
No. electrons per unit cell (F(qqq)
Linear absorption coefficient,
yU(MoKcO
C2VH34°4BrB 
513.3 a.m.u.
orthorhombic
P2 2 2 
1 1 1
a= 16.847(28)A
b= 13.294(18) A
c= 11.082(10)A
2482.0 A3
1.42 g.cm 
1.37 g.cm 
4
1072'
-3
-3
17.90 cm
0.136
-1
The boronate ester ring was found to be six-membered, 
incorporating the oxygen functions at C-17& and C-21, while the 2013- 
hydroxyl group remained free. The structure and stereochemistry of 
the molecule are shown in figs. 49 and 50, respectively; some/
some relevant bond lengths and angles are cited in Tables 22 and 23 . Mean
plane calculations on the boronate moiety indicated that C(17), C(2l), □(2)
0(3) and the boron atom were all coplanar, while C(20) lay 0.69A out
of the plane; this corresponds to a "flattened" boat conformation
of the boronate ester. The unusually high stability of pregnane-17(X ,
20, 21-triol boronate derivatives towards hydrolysis might be taken
to indicate some degree of interaction between the unfilled p-orbital
of the boron and a lone pair on the oxygen attached to C(20) (o(4) in
fig.50). However, the distance between these two atoms was found to 
o
be 3.05A, which is very close to the Van der LJaals contact distance 
of 3.07$. Consequently an interaction of the above type cannot be 
inferred on the basis of the X-ray data.
49; The structure of the £-bromophenylboronate ester
obtained from 17 a ,20 p ,21-trihydroxy-4-pregnen-3-one.
C(21)
Fig. 50: A general view of the compound in fig.49, indicating
three-dimensional structure.
Table 22 Intramolecular bonded distances and estimated standard
. . . .  ‘ 287)deviations.
C(17) - 0(2) 1.46 (5)
0(2) B 1.38 (6)
B - 0(3) 1.42 (6)
0(3) - 0(21) 1.59 (5)
C(17) C(20) 1.57 (6)
C(20) - 0(21) 1.45 (6)
C(20) - 0(4) 1.47 (6)
Table 23 Valency angles (degrees) and estimated standard
. ... 287)deviations.
C(17) - 0(2) - B 121 (3)
0(2)' B 0(3) 121 (2)
B^  - 0(3) - C(21) 121 (3)
0(2) - 0(17)- C(20) 109 (3)
C(17) - C(20)- C(21) 114 (3)
C(20) - C(2l)-0(3) 102 (2)
C(17) - C(20)-0(4) 109 (3)
C(21) - C(20)-0(4) 113 (3)
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